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The Sec pathwayprovides amechanism for the translocation of proteins across or into the
cytoplasmicmembrane. In bacteria, SecA is a core component of the Secmachinery. YecA
has a 20-amino acid sequence at its carboxy-terminus that has high sequence identity to
the zinc-binding domain at the carboxy-terminus of SecA. This study provides evidence
to show that YecA is a novel component of the Sec machinery of E. coli. The yecA gene
is not essential for the viability of E. coli but the deletion of yecA interferes with Sec-
dependent translocation and the combined deletion of the yecA and secB genes results
in a severely cold-sensitive phenotype. The genetic investigations were supported by bio-
chemical evidence that suggests that YecA improves the translocation-coupled ATPase
activity of SecA. Structural investigations suggest that YecA is a monomer in solution.
The α-helical domain that forms the main body of YecA is connected via a short linker
with limited flexibility to an independent metal-binding domain that has two conforma-
tions. The purification of YecA suggested the presence of iron. Biophysical experiments
were used to confirm the interaction of the YecA metal-binding domain with iron. This
study provides evidence for an additional component of the translocation machinery.
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1.1 Prokaryotic cell structure
Prokaryotic cells do not have membrane-bound organelles. For example, instead of a nu-
cleus, prokaryotes have a nucleoid region that contains a circular, double-stranded DNA
chromosome. Most cellular processes occur in the cytoplasm. The cytoplasm is bounded
by a phospholipid bilayer, which is called the cytoplasmicmembrane. Bacteria are divided
into Gram-positive and Gram-negative bacteria. Gram-positive bacteria have a thick cell
wall of between 20-30 nm of multilayered peptidoglycan. Gram-negative bacteria have a
thinner cell wall than Gram-positive bacteria and a single layer of peptidoglycan. Gram-
negative bacteria have a periplasmic space that surrounds the cytoplasmic membrane,
which is bounded by an outer membrane.
1.2 Gram-negative secretion pathways
Bacteria have evolved several export mechanisms for cell envelope and membrane
biogenesis (Figure 1.1). Proteins must be correctly localised to enable cells to function
correctly. Approximately a third of proteins do not function within the cytoplasm,
where they are synthesised (Driessen andNouwen, 2008). These proteins can be inserted
into membranes, secreted into the periplasm, secreted to the extracellular milieu or
injected into other cells. Gram-negative bacteria often use dedicated secretion systems to
export virulence proteins or even transport virulence factors directly into the cytoplasm
of a target cell. In Gram-negative species, secreted proteins must cross one, two or
even three phospholipid membranes before reaching the intended location (Green and
Mecsas, 2016).
Specialised protein secretion systems have evolved to transport protein cargo between
locations (Green and Mecsas, 2016). Newly synthesised proteins can be inserted into
the inner membrane or proteins destined for the periplasm and outer membrane can
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be exported through the inner membrane and subsequently inserted into the outer
membrane. Some proteins are targeted to the cell surface while others are secreted into
the extracellular milieu. The successful secretion of proteins is often required for biofilm
formation and other functions such as pathogenicity and nutrient acquisition (Dalbey
and Kuhn, 2012). Proteins can be exported directly out of the cell from the cytoplasm by
a one-step process or exported by two-step process that involves the export of the protein
to the periplasm before its export across the outer membrane. The Sec pathway, which
is found in all domains of life, is responsible for the export of the majority of proteins
across the inner membrane of bacteria (Pohlschroder et al., 2005; Figure 1.2)
1.2.1 Insertion of proteins into the inner membrane
Substrate proteins of the Sec pathway are translocated through a narrow protein
channel, SecYEG, in the cytoplasmic membrane (Osborne et al., 2004). SecYEG, by
convention, is known as the Sec translocon. Only unfolded substrate proteins can be
translocated through the Sec translocon. YidC, alone or in conjunction with the Sec
pathway, facilitates the insertion of some inner membrane proteins (Tsirigotaki et al.,
2017). The Sec pathway catalyses the translocation of hydrophilic regions of polypeptide
across the membrane and inserts hydrophobic segments into the inner membrane. A
subset of proteins is inserted into the inner membrane by YidC (Akopian et al., 2013).
Signal peptidase (Lep) and lactose permease are examples of inner membrane proteins.
Lep has two transmembrane segments and a large periplasmic domain at the carboxy-
terminus (Dalbey and Kuhn, 2012). Lep is targeted to the inner membrane by the signal
recognition particle (SRP) and also requires ATP hydrolysis by SecA, which is unusual
(Gierasch, 1989; Dalbey and Kuhn, 2012). Lac permease does not require SecA for
insertion into the inner membrane (Dalbey and Kuhn, 2012).
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Figure 1.1: Secretion across the bacterial membranes and host membrane
In bacteria, the Sec pathway (blue) mediates the export of most exported proteins. YidC,
alone or in complex with SecYEG, facilitates the insertion of inner membrane proteins.
The twin-arginine translocation (Tat, dark green) pathway exports aminority of proteins
that fold and/or associate with cytoplasmic cofactors in the cytoplasm before crossing the
inner membrane. Gram-negative bacteria have specialised export systems. Proteins that
function in pathogenesis or nutrient scavenging are transported by the type 1 secretion
system (T1SS, yellow). Flagellumproteins are transported by the flagellar type 3 secretion
system (T3SS, light blue) and toxins are exported by the pathogenic T3SS. Proteins (e.g.
virulence factors) and nucleic acids (e.g. for genetic exchange) are injected into other cells
through the type 4 secretion system (T4SS, lilac). Pathogenic effectors are injected into a
eukaryotic or bacterial target cell through the type 6 secretion system (T6SS, not drawn).
Gram-positive bacteria have three specialised secretion systems. Virulence proteins cross
the cytoplasmic membrane through the type 7 secretion system (T7SS, not drawn). Spe-
cialised proteins called sortases recognise, cleave and attach proteins that have a carboxy-
terminal sorting signal to the membrane. The assembly of pilus structures is dependent
on sortases. Virulence factors or genes are injected into other cells by the injectisome (or-
ange). Figure adapted from Green andMecsas (2016).
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Portions of Lep can be inserted into the inner membrane when the Sec pathway is dis-
rupted. Cross-linking studies show that both hydrophobic segments of Lep can be cross-
linked toYidC, indicating that Lep inserts into themembrane at a site containing SecYEG
and YidC (Samuelson et al., 2000). YidC can also function independently to insert pro-
teins into the inner membrane (Samuelson et al., 2000). This YidC-only pathway is evo-
lutionarily conserved and is also found inmitochondria and chloroplasts but the number
of YidC-only substrates is unknown (Dalbey and Kuhn, 2012).
1.2.2 Secretion of proteins into the periplasmic space
Secretion of proteins across the inner membrane into the periplasmic space is dependent
on either the Sec or the twin arginine translocation (Tat) pathway. The Sec pathway
translocates unfolded proteins through the SecYEG channel in the inner membrane
(Driessen and Nouwen, 2008). In contrast to the Sec pathway, the Tat pathway
primarily secretes folded proteins (Berks et al., 2005; Figure 1.1), which allows the export
of proteins with post-translational modifications, such as redox factors, that form in the
cytoplasm (Berks et al., 2005).
In E. coli, the TatABC machinery transports folded Tat substrates. It is thought that
TatBC is involved in the recognition of the Tat signal peptide while TatA, which forms
channel complexes that have variable diameters, can mediate the translocation event
(Berks et al., 2005;Dalbey andKuhn, 2012). Onemodel suggests that the signal sequence
binds to the TatBC complex before associating with TatA homooligomer. The substrate
is then transported through the pore in the inner membrane that is formed by the TatA
homooligomer (Dalbey and Kuhn, 2012).
1.2.3 Secretion of proteins from the periplasm to the outer membrane
There are twopathways bywhich proteins are sorted and targeted to the outermembrane











Figure 1.2: The secretion of proteins after translocation by the Sec pathway
The Sec pathway is the primary secretion step for many proteins. Secreted proteins are
either inserted into the inner membrane or exported to the periplasm by the Sec machin-
ery, or in some cases by the Tat pathway. After secretion to the periplasm, outer mem-
brane proteins and pili are assembled. In addition, many secreted proteins that have been
exported to the periplasm by the Sec machinery are subsequently secreted to the extracel-
lular milieu. Figure adapted fromDalbey and Kuhn (2012).
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the β-barrel assembly (Bam) pathway, is responsible for the export of β-barrel proteins.
The Lol pathway is essential for the transport of lipoproteins from the inner to the
outer membrane. In E. coli, there are five proteins, LolABCDE, that are all essential
for viability. Lipoprotein is inserted into the inner membrane by the Sec pathway and
modified by diacylglyceride before the cleavage of signal sequence by signal peptidase.
ATP hydrolysis by LolCDE releases the lipoprotein from the outer face of the inner
membrane. Subsequently, the chaperone, LolA, transports the lipoprotein from the
inner to outer membrane. The lipoprotein is transferred from LolA to LolB, the outer
membrane receptor, and is then inserted into the outer membrane.
The Bammachinery, which is comprised of BamA and four lipoproteins (BamBCDE) in
E. coli, can catalyse the outer membrane integration of β-barrel proteins. Outer mem-
brane proteins require periplasmic chaperones to direct them to the outer membrane
(Dalbey and Kuhn, 2012; Hussain and Bernstein, 2018). The periplasmic chaperones
SurA, Skp, and DegP have all been implicated in the transport of outer membrane pro-
teins to the outer membrane. The structure of the Bam complex has been solved using
both X-ray crystallography and cryo-electronmicroscopy but themechanism bywhich it
integrates β-barrel proteins into the outer membrane remains poorly understood (Bake-
lar et al., 2016; Gu et al., 2016; Iadanza et al., 2016; Hussain and Bernstein, 2018). It has
been proposed that the rotation of the ring-like structure formed by the periplasmic ele-
ments of the Bam complex leads to the opening of an unstable join between the first and
last β-strands of the BamA β-barrel, which allows the stepwise insertion of outer mem-
brane proteins into the lipid bilayer (Bakelar et al., 2016; Gu et al., 2016; Iadanza et al.,
2016; Hussain and Bernstein, 2018).
8
1.2.4 Secretion out of the cell
In Gram-negative bacteria, secretion out of the cell can occur via two one-step or
two-step secretion. One-step secretion involves export from the cytoplasm into the
extracellular milieu or into another cell using a continuous channel that spans the inner
membrane, the periplasm, and the outer membrane. Two-step secretion substrates are
exported to the periplasm before transportation across the outer membrane. The Sec
pathway, or in some instances the Tat pathway, exports two-step secretion proteins to the
periplasm (Figures 1.1 and 1.2). The periplasmic intermediate is then exported across the
outer membrane in the second step. The two-step systems secrete extracellular proteins
that are often involved in pathogenesis (Dalbey and Kuhn, 2012).
Type 1 secretion systems (T1SSs) are one-step secretion systems, which means that
substrates are exported across the inner and outer bacterial membranes together (Figure
1.1). T1SSs are comprised of an ABC transporter, a membrane fusion protein and an
outer membrane factor. The ABC transporter protein is located in the inner membrane
and catalyses the hydrolysis of ATP. The membrane fusion protein crosses the inner
membrane and joins the ABC transporter protein to the outer membrane factor of the
T1SS. The outer membrane factor forms a pore in the outer membrane. The recognition
of substrate proteins by the ABC transporter protein results in the recruitment of the
outer membrane factor to the membrane fusion protein, which forms of a channel that
spans both the inner and outer membranes (Thomas et al., 2014). Some bacteria have
several T1SSs, with each one dedicated to transporting one or a few unfolded substrates
(Thomas et al., 2014). T1SSs are generally Sec-independent and proteins that are secreted
by this system typically have a signal sequence at the carboxy-terminus that is not cleaved
after export.
Type 3 secretions systems (T3SSs) secrete a wide variety of proteinaceous substrates
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across both the inner and outer bacterial membranes (Büttner, 2012). Substrates of
T3SSs are transported via an “injectisome” from the cytoplasm of the bacterial cell
directly to the cytoplasm of a eukaryotic host cell (Figure 1.1). The injectisome is
composed of an extracellular needle that is attached to a basal body, which spans the in-
nermembrane, periplasm, and outermembrane of the bacterial cell (Abrusci et al., 2014).
Type 4 secretion systems (T4SSs) secrete substrates into other cells (Figure 1.1). These
macromolecular complexes are largely found in Gram-negative bacteria, where they
transport protein and DNA across both the inner and outer membranes for insertion
into other bacteria or eukaryotic cells (Green andMecsas, 2016).
Type 2 secretion systems (T2SSs), or the “general secretion pathway”, is a two-step
secretion pathway (Green and Mecsas, 2016). The first step in this pathway involves
the Sec pathway, or in some cases the Tat pathway, to translocate proteins from the
cytoplasm to the periplasm (Figures 1.1 and 1.2). The substrates of T2SSs are folded in
the periplasm prior to secretion. It is not known how the substrates are recognised in the
periplasm but it is unlikely that a linear secretion signal is responsible. The T2SS system
has an ATPase, a signal peptidase, and a secretin. ATP hydrolysis provides the energy for
export of T2SS substrates across the inner membrane. The formation of a pseudopilus,
also stimulated by ATP hydrolysis, in the periplasmic space is thought to push substrates
through the outer membrane pore, which is formed by a dodecamer of secretin (Dalbey
and Kuhn, 2012).
Type 5 secretion systems (T5SSs) substrates are often called autotransporters because they
secrete themselves across the outer membrane (Figure 1.1). Autotransporter proteins are
synthesised with an amino-terminal passenger domain, which is secreted across the outer
membrane, and a carboxy-terminal domain. After export to the periplasm via the Sec
pathway, the carboxy-terminus forms a β-barrel in the outermembrane and the passenger
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domain is exposed on the cell surface (Dalbey and Kuhn, 2012; Green andMecsas, 2016;
Leyton et al., 2012).
1.3 The bacterial Sec pathway
The Sec machinery is responsible for the export of unfolded proteins to the periplasm.
Most outer membrane lipoproteins, outer membrane β-barrel proteins and surface pili
are first translocated across the inner membrane by the Sec system (Dalbey and Kuhn,
2012). All substrate proteins of the Sec pathway are called secretory proteins. Secretory
proteins are often synthesised as preproteins, which are also called precursor proteins,
that have a mature portion and an amino-terminal signal sequence (Tsirigotaki et al.,
2017). The signal sequence is recognised by ribosome-bound components of the Sec
machinery as it emerges from the exit channel of the ribosome. The signal sequence is
cleaved after translocation and the mature secretory protein folds into its native state.
Most secretory proteins of the Sec pathway are translocated after they have been either
fully or mostly synthesised (Randall, 1983; Figure 1.3). This is called posttranslational
translocation. The remaining subset of proteins are translocated concurrently with pro-
tein synthesis, which is called cotranslational translocation. The translocation of secre-
tory proteins by the cotranslational pathway circumvents one of the major problems for
the Sec machinery, which is the maintenance of secretory proteins in a translocation-
competent state. The SecYEG pore allows the translocation of unfolded proteins only.
Export by the posttranslational translocation pathway is still possible because of several
factors that maintain synthesised secretory proteins in a translocation-competent state.
Firstly, it is thought that the presence of the amino-terminal signal sequence destabilises
the folded protein (Beena et al., 2004), while the reducing environment of the cytoplasm
prevents the formation of certain structural features, like disulphide bonds, which form
readily in the oxidising environment of the periplasm (Denoncin and Collet, 2013). In
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addition, the presence of ribosome-associated or cytoplasmic chaperones maintains pre-
proteins in a translocation-competent state. This introduction describes the two mecha-
nisms by which substrates of the Sec pathway are translocated from the cytoplasm.
1.3.1 The SecYEG channel
In bacteria, the channel through which proteins are translocated is known as the SecYEG
channel. This channel is a heterotrimer that is comprised of SecY, SecE and SecG
(Corey et al., 2016). Bacterial SecY is equivalent to the eukaryotic α-subunit and SecE is
equivalent to the eukaryotic γ-subunit. There is high sequence conservation between
these bacterial and eukaryotic subunits and both are essential for cell viability. The
eukaryotic β-subunit and SecG are not homologous.
In E. coli, SecY and SecE are minimally required to support protein translocation
(Brundage et al., 1990; Natale et al., 2008). SecY has 10 transmembrane helices. Three
cytoplasmic loops of SecY interact with SecA (Mori and Ito, 2006). Studies have sug-
gested that, at the “front ” of SecY, there is a lateral opening between two transmembrane
helices, which is called the lateral gate. The lateral gate opens to release signal sequences
and transmembrane segments from the channel (van den Berg et al., 2004). SecE has
3 TM domains that sit at the “back” of SecY (Kudva et al., 2013). SecE is essential for
protein transport because it stabilises SecY and in the absence of SecE, SecY is rapidly
degraded by FtsH, a membrane protease (Kihara et al., 1995).
InE. coli, the SecG subunit has 2 TMhelices. SecG is neither essential for the viability of
cells nor protein translocation in Escherichia coli (Kudva et al., 2013). SecYEG forms a
passive hydrophilic pore through which unfolded secretory proteins can be translocated
cotranslationally or posttranslationally (van den Berg et al., 2004; Zimmer et al., 2008;
Tsirigotaki et al., 2017). During cotranslational translocation, GTP hydrolysis by the
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Figure 1.3: The bacterial Sec pathway
Unfolded proteins (dark purple) that contain signal peptides (red) and inner membrane
proteins are either cotranslationally recognised and targeted to the transmembrane Se-
cYEG channel (dark pink) by the signal recognition particle (SRP; green) or posttransla-
tionally recognised and targeted by SecA (orange). FtsY (grey) is the membrane receptor
of SRP. Trigger factor (lilac) and the ATPase motor SecA bind to preproteins either by
docking near the exit channel of the ribosome or in the cytoplasm. SecB (purple) binds to
partially or fully synthesised preproteins but does not bind to the ribosome. Preproteins
pass through SecYEG and are secreted into the periplasm or into the plasma membrane.
The process of posttranslational translocation is powered by repeated cycles ofATPbind-
ing and hydrolysis by SecA and the proton motive force (PMF), while cotranslational
translocation is powered by the translating ribosome. The auxiliary components SecDF-
YajC (yellow) and YidC (dark orange) enhance translocation efficiency. Signal peptidases
(bright blue), which are located in the inner membrane, cleave signal peptides.
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proteins directly into the SecYEG channel. ATP hydrolysis by SecA and proton motive
force provide the energy for the translocation of posttranslationally translocated secre-
tory proteins (Schulze et al., 2014).
The crystal structure of SecYEG fromMethanococcus jannaschii shows that the SecYEG
channel has an hourglass shape with a 5-8 Å ring of aliphatic residues at the narrowest
point of the channel, which allows the passage of an unfolded polypeptide (van den Berg
et al., 2004). These residues are thought form a hydrophobic seal to prevent the export
of proteins with either a secondary or tertiary structure (Park and Rapoport, 2011).
The ring is comprised of six isoleucine residues in E. coli. The shape of the channel
and the lack of charged residues in the cavities on either side of the pore is thought to
minimise the contact between the translocating peptide and the SecYEG channel to the
hydrophobic ring and increase the efficiency of translocation (van den Berg et al., 2004).
The selectivity of the SecYEG channel is thought to be derived from one of the ten
trans-membrane helices that forms a plug domain. The plug locates to the middle of
the pore to close the SecYEG channel and maintain the integrity of the cytoplasmic
membrane. It is thought that the interaction between the secretory protein and the
SecYEG channel displaces the plug domain and opens the channel until translocation is
complete, at which point the plug returns to the original, closed conformation (van den
Berg et al., 2004). Deletion of the plug does not significantly affect translocation,
however the “open” and “closed” states are not as stable without this domain and the
permanently open state of SecYEG is toxic in E. coli (Harris and Silhavy, 1999; Li et
al., 2007; Kudva et al., 2013). Computational modelling indicates that mutations in
SecYEG, which are known to allow the export of secretory proteins with defective signal
sequences, are likely to destabilise the closed state of the channel. It is possible that the
destabilisation of the closed state would facilitate the export of these secretory proteins
with defective signal sequences (Smith et al., 2005). Therefore, the SecYEG channel
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structure may provide a substrate specificity step in the Sec pathway.
1.3.2 Substrate protein recognition
Secretory proteins are often synthesised as preproteins that have an amino-terminal
signal sequence that directs them for export by the Sec pathway (von Heijne, 1985;
Figure 1.4). The length of the signal sequence varies but the median length of a signal
sequence in E. coli is 22 amino acid residues and the minimum length is 15 amino acid
residues (Cranford-Smith and Huber, 2018). These signal sequences are cleaved either
during or after export (Payne et al., 2012). Signal sequences have a tripartite architecture.
The core is comprised of hydrophobic residues that can form an alpha-helical secondary
structure. The core is flanked by one or several positively charged, basic residues at the
amino terminus and a cleavage site at the carboxy-terminus of the signal sequence. The
cleavage site is recognised by the signal peptidase in the periplasm (Figure 1.3).
Most inner membrane proteins contain instructions for their secretion within their
hydrophobic, transmembrane domains and do not have a cleavable signal sequence,
although some are synthesised with an amino-terminal signal sequence. The subset
of inner membrane protein that contain an amino-terminal signal sequence is distin-
guished from secreted proteins by stop-transfer sequences that anchor the protein in
the cytoplasmic membrane (von Heijne, 1994). Stop-transfer sequences are usually 20
amino acid residues long and are hydrophobic (Facey and Kuhn, 2004).
The targeting of secretory substrates to the SecYEG complex in the plasma membrane
occurs either cotranslationally or posttranslationally. A greater proportion of prepro-
teins interact with SecA, the motor ATPase, for export. In bacteria, the SRP gener-
ally recognises more hydrophobic nascent signal sequences (Lee and Bernstein, 2001;
Cranford-Smith and Huber, 2018), which directs the nascent polypeptide for cotrans-
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Figure 1.4: General architecture of the Sec signal sequence
The general structure of a signal sequence is conserved in all domains of life (Natale
et al., 2008). The signal sequence is located at the amino-terminus of the preprotein
and is cleaved from the mature domain after translocation. The median length of a sig-
nal sequence in 22 amino acid residues (Cranford-Smith and Huber, 2018). The sig-
nal sequence has a tripartite structure that is comprised of a positively charged amino-
terminus (N-region, blue), a hydrophobic core (H-region, yellow), and a polar carboxy-
terminus (C-region, green) region. The C-region contains the signal peptidase cleavage
motif. Apart from the presence of the cleavage motif, Sec signal sequences do not have a
conserved amino acid sequence. The tripartite structure of the signal sequence is recog-
nised by the Sec machinery. The H-region typically consists of hydrophobic amino acid
residueswith a propensity to formanα-helical secondary structure, whereas the positively
charged N-region has been implicated in electrostatic interactions with membrane phos-
pholipids. SecA and the signal recognition particle (SRP) recognise theH- andN-regions




Cotranslational translocation is the translocation of secretory proteins during protein
synthesis. The process of cotranslational translocation begins when the emerging
secretory protein is recognised by the SRP at the ribosomal exit channel. Subsequently,
the ribosome-nascent polypeptide complex (RNC) is delivered to the Sec translocon,
which is sometimes supplemented by YidC (Akopian et al., 2013). YidC is a cytoplasmic
membrane protein that mediates the insertion of proteins into the cytoplasmic mem-
brane (Samuelson et al., 2000). The SRP delivers the translating ribosome to SecYEG
by interacting with the membrane receptor FtsY (Huber et al., 2005; Figure 1.3). FtsY
is a peripheral membrane protein that facilitates the insertion of the nascent secretory
protein into Sec translocon.
The SRP is a ribonucleoprotein complex that is comprised of Ffh and 4.5S RNA. Ffh is
homologous to the 54 kDa, mammalian SRP. Ffh has tripartite domain structure that
consists of an α-helical amino-terminal domain, a GTPase domain and amethionine-rich
domain. The amino-terminal α-helical domain and theGTPase domain of Ffh both dock
at L23 and L29 near the ribosomal exit channel and the methionine-rich domain inserts
into the exit channel. The methionine-rich domain is responsible for the recognition of
nascent secretory proteins as they are synthesised (Zopf et al., 1990). The emergence of a
SRP secretory substrate stabilises the binding of the SRP to the ribosome (Saraogi et al.,
2014). Substrate specificity is further enhanced by the recruitment of FtsY.
After the recognition of the nascent secretory proteins by the SRP, the RNC and FtsY
form a complex with the SRP (RNC-SRP-FtsY complex) (Shen et al., 2012). FtsY,
like Ffh, has an amino terminal domain and a GTPase domain. Ffh and FtsY interact
until GTP hydrolysis occurs. GTP hydrolysis occurs when a nascent polypeptide has
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only weak affinity for the SRP. As such, GTP hydrolysis causes the dissociation of the
RNC-SRP-FtsY complex in the cytoplasm (Shen et al., 2012; Tsirigotaki et al., 2017),
whichmeans that only SRP-substrates are targeted to the Sec translocon. The interaction
between FtsY, SecYEG and cytoplasmic membrane lipids weakens the affinity of SRP for
the RNC. The SRP is released from the RNC by the stimulation of GTP hydrolysis by
SecYEG (Saraogi et al., 2014).
Secretory proteins are either translocated across the cytoplasmic membrane or, as is the
case for the majority of cotranslationally translocated proteins, they are inserted into the
cytoplasmic membrane. YidC is located adjacently to the lateral gate of SecYEG, through
which proteins pass for subsequent insertion (Sachelaru et al., 2013; Figure 1.3). Studies
have suggested that SecA is recruited to the Sec machinery in the inner membrane to
assistwith the insertionofmembraneproteins (Deiterman et al., 2005;Dalbey andKuhn,
2012), although themechanism for this in vivo remains unclear because the ribosome and
SecA cannot both bind SecYEG in vitro (Wu et al., 2011).
1.3.4 Posttranslational translocation
Posttranslational translocation is the translocation of fully or mostly synthesised secre-
tory proteins. The majority of secretory proteins are posttranslationally translocated.
In bacteria, all secretory proteins that are exported posttranslationally require SecA, an
ATPase, and proton motive force, to provide the energy for efficient translocation (Lill
et al., 1989). Historically, it was thought that recognition of these secretory proteins
occurred in the cytoplasm, after the protein had been synthesised (Zito andOliver, 2003;
Chatzi et al., 2014).
Subsequent studies indicate that posttranslationally translocated secretory proteins
are recognised cotranslationally as they emerge from the ribosomal exit channel by
ribosome-bound SecA or Trigger Factor (Oh et al., 2011; Huber et al., 2011; Tsirigotaki et
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al., 2017). SecA binds L23 near the ribosomal exit channel. Furthermore, SecA interacts
with nascent polypeptides earlier in translation than SecB, which is a cytoplasmic chap-
erone (Huber et al., 2016). The SRP is present in lower concentrations in the cytoplasm
than the ribosome, therefore it is likely that substrate recognition by the SRP occurs
swiftly to stabilise the interaction between the SRP, the emerging nascent polypeptide
and the ribosome (Luirink and Sinning, 2004). The evasion of the SRP by a nascent
polypeptide may provide an opportunity for their recognition by ribosome-bound,
posttranslational translocation factors, like SecA.
After secretory proteins are synthesised, chaperones, like SecB in E. coli, are recruited to
themature portion of the preprotein. SecB functions as a holdase chaperone tomaintain
the preprotein in an unfolded conformation (Randall et al., 1997; Randall and Hardy,
2002). Subsequently, SecA interacts with the preprotein, which is then translocated
through the SecYEG channel (Chatzi et al., 2013, 2014).
1.3.5 SecA
SecA is a central or “core” component of the Sec pathway in bacteria (Lill et al., 1990).
SecA interacts with ATP, SecB, lipids, the ribosome, SecYEG and preproteins (Vrontou
and Economou, 2004). SecA cycles between a cytoplasmic form and a peripheral
cytoplasmicmembrane form (Nakatogawa et al., 2004). The energy for the translocation
of preproteins is provided by the hydrolysis of ATP by SecA.
SecA autoregulates the translation of the secA mRNA. Immediately upstream of the
secA gene is the secM gene. The genes are co-transcribed as a single mRNA that can
form secondary structures (Nakatogawa et al., 2004). The initiation of secA translation
is prevented through the interaction of SecA with the secondary structure of its own
mRNA (Schmidt and Oliver, 1989). SecM is an exported protein and studies have
suggested that the defective export of SecM results in the increased expression of secA
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(b) Schematic representation of a monomer of SecA
Figure 1.5: Illustration of the domain organisation of SecA
SecA is comprised of three domains, which are the DEAD motor, the PPXD and the
C-domain. 1.5a shows a schematic of the unfolded domain organisation of SecA. The
residues indicated in the C-domain refer to the E. coli SecA (Papanikou et al., 2007).
1.5 shows a schematic for the tertiary structure of SecA (adapted from Vrontou and
Economou, 2004). The DEADmotor contains NDB (blue) and IRA2 (turquoise). The
PPXD (magenta) loosely interacts with the helix-turn-helix of IRA1 (orange) in the C-
domain. The scaffold domain (green) interacts with the length of the DEAD motor
and IRA1. The HWD (red) is flexible. The carboxy-tail (purple) can interact with the
PPXD. At the extreme carboxy-terminus of SecA is a 20-amino acid residue domain
(SecA-MeBD) that is unresolved crystallographically. Figure 1.5 is adapted from (Vron-
tou and Economou, 2004).
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(Oliver et al., 1998).
The E. coli SecA is 102 kDa and has three structural units: the DEAD motor, the
polypeptide binding domain (PPXD) and the C-domain (Vrontou and Economou,
2004; Figure 1.5). The amino-terminal DEAD motor is comprised of the nucleotide
binding domain (NBD) and the intramolecular regulator of ATPase domain (IRA2),
which bind a single molecule of ATP (Ye et al., 2004). The DEAD motor is an ATPase
domain that is structurally homologous to the DEAD box helicase superfamily of
proteins (Ye et al., 2004). The functional specificity of DEAD box proteins is conferred
by the other domains of the protein. ATPase activity of SecA is regulated allosterically
by interactions withMg2+ and SecYEG.
The PPXD interacts with the C-domain and binds to secretory proteins. This portion
of SecA is sometimes referred to as the substrate specificity domain (Vrontou and
Economou, 2004). Studies have suggested that the preprotein binding domain can
interact with either the signal sequence or the mature region (Papanikou et al., 2005;
Gelis et al., 2007). The C-domain is almost exclusively α-helical and is comprised of four
sub-domains. The scaffold domain (SD) is a single α-helix that spans both components
of the DEAD motor. The other side of the SD interacts with a second intramolecular
regulator of ATPase domain (IRA1). IRA1 is a helix-turn-helix that regulates transloca-
tion. The helical wing domain (HWD), which interacts loosely with the rest of SecA, is
flexible. DuringATP hydrolysis, conformational changes that occur in theDEADmotor
are conferred to the HWD (du Plessis et al., 2011). In crystal structures of full-length
SecA, the carboxy-tail of SecA is mostly crystallographically unresolved (Vrontou and
Economou, 2004). The carboxy-tail of SecA can be further divided into two regions.
The more proximal of the two regions can interact with the stem of the PPXD and is
known as the flexible linker. The flexible linker could have an autoinhibitory role via
the occlusion of the peptide-binding groove (Gelis et al., 2007). The most distal of the
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two regions is comprised of 22 amino acid residues at the extreme carboxy-terminus
of SecA and contains the only β-sheet secondary structure in the C-domain (Dempsey
et al., 2004). This domain is referred to as the SecA-MeBD in this study. Studies have
shown that the SecA-MeBD coordinates zinc (Fekkes et al., 1999). Further to this, the
SecA-MeBD can bind lipids and SecB (Breukink et al., 1995; Fekkes et al., 1998; Randall
et al., 2004).
SecA is dimeric in physiologically relevant conditions in vitro and it is thought that
SecA forms dimers in the cytoplasm in vivo (Woodbury et al., 2012). However, several
different, published crystal structures of SecA reveal a number of different dimeric
interfaces (Lycklama a Nijeholt and Driessen, 2012). The dimerisation of SecA is
affected by temperature, salt concentration, lipid-binding or ligand-binding (Or et al.,
2002; Woodbury et al., 2012). The conditions required to form SecA crystals for X-ray
crystallography could result in aberrant dimerisation by SecA. Studies of soluble SecA
indicate that SecA forms an antiparallel homodimer (Ding et al., 2003; de Keyzer et al.,
2005).
The functional role of SecA dimerisation is unclear and remains controversial (Vrontou
and Economou, 2004). None of the studies that investigated the state of SecA in
response to different conditions included SecYEG (Kusters et al., 2011), therefore a clear
understanding of how different components of the Sec machinery influence the state
of SecA during translocation remains elusive. Both monomeric and dimeric states of
SecA have been suggested to associate with SecYEG. Studies have suggested that SecA
is a dimer when actively engaged in preprotein translocation (Ding et al., 2003; Kusters
et al., 2011). However, the interaction of SecA with cytoplasmic membranes, substrate
protein and SecYEG promotes monomerisation in vitro. In addition, a mutant SecA
that is preferentially monomeric is functional in vitro and in vivo (Or et al., 2005) and
covalently crosslinked SecA dimers did not have translocation activity in vitro (Or and
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Rapoport, 2007).
The 22 amino acid residues at the carboxy-terminus of SecA comprise the SecA-MeBD.
The SecA-MeBD is present in most bacteria but is dispensable for translocation (Kara-
manou et al., 2005). The SecA-MeBD is an auto-inhibitor of the peptide binding activity
of SecA (Gelis et al., 2007). The E. coli SecA-MeBD interacts with the the flat β-sheet
of dimeric SecB, although other sites of interaction have been identified (Randall et al.,
2004, 2005; Patel et al., 2006). It is thought that the binding of carboxy-terminus of
SecB to SecA induces a conformational change in SecA to allow the accommodation of
a secretory protein (Patel et al., 2006; Gelis et al., 2007). The interaction between the
SecA-MeBD and SecB is stabilised by the presence of zinc (Fekkes et al., 1999), which is
an example of how the presence of a metal cofactor can influence the structure and func-
tion of a metalloprotein. Four amino acid residues, Cysteine 884 - X2 - Cysteine 887 - X8
- Cysteine 896 - Histidine 897 (where X represents any amino acid residue) coordinate
the zinc ion, with the assistance of a conserved serine residue at position 889 in E. coli
(Dempsey et al., 2004). The coordination of zinc by these residues is proposed to fold
the SecA-MeBD correctly to allow the interaction with SecB (Dempsey et al., 2004).
1.3.6 The accessory proteins of the Sec pathway
A number of accessory proteins that assist with the translocation of secretory substrates
in vivo have been identified. The accessory proteins include YajC, YidC, SecD and
SecF. YidC is more abundant than SecYEG and it is proposed that a pool of YidC
functions independently in the cytoplasmic membrane with one copy of YidC per
SecYEG (Sachelaru et al., 2015; Urbanus et al., 2002). Indeed, it has been suggested
that YidC enables the translocation of some proteins, without the assistance of the
core translocation machinery or ATP in vitro (Serek et al., 2004). In E. coli, a channel
in the cytoplasmic membrane, which is comprised of SecYEG-YidC-SecDF-YajC, is
known as the holotranslocon. One copy of each of the seven subunits is present in in
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the holotranslocon (Botte et al., 2016). The formation of the holotranslocon in vitro
stimulates the ATPase activity of SecA and increased membrane insertion efficiency
(Schulze et al., 2014; Botte et al., 2016). It is proposed that conformational changes
within SecDF couple protonmotive force to translocation (Tsukazaki et al., 2013), which
is supported by stimulation of translocation through the holotranslocon by proton
motive force in vitro (Schulze et al., 2014). The ability of the translocation machinery to
formmultiple different protein channels (YidC alone, dimeric SecYEG, SecYEG, and the
holotranslocon) could provide the Sec pathway with the flexibility to respond to specific
requirements of different secretory proteins (Botte et al., 2016).
SecD and SecF are found in the cytoplasmic membranes of archaea and bacteria (Eichler,
2003). The two proteins are co-conserved and, in some species, are fused into a single
protein (Tseng et al., 1999). Deletion of either secD or secF results in a cold-sensitive
phenotype and the over-expression of both SecD and SecF allows the export of secretory
proteins with defective signal sequences (Pogliano and Beckwith, 1994). SecD and SecF
stabilise the interaction of SecA with the cytoplasmic membrane, although the effect on
translocation is limited (Economou. et al., 1995).
YidC is essential for cell viability and depletion of this protein results in a severe translo-
cation defect (Samuelson et al., 2000). YidC associates with the SecYEG channel (Scotti
et al., 2000) at the lateral gate, a position that is displaced by translocating polypeptides,
which is proposed to facilitate the insertion of membrane proteins into the lipid phase
of the cytoplasmic membrane (Sachelaru et al., 2013). Oxa1p is a homologue of YidC
that is found in the mitochondrial membrane, which lacks SecA. Oxa1p is thought to be
involved with the insertion of F-ATPase or membrane protein folding. The localisation
of YidC at the lateral gate of SecYEG is independent of SecD and SecF.
YajC is an integral membrane protein. YajC interacts with SecD and SecF in vivo (Gardel
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et al., 1990; Duong and Wickner, 1997). YajC is not essential for cell viability, however
overexpression of the yajC gene confers ethanol tolerance to Lactobacillus buchneri and
E. coli (Liu et al., 2016). The mechanism by which YajC aids the increased tolerance to
ethanol was not investigated, however ethanol stress includes damage to the cell wall and
reduced membrane potential.
1.3.7 Cytoplasmic chaperones
Molecular chaperones are proteins that assist with folding and unfolding of other
proteins or charging proteins with ligands, for example. A holdase is a specific type
of molecular chaperone that prevents the folding of proteins. The posttranslational
pathway requires the presence of cytoplasmic chaperones to maintain secretory proteins
in a translocation-competent state in the cytoplasm (Randall and Hardy, 2002).
SecB is a cytoplasmic holdase that is responsible for maintaining secretory proteins in
a translocation-competent, unfolded state. Early discovery of SecB means that it is the
model for Sec chaperones, despite only contributing to the export of approximately
4% of the secreted proteins in E. coli (Chatzi et al., 2013; Tsirigotaki et al., 2017).
Monomeric SecB is a 17 kDa protein that is found in α-, β- and γ-proteobacteria.
Biochemical studies of the E. coli SecB and X-ray crystallography of the SecB from
Haemophilus influenzae both indicate that SecB assembles into a stable dimer of dimers
(Topping et al., 2001; Randall and Hardy, 2002). SecB maintains secretory proteins in
a translocation-competent, unfolded state. It is suggested that secretory proteins are
targeted by SecB to SecA in the cytoplasm. However, as discussed in Section 1.3.5, more
recent studies suggest that SecA can cotranslationally interact with nascent secretory pro-
teins before SecB. SecB interacts with nascent proteins after 150 amino acid residues have
emerged from the exit channel (Huber et al., 2011). The binding of SecB to an emerging
polypeptide is dependent on slow folding rather than the presence of an amino-terminal
signal sequence (Bukau et al., 2006). Studies have shown that the signal sequence
25
decreases the rate of folding in the cytoplasm, which suggests that the signal sequence
indirectly contributes to the interaction of SecBwith secretory proteins. (Liu et al., 1989).
Studies have suggested that SecB is not a dedicated Sec chaperone (Ullers et al., 2004).
The deletion of other chaperones, GroEL, GroES, DnaK or DnaJ caused the overex-
pression of SecB, which implies that SecB can compensate for the absence of these other
chaperones. The deletion of secB results in the defective export of some proteins, which
can be rescued by the overexpression ofDnaK andDnaJ (Wild et al., 1992). Furthermore,
SecB prevents the aggregation of insulin B-chains, a non-native substrate, in vitro (Pans
et al., 2000). The role of the heatshock chaperones, DnaK and DnaJ, in the export of
secretory proteins is not specific to proteins that are dependent on SecB for export. For
example, deletion of dnaK and dnaJ results in aberrant export of PhoA (Wild et al.,
1992).
Trigger Factor is a chaperone that is proposed to exist as a dimer but binding studies
indicate that Trigger Factor binds the ribosome as a monomer near the ribosomal exit
channel (Kaiser et al., 2006; Schlünzen et al., 2005). Trigger Factor interacts with
substrates with a lower affinity than SecB does, however the location of Trigger Factor at
the exit channel means that it is likely to be the first chaperone encountered by emerging
polypeptides (Kramer et al., 2002). E. coli can tolerate the absence of Trigger Factor.
However, the deletion of both tig, which encodes Trigger Factor, and dnaK genes results
in a temperature-sensitive pheonotype, which is the result of protein aggregation (Ullers
et al., 2004). It has been proposed that the two chaperones cooperate to facilitate de novo
folding of proteins in vivo (Bukau et al., 2000).
SecA has been predominantly studied as a motor protein that cycles between the cy-
toplasm and the SecYEG channel in the cytoplasmic membrane. Recently, it has been
shown that SecAbinds to the ribosome close to the exit channel and interactswithnascent
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polypeptides independently of SecB andTrigger Factor (Huber et al., 2011, 2016). A sub-
set of the nascent polypeptides that interact with SecA also interact with the SRP. SecA is
implicated in the insertion of a subset of membrane proteins. These results lend support
to the hypothesis that a complex network of chaperones recognise, hold and target pro-
teins for translocation (Wild et al., 1992; Randall and Hardy, 2002; Huber et al., 2016).
1.4 Metalloproteins
Up to one half of proteins contain metal cofactors (Bartinkas and Gitlin, 2001; Waldron,
2009). The generic term for a protein that contains a metal cofactor is a metalloprotein.
The role of a metal cofactor can be solely structural or it can drive catalysis as well
(Waldron, 2009). During the purification of metalloproteins, the metal cofactor can
disassociate from the protein, even under non-denaturing conditions, which results
in heterogenous populations of metal cofactors (Bollinger Jr., 2010; Cotruvo Jr. and
Stubbe, 2012). This illustrates the difficulty for cells in charging the proteins with the
correct metals, and for researchers in the characterisation of these metalloproteins. The
coordination of a different metal cofactor can result in the mischaracterisation of the
function of that protein or enzyme (Waldron, 2009).
The Irving-Williams series refers to the relative stabilities of complexes formed by ametal
ion (Irving andWilliams, 1953; Waldron, 2009). The stability of high-spin complexes of
the divalent ions of first-row transition metals follows the order:
Mn2+ < Fe2+ < Co2+ <Ni2+ < Cu2+ > Zn2+
The Irving-Williams series is independent of the ligand. The ionic radii decreases from
Mn2+ to Cu2+ because the additional positive charge is inadequately screened by the
additional electron. The discrepancy with copper and zinc occurs because six-coordinate
copper complexes are thought to be distorted but more stable than zinc.
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Bacteria have evolved a network of pathways andmechanisms to facilitate the acquisition
of the correct metal cofactor by the protein. Metal ion chaperones, which are known as
metallochaperones, can deliver the metal directly to the metalloprotein. In E. coli, for
example, SlyD charges hydrogenase enzymes with nickel (Zhang et al., 2005), while IscA
coordinates free Fe2+ in the cytoplasm for the biogenesis of iron-sulphur clusters (Ding
and Clark, 2004). However, cognate metallochaperones have not been identified for the
majority of metalloproteins and it is generally considered that most metalloproteins ac-
quire the metal cofactor from the cytoplasmic pool (Tottey et al., 2008; Waldron, 2009).
For example, the comparison ofMncA and CucA, which can both bindMn2+ and Cu2+,
in cyanobacteria suggested that the export of MncA as a quaternary structure by the Tat
pathway allows the protein to bindMn2+ in the cytoplasm prior to export. Once MncA
is bound to Mn2+ exchange with Cu2+ was not observed. The concentrations of free
ions in the cytoplasm is tightly regulated to limit the contamination of metal-binding
sites with the incorrect metal cofactor.
1.5 YecA, a protein with sequence homology to SecA
The current literature suggests that SecA and SecB interact via the SecA-MeBD.
However, the SecA-MeBD is not always present in organisms that contain SecB. It was
hypothesised that identifying and characterising homologues of the SecA-MeBD may
provide insight into the role of this domain in vivo (Dr. D. Huber, personal commu-
nication). YecA is a protein of unknown function that was identified by searching for
similar regions to the carboxy-terminus of the E. coli SecA using BLASTp (Altschul et
al. 1990; Table 1.1). Like SecA, this region of YecA is located at the carboxy-terminus
of the protein. The 20-amino acid residue domain at the carboxy-terminus is called the
YecA-MeBD in this study. 16 amino acid residues of the 22-amino acid sequence of the
SecA-MeBDwere identical in the YecA-MeBD.
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There are several differences between the two carboxy-terminal domains. Firstly, the
SecA-MeBD is two amino acid residues longer at the most distal end than YecA.
Secondly, the tyrosine residue at position 893 (Y893) of SecA is replaced with a
phenylalanine residue at position 214 (F214) of YecA. Structurally, phenylalanine and
tyrosine are similar, although phenylalanine is more hydrophobic. In Rhodobacter
capsulatus, the tyrosine residue of SecA is replaced with a phenylalanine (Fekkes et
al., 1997). The histidine residue at position 897 (H897) of SecA is replaced with a
cysteine residue at position 219 (C219) in YecA. Histidines are commonly found in
the binding sites of proteins and they can coordinate metal ligands (Betts and Russell,
2003). The E. coli SecA coordinates a zinc ion via three cysteine residues and the
histidine residue (Dempsey et al., 2004). However, H897 is sometimes functionally
replaced with a cysteine residue, as in Bacillus subtilis and Staphylococcus carnosus
(Fekkes et al., 1997). The SecA-MeBD has a conserved serine residue at position
888 in E. coli that is also found in the YecA-MeBD. The serine residue has been
implicated in zinc coordination by the SecA-MeBD although the interaction is not
direct (Dempsey et al., 2004). Therefore, the YecA-MeBD is a predicted zinc-binding
motif due to the sequence identity to the SecA-MeBD (TheUniProt Consortium, 2016).
YecA is a 25 kDa protein that has, in addition to the YecA-MeBD, a 192-amino acid
residue domain calledUPF0149 (Figure 1.6). UPF0149 is a domain of unknown function.
This domain is found in one other protein in E. coli, YgfB, which is proposed to interact
with RNA polymerase (Malecki et al., 2014). However no function has been attributed
to this interaction. The structure of YgfB is mostly α-helical and is structurally similar to
the γ-subunit of DNApolymerase III andDnaK, the heat-shock chaperone (Bermand et
al., 2000). YgfB has been found to bind within the wcaC operon (Ishihama et al., 2016).
The genes expressed from this operon are proposed to be involved with acid and heat





Figure 1.6: The domain structure of YecA
YecA is a 25 kDa protein with two domains. At the amino-terminus is a 192 amino
acid residue domain called UPF0149, which is a domain of unknown function. At the
carboxy-terminus of YecA is the YecA-MeBD, which is 20-amino acid residues in length.
The YecA-MeBD has high sequence similarity to the SecA-MeBD.
Table 1.1: Sequence alignment of the SecA-MeBD and the YecA-MeBD fromEscherichia
coli, strain K12, using BLAST and CLUSTALO alignment platforms
The YecA-MeBD (residues 201 - 221) is 75% (1822 ) similar to the SecA-MeBD (880 - 901)
Protein (residues) Amino acid sequence
SecA (879 - 901) GRNDPCPCGSGKKYKQCHGRLQ
YecA (201 - 221) GRNDPCPCGSGKKFKQCCLH
BLAST alignment GRNDPCPCGSGKK+KQC




which could suggest a role for YgfB in antagonising the general gene-silencerH-NS.How-
ever, the specific function of YgfB in relation to these interactions remains unclear and
YgfB is still classified as a protein of unknown function (TheUniProtConsortium, 2016).
Initial studies indicated that YecA could interact with the ribosome in vitro (Dr. D.
Huber, personal communication) but the function of YecA remains unknown. The
sequence homology between the SecA-MeBD and the YecA-MeBD suggested that the
two domains had a related function. However, the specific function of the SecA-MeBD
is not clear because although the SecA-MeBD interacts with lipids and SecB, a SecA
mutant that lacks the most distal 70-amino acid residues is still functional (Karamanou
et al., 2005; van Wely et al., 2000). Furthermore, Gram-positive bacteria do not contain
a SecB homologue but often contain a SecA that has a SecA-MeBD.
The primary aim of this study was to investigate whether YecA was involved with the
translocation of secretory proteins in vivo and in vitro and to investigate whether the
YecA-MeBD was important for the function of YecA. The secondary aim of this study
was to investigate the structure of YecA. The final aim of this study was to investigate the





2.1 Culture media, growth conditions and strains
Lysogeny broth (LB), composed of 10 g/l tryptone, 10 g/l NaCl and 5 g/l yeast extract,
was used for most experiments. Overnight cultures were grown in 5 ml LB in 20ml glass
universal tubes. Protein expression cultures were grown in 2 l baffled Erlenmeyer flasks.
All other liquid cultures were grown in unbaffled Erlenmeyer flasks. All cultures were
incubated in a shaking incubator at 180 rpm.
LB agar was made by adding 1.5% (w/v) agar to LB. Unless otherwise indicated, cul-
tures and plates were grown at 37°C. Where indicated, media was supplemented with
50 µM/ml kanamycin, 200 µM/ml ampicillin or 50 µM/ml ampicillin (chromosomal ex-
pression of the resistance cassette).
2.1.1 Dilution plates
Square Petri dishes of 120 mm x 120 mm (Greiner Bio One) were filled with 50 ml LB
agar. Overnight cultures were serially diluted 1 in 10 to 10-7 in a 96-well plate (Greiner Bio
One). From each dilution, 2 µl was pipetted onto the plate with a multichannel pipette.
2.2 Molecular genetics
2.2.1 Preparation of DNA
Plasmid DNA was purified from an overnight culture using the GeneJET Plasmid
Miniprep Kit (Thermo Fisher) according to the manufacturer’s instructions. For the
preparation of genomic DNA, the STRATEC RTP Bacteria DNA Mini kit was used
according to the manufacturer’s instructions.
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2.2.2 Polymerase chain reaction
Primers used in this study are found in Table 2.7. DNA fragments used for cloning
and mutagenesis were amplified using Phusion® High-Fidelity DNA Polymerase (New
England Biolabs). Unless otherwise specified, reactionmixtures were compiled according
to Table 2.1 the thermocycling conditions for QuikChange PCR were as in Table 2.2.
PCR products amplified by Phusion® High-Fidelity DNA Polymerase were purified
using the GeneJet PCR purification kit (ThermoFisher Scientific).
MyTaqRedMix (Bioline) was used for colony PCR. A single bacterial colony was picked
using a sterile 10 µl pipette tip and resuspended directly in the reaction mixture. The
thermocycling conditions included a 10-minute initial denaturation step of 95°C to lyse
the cells, and an annealing temperature of 55°C (unless otherwise specified).
2.2.3 Agarose gel electrophoresis
DNA fragments were separated using 1% (w/v) agarose (Bioline) gels in 1X TAE buffer
(40 mM Tris, 20 mM acetic acid, 1 mM EDTA) plus the DNA dye, 0.01% SYBR® Safe
(Thermo Fisher). DNA samples were prepared in 6XDNA loading buffer (Bioline) (1 µl
loading buffer to 5 µl DNA sample). Samples that were amplified usingMyTaq Redmix
were not prepared with the loading buffer because the mix included a loading dye. A 1
kb Hyperladder (New England Biolabs) was used as a ladder. Gels were run in 1X TAE
buffer at 120 V until the dye front had reached the end. Gels were viewed under UV light
(300 nm) in a Gel Doc (Bio-Rad).
2.2.4 Cloning
Purified PCR fragments and plasmids were digested with two restriction enzymes, BsaI
and BamHI HF (Thermo Scientific), in CutSmart® Buffer (New England Biolabs). Di-
gested productswere separated by agarose gel electrophoresis and extracted usingGeneJet
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Table 2.1: QuikChange® mutagenesis reaction mixture
Reagent Control Construct
SDW 41 µl 39 µl
5X Phusion HF Buffer 5 µl 5 µl
10 mM dNTPs 2 2
10 µM forward primer 1.25 µl 1.25 µl
10 µM reverse primer 1.25 µl 1.25 µl
Template 1 ng 1 ng
Nuclease free water to a final volume of 50 µl
5X Phusion HF Buffer 1 µl 1 µl
Table 2.2: QuikChange® mutagenesis PCR reaction programme
Cycles Temperature (°C) Time (s)
Initial denaturation 1 95 300
Denaturation 20 95 10
Annealing 65 5
Extension 72 300
Final Extension 1 72 120
Hold - 4 ∞
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GelExtractionkit. The vectorwas treatedwithAntarctic Phosphatase (NewEnglandBio-
labs) to prevent vector re-ligation. DNAwas quantified usingNanodrop (ThermoFisher
Scientific) and the insert was ligated into the vector at a 3:1 ratio with 50 ng of vector
DNA, using T4 ligase (New England Biolabs). An overnight temperature gradient to
4°C overnight was used for the ligation. The temperature gradient was achieved by plac-
ing the ligation reaction in a 22°C waterbath inside a sealed Styrofoam™ box, which was
then incubated at 4°C. Subsequently, the salts were removed from the ligation reaction
by incubating ligation reaction with an equal volume 7.5 MNH4AOc and two volumes
of ice-cold isopropanol. The mixture was vortexed and incubated on ice for 20 minutes.
The mixture was centrifuged for 15 minutes at 12000 g at 4°C. The supernatant was dis-
carded and the pellet was dried for 5 minutes in the Concentrator 5301 (Eppendorf) be-
fore 10 µl sterile, deionised water was added. Subsequently, 5 µl of the ligation mixtures
were transformed into DH5α E. coli (unless otherwise stated) and plated onto LB agar
supplemented with the appropriate antibiotics.
2.3 Bacterial transformation
Chemical transformation
Anovernight culture of the desired strainwas subcultured 1:1000 into 5mlLB and grown
toOD600 0.1 - 0.2. 100 µl of culture was incubated on ice with TSS (5 g 10% Polyethylene
glycol, 2.5 ml 5% Dimethyl Sulfoxide, 1 ml 20mMMgCl2 and made up to 50 ml sterile
LB) and 3 µl plasmid DNA in a 1.5 ml microcentrifuge tube for 5 minutes. The mixture
was heat-shocked for 1 minute in a 42°C ThermoMixer (Eppendorf) and returned to ice
for 5 minutes. 1 ml LB was added to the mixture and the cultures were incubated for 1
hour at 37°C (unless otherwise stated) for 1 hour. The cultures were pelleted at 6000 g for
5 minutes. The supernatant was decanted and the cell pellet was resuspended in 100 µl
LB. The resuspended pellet was plated on LB agar containing the appropriate antibiotic
and incubated overnight at 37°C (unless otherwise stated).
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Transformation by electroporation
All reagents, microcentrifuge tubes and electroporation cuvettes were kept on ice
throughout. All centrifugation steps were done at 6000 g for 5 minutes at 4°C in 1.5
ml microcentrifuge tubes unless otherwise stated. 1 ml of an overnight culture of the
desired strain was centrifuged. The LB was removed completely and the cell pellet
was resuspended in 100 µl ice-cold H2O. The mixture was centrifuged. This step was
repeated three times: twice more with 100 µl ice-cold H2O and once with 100 µl ice-cold
10% glycerol. The glycerol supernatant was removed and the pellet was resuspended in
50 µl 10% glycerol.
30 µl electrocompetent cells were mixed with 50 ng plasmid DNA in a 1 mm electropo-
ration cuvette (Geneflow). The mixture was electroporated at 1750 V and 1 ml LB was
added immediately. The cells were mixed with the LB by pipetting and the mixture was
transferred to a 1.5 ml microcentrifuge tube for recovery for 1 hour at 37°C (unless oth-
erwise stated). The cultures were pelleted at 6000 g for 5 minutes at room temperature.
The supernatantwas decanted and the cell pelletwas resuspended in 100µl LB.The resus-
pended pellet was plated on LB agar containing the appropriate antibiotic and incubated
overnight at 37°C (unless otherwise stated).
2.4 Strain construction
2.4.1 P1 transduction
P1 transduction, first described in 1972 byMiller (1972), was used to transducemutations
from the Keio collection (Baba et al., 2006) to new strains of E. coli.
To make the P1 lysate, 5 ml LB was inoculated with a single colony of the donor strain
using a sterile loop. The cultures were grown at 37°C to OD600 0.1. 50 µl CaCl2 and 2 µl
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P1 virus stock was added. The cultures were grown at 37°C in a shaking incubator (180
rpm) until lysis occurred. Using a Pasteur pipette, 5 drops of CHCl3 were added to the
culture. 10 µl 10% w/v SDS was also added. The culture was vortexed and left on the
bench for 5 minutes to lyse. The top 2 ml of the culture was centrifuged for 10 minutes
at 6000 g. The top 1 ml of the supernatant was stored at 4°C.
The recipient strainwas grown overnight in LB. 200 µl of the overnight culture plus 50 µl
CaCl2 was incubated for 20 minutes at 37°C without shaking in the presence of either 0
µl , 1 µl 2 µl, 5 µl or 10 µl of P1 lysate in a sterile 25 ml universal. Subsequently, 0.1 ml 1M
Na3C6H5O7 and 0.5 ml LB were added and the cultures were incubated for 1 hour. The
culture was pelleted and the supernatant was discarded. The cell pellet was resuspended
in 50 µl LB and plated onLB agar supplementedwith the appropriate antibiotic selection
and 20mMNa-Citrate. Aphage only controlwas also plated by spotting 20µl of P1 lysate
onto LB agar.
2.4.2 λInCH
To stably integrate a single copy of a gene at the λ-locus, λInCH was used according to a
protocol described by Boyd et al. (2000). DHB6521 was transformed by electroporation
and re-streaked to purify to colonies. An overnight culture was grown at 30°C. The
overnight culture was diluted 1:100 in LB supplemented with 2 mMMgSO4 and grown
at 30°C (180 rpm) to mid-log phase. The culture was put in a 42°C water-bath for 15
minutes and then in a 37°C incubator until lysis begins. 100 µl chloroform was added
to the cultures and vortexed. The cultures were allowed to lyse on the bench at room
temperature for 5 minutes. 2 ml of lysate was centrifuged at 6000 g for 5 minutes to
clarify the lysate. The top 1 ml was aliquoted and stored at 4°C.
An overnight of the recipient strain was grown in LB supplemented with 2mMMgSO4.
In 4 separate microcentrifuge tubes 100 µl overnight culture was mixed with 1 µl, 2 µl, 5
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µl, 10 µl and incubated at 30°C for 15 minutes without shaking. 1 ml LB supplemented
with 200 mM Na3C6H5O7 was added to each of the mixtures and then incubated
at 30°C (180 rpm) for 1 h. The cultures were pelleted at 6000 g for 5 minutes and
resuspended in 100 µl LB. The resuspended cells were plated on LB agar supplemented
with the appropriate antibiotic at the correct concentration. The plates were incubated
at 30°C overnight.
To avoid double lysogens, colonies from the lowest dilution plate were selected. The
colonies were re-streaked on the appropriate antibiotic at 30°C, kanamycin at 30°C and
on the appropriate antibiotic at 42°C. Correct lysogens were resistant to the appropriate
antibiotic, sensitive to kanamycin and temperature sensitive.
An overnight culture of the correct lysogen was grown to cure the strain of the λlytic
phage. A sterile loopwas used to inoculate a LB agar plate supplemented with the appro-
priate antibiotic in tight, but not over-lapping, oscillations, and incubated overnight at
42°C. Single colonies from the lowest dilution were re-streaked and tested for resistance
to the appropriate antibiotic and growth at 42°C.
2.5 Protein analysis
2.5.1 Buffers for protein purification
Buffer 1 10 mM [HEPES]-KOH [pH 7.4], 100 mM KOAc, 10 mM
Mg(OAc)2
Lysis buffer 10 mM [HEPES]-KOH [pH 7.4], 100 mM KOAc, 10 mM
Mg(OAc)2) plus 10 mg Dnase I (Thermo Scientific) and 1 mM
phenylmethylsulfonyl fluoride (PMSF; Thermo Scientific)
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Elution buffer 10 mM [HEPES]-KOH [pH 7.4], 100 mM KOAc, 10 mM
Mg(OAc)2, 0.5 mM imidazole
High Salt buffer 10 mM [HEPES]-KOH [pH 7.4], 1 M KOAc, 10 mMMg(OAc)
Protease buffer 10 mM [HEPES]-KOH [pH 7.4], 100 mM KOAc, 10 mM
Mg(OAc), 5 mM β-mercaptoethanol
2.5.2 SDS-PAGE analysis
Protein samples were analysed on 15% resolving and 6% stacking gels made in 0.75 mm
casts (BioRad). 10 ml of resolving buffer contained 5 ml 30% (w/v) acrylamide (Proto-
gel), 2.6 ml 1.5 M Tris-HCl [pH 8.8], 0.1 ml 10% (w/v) sodium dodecyl sulphate (SDS),
0.1 ml 10% (w/v) ammonium persulfate (APS) and 4 µl tetramethylethylenediamine
(TEMED). 10 ml of stacking buffer contained 1.7 ml 30% (w/v) acrylamide (Protogel),
2.5 ml 0.5 M Tris-HCl [pH 6.8], 0.1 ml 10% (w/v) SDS, 0.1 ml 10% (w/v) APS and 1 µl
TEMED.
Protein samples were prepared in 2X Laemmli sample buffer (Sigma Aldrich) at a 1:1
ratio and boiled, unless otherwise indicated. Gels were run at 100 V until the loading
dye reached the bottom of the gel. Gels were stained with 1.25% (w/v) R-250 Coomassie
Brilliant Blue (Thermo Scientific) in 50% ethanol.
2.5.3 Western blotting
Samples for Western blotting were separated by SDS-PAGE. The proteins were trans-
ferred to anitrocellulosemembraneusing either the iBlot 2DryBlotting System (Thermo
Fisher) or by using aWestern Sandwich cassette with 1x Transfer Buffer (25mMTris, 190
mM glycine, 20% ethanol). Membranes were blocked in 5% (w/v) Milk Buffer (per l: 50
g skimmed milk powder (Tesco), 2.42 g Tris base, 8 g NaCl, pH 8.4) for 1 h at 4°C on an
orbital shaker. The membrane was washed for 15 minutes at 4°C with TBST (per litre: 1
mlTween-20, 2.42 gTris base, 8 gNaCl, pH8.4) three times. Themembranewas then in-
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cubated with the primary antibody (diluted in TBST) overnight on the orbital shaker at
4°C.Themembranewaswashed three timeswithTBST for 15minutes and subsequently
incubated withHRP-linked α-rabbit antibody (BioRad) for 1 hour andwashed a further
three times with TBS. The western blot was developed using ECL Prime Western Blot-
ting Detection Reagent (Amersham), and visualised using a Bio-Rad Chemi XR.
2.5.4 Protein expression
For protein production, the desired gene was cloned into either pCA528 or pCA597,
which are cloning vectors that encode either His6-SUMO or Strep(II)-SUMO tag at the
respective amino-termini. The plasmids were transformed by electroporation into elec-
trocompetent E. coli strain BL21 DE3. Transformants were incubated overnight in LB
supplemented with kanamycin and subcultured 1:1000 into 1 l of LB (protein expression
for antibody production or biochemical assays) or 1 l of M9 media containing 15NH4Cl
(preparation of single-labelled samples for NMR studies) of 1 l of M9 media containing
15NH4Cl and 1H7-13C6-glucose (2 g/l) (preparation of double-labelled samples forNMR
studies). Cultures were grown to an OD600 of 0.8 at 37°C, at which point the tempera-
ture was dropped to 18°C. After 30 minutes at 18°C protein expression was induced with
1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) overnight.
2.6 Protein purification
2.6.1 Cell lysis
Protein expression was done as described in Section 2.5.4. IPTG-induced cells were har-
vested by centrifugation at 16000 g for 30minutes at 4°C.The cell pellet was resuspended
in Lysis Buffer (10 mM [HEPES]-KOH [pH 7.4], 100 mM KOAc, 10 mMMg(OAc)2)
plus 10mgDnase I (ThermoScientific) and 1mMphenylmethylsulfonyl fluoride (PMSF;
Thermo Scientific) and lysed in a C3 cell disruptor until lysis was visually apparent. Un-
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broken cells andmembranes were removed from the lysate by centrifuging the raw lysate
at 17400 g for 20 minutes at 4°C. The lysate was further clarified by injecting the super-
natant over a 0.45 µM filter unit (Millex-HP), where indicated.
2.6.2 Nickel affinity chromatography and cleavage of the affinity tag
Protino Ni-TED Resin
The clarified lysate was incubated for 1 h with 1 g of Protino Ni-TED Resin (Macherey-
Nagel) at 4°C for 1 hour on a roller. The resinwaswashed five timeswithHigh Salt Buffer
(10 mM [HEPES]-KOH [pH 7.4], 1 M KOAc, 10 mMMg(OAc)2) for 15 minutes and
five times with Buffer 1. The sample was incubated with 100 µl 4.3 µM SUMO protease
overnight at 4°C on the Protino Ni-TED Resin in protease buffer (10 mM [HEPES]-
KOH [pH 7.4], 100 mM KOAc, 10 mM Mg(OAc), 5 mM β-mercaptoethanol). The
sample and the SUMO protease were eluted from the column with Buffer 1 + 0.5 mM
imidazole. The flow through, washes and elutions were analysed by SDS-PAGE.
1 ml HisTrap column
The clarified lysate was then bound to a 1 ml HisTrap FT column (GE Healthcare)
overnight using a peristaltic pump at 4°C.The clarified lysate was stirred using amagnetic
stirrer and stir bar. After binding the column was washed with Buffer 1 (15x column
volume) and High Salt Buffer(5x column volume). Protein elutions in 15x 1 ml fractions
in elution buffer (Buffer 1 + 500mM imidazole). The flow through, washes and elutions
were analysed by SDS-PAGE.
The sample was dialysed against Buffer 1 + 5 mM β-mercaptoethanol at 4°C overnight
to remove the imidazole and incubated with His6-Ulp1 to cleave the amino-terminal tag
using SnakeSkin™ Dialysis Tubing (10KMWCO) (ThermoFischer Scientific). The dial-
ysis was set up at a 1:500 ml sample:buffer ratio. Where indicated, the tag and His6-Ulp1
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was separated from the cleaved protein by a negative nickel affinity purification step: the
sample was passed over the column and the flow through was collected. His6-Ulp1, the
cleaved tag and the uncleaved recombinant protein was eluted with Buffer 1 + 500 mM
imidazole. The resulting fractions were analysed fractions were analysed by SDS-PAGE.
2.6.3 Anion exchange chromatography
The sample was applied to a 1 ml RESOURCE Q column (GE Healthcare) the sample
was purified using a linear gradient of 100 mMKOAc to 1 M KOAc on the ÅKTA pure
(GEHealthcare). A flow rate of 0.5 ml/min was used. The elution volume was collected
in fractions of 500 µl were analysed by SDS-PAGE. Protein-containing fractions were de-
tected automatically by the ÅKTA pure system using that absorbances at 280 nm and
254 nm. These fractions were analysed by SDS-PAGE and Coomassie staining. The frac-
tions were pooled and concentrated using a Vivaspin 500 concentrator (GE Healthcare,
MWCO 10000) indicated.
2.6.4 Size exclusion chromatography
A Superdex 75 10/300 GL (GE Healthcare; S75 10/300) was used as a final purification
step. The columnwas pre-equilibrated in Buffer 1 + 1mMTCEP.A flow rate of 1ml/min
was used. The elution volume was collected in 5 ml fractions. Final elutions were anal-
ysed by SDS-PAGE. Protein-containing fractions were pooled and concentrated using a
Vivaspin 500 concentrator (GE Healthcare, MWCO 10000) where indicated. Protein
was stored at -80°C after being snap-frozen in liquid nitrogen.
2.6.5 Determination of protein concentration
Protein concentrations were determined spectrophotometrically at 280 nm. The extinc-
tion coefficientwas determinedusing theonlineplatformProtParam (Artimo et al., 2012)
as 44710M-1 for YecA and 44460M-1 for YecA201.
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2.7 Generation of polyclonal α-YecA
Full-length YecAwas purified as described in Section 2.5.4. The proteinwas sent to Euro-
gentec for the Anti-protein 87-day package. This package raises antibodies to the protein
of interest by injecting 2 rabbits with 200 µg YecA on days 0, 14, 28 and 56. The serum
was collected on day 87. Azide was added to the final serum at a final concentration of
0.02% (w/v) to prevent microbial contamination. The final serum was aliquoted and
used to detect YecA and YecA201 byWestern blot (1:1500 dilution)
2.8 β-galactosidase assay
2.8.1 Data collection
The β-galactosidase activity was determined according to a protocol described by Miller
(1972) with a few adjustments. Cultures were grown in M63 media supplemented with
0.2%maltose to anOD600 of between 0.4 and 0.5 at 37°C. 1 mM IPTGwas added to the
cultures. After 2 h the cells were lysed. For cell lysis, 0.5 ml cell culture was added to 0.5
ml of Z-buffer (60mM Na2HPO4 •7H2O, 40mM NaH2PO4 •H2O, 10 mM KCl, 1 mM
MgSO4 •7H2O, 1 mM β-mercaptoethanol, pH 7.0), 5 µl SDS, 10 µl chloroform and vor-
texed for one minute. After incubating the cell lysate for 5 minutes in a 28°C waterbath,
the assay was initiated by adding 200 µl of 4mg/ml o-nitrophenyl β-D-galactopyranoside
to each reaction. When a visible yellow colour was produced the reaction was terminated
by the addition of 500 µl of 1 M Na2CO3 and the time was recorded. Subsequently, the
samples were centrifuged at 13000 g for 5minutes to pellet the cell debris and the top 1ml




The absorbance data A420, A550 and OD600 were collated and β-galactosidase specific ac-
tivities in Miller units (a.u.) were calculated according to the formula:
Miller Units =
1000 (A420 − 1.75 × A550)
T × V ×OD600
where T refers to the time between the initiation of the reaction and its termination and
V is the volume of cell culture.
Data were analysed using one-way ANOVA and a Tukey post hoc test. A p value of <0.05
was considered to be significant.
2.9 Cold sensitivity assay
Strains that did not contain a plasmid were streaked on LB agar. Strains that contained a
multi-copy plasmid were streaked on LB agar supplemented with ampicillin. The strains
were grown for 24h at 37°Cand re-streaked in duplicate. Oneplatewas incubated at 37°C
and the other was grown at 25°C. Suppression was measured after colony formation at
25°C after 36 h. Plates were imaged using a Gel Doc (BioRad) or iPhone 5s (Apple).
2.10 Cold-sensitive suppressor frequency assay
Overnight cultures were grown at 37°C and serially diluted in duplicate, as described
above in Section 2.1.1. One plate was incubated at 37°C and the other at 25°C and grown
for 36 h. The suppressor frequencywas calculated by dividing the number of suppressors




The desired genewas cloned into pCA597, which has a amino-terminal Strep(II)-SUMO
tag, and the plasmid was transformed into E. coli strain BL21 DE3 by electroporation.
Transformants were streaked on LB supplemented with kanamycin. A single colony was
used to inoculate 25 ml LB supplemented with kanamycin in a 250 ml Erlenmeyer flask.
Cells were grown to late log phase at 37°Cuntil anOD600 of 1.00was achieved. The flasks
were moved to 30°C for 30 minutes before protein expression was induced for 2 hours
with 1 mM IPTG.
2.11.2 Protein purification
The induced cells were pelleted at 16000 g for 5 minutes at 4°C. The pelleted cells were
resuspended in Lysis Buffer (10 mM [HEPES]-KOH [pH 7.4], 100 mMKOAc, 10 mM
Mg(OAc)2) plus 10 mg Dnase I (Thermo Scientific) and 1 mM phenylmethylsulfonyl
fluoride (PMSF; Thermo Scientific). Lysis was achieved by sonication at 4°C using the
Biodisruptor® Plus (diagenode). Cells were sonicated for two sets of 10 x 30 seconds on
the highest setting. The cell debris was pelleted at 16000 g for 5 minutes at 4°C. 50 µl of
Strep(II)-Tactin® Sepharose® 50% suspension (iba) was pipetted into a microcentrifuge
tube using a pipette tip with a cut tip and centrifuged at 4000 g for 5minutes. The super-
natant was discarded carefully and the resin was resuspended in 1 ml Buffer 1. The wash
step was repeated three times. On the third wash, the resin was resuspended in 50 µl
Buffer 1. The clarified lysate and the Strep(II)-Tactin® Sepharose® 50% suspension were
incubated together in a microcentrifuge tube for 5 minutes at 4°C on an orbital shaker.
The resin was pelleted at 4000 g at 4°C for 1 minute and the supernatant was discarded.
The resin was resuspended in 1 ml Buffer 1 and incubated at 4°C for 1 minute on the or-
bital shaker. The resin was pelleted at 4000 g at 4°C for 1minute and the supernatant was
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discarded. The resin was resuspended in 1 ml High Salt Buffer (10 mM [HEPES]-KOH
[pH7.4], 1MKOAc, 10mMMg(OAc)2) and incubated at 4°C for 1minute on the orbital
shaker. The resin was pelleted at 4000 g for 1 minute at the supernatant was discarded.
The resin was dried using the Concentrator 5301 (Eppendorf) at 60°C. The dried resin
was resuspended in 50 µl 2X Laemmli sample buffer (Sigma Aldrich) and analysed by
SDS-PAGE and Coomassie staining.
2.11.3 Mass Spectrometry
Coomassie stained protein samples were excised from the SDS-PAGE gel using a razor
blade and stored at -20°C in a microcentrifuge tube that had been sealed with parafilm
until analysis. Samples were submitted for analysis by MALDI mass spectrometry (Dr.
Jinglei Yu, Functional Genomics, University of Birmingham). Peptides were referenced
to E. coli K12.
2.11.4 Analysis of mass spectrometry data
The results of the mass spectrometry were analysed manually. Each protein identified by
the mass spectrometry was given a score that was the sum of the ion scores of all peptides
that were identified, which gave an indication of the prevalence of the protein in the sam-
ple analysed. The score was determined by Dr. Jinglei Yu. A minimum score of 40 was
applied to each of the biological replicates. If the protein was present in both biological
replicates after the initial scoring filter was applied, then the interaction was considered
to be positive.
2.12 Citrate synthase aggregation assay
The citrate synthase assay was done as described in Shah et al. (2016), with a few differ-
ences. Porcine heart citrate synthase (Sigma) at a concentration of 200 nM (monomer
concentration) was mixed in 1 ml of assay buffer (10 mM [HEPES]-KOH [pH 7.4], 100
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mMKOAc, 10 mMMg(OAc)2) with the protein of interest at a 1:1 molar ratio in micro-
centrifuge tubes. The reaction mixture was incubated in a preheated ThermoMixer® C
(Eppendorf) at 50°C. After 30minutes, the samples were transferred to 1ml cuvettes and
the light scatteringwasmeasured at 320 nm. Datawere analysed using one-wayANOVA.
A p value of <0.05 was considered to be significant.
2.13 ATPase assay
For the ATPase assay, the protocol described by Robson et al. (2009b) was used.
proOmpA-myc was used as the model substrate. Reactions of 30 µM SecA, 4.6 µM
SecYEG-reconstituted proteoliposomes, 20 mM phosphoenolpyruvate, 20 µMNADH,
9-14 Units of Pyruvate Kinase/Lactic Dehydrogenase and 30 nM SecAN95 (monomer
concentration) in TKM buffer (20 mM [Tris]-HCl [pH 7.5], 50 mM KCl, 2 mM
MgCl2 were incubated at 25°C with 10 µM of the protein of interest. 1mM ATP and
0.7 µMproOmpA-mycwere added sequentially to each reaction andmixed by pipetting.
ATP consumption was coupled to NADH depletion using a pyruvate kinase/lactate de-
hydrogenase regenerating system in the presence of excess phosphoenolpyruvate at 25°C.
The absorbance at 340nm followedusing aLambda 25 spectrophotometer (PerkinElmer
Life Sciences). Rates were determined bymanually fitting the change in NADH concen-
tration to a straight line, and the slopes (inΔA390.min−1) divided by the concentration of
SecAN95 and the molar extinction coefficient of NADH (6220 M−1 at 340 nm) to give
(M ATP).(M SecA)−1.min−1. Significance was determined using single-factor ANOVA.
A p value of <0.05 was considered to be significant.
2.14 Translocation assay
Translocation efficiencies were determined using an in vitro translocation assay (Gold et
al., 2007; Robson et al., 2009b; Allen et al., 2016). proOmpA-myc was used as themodel
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substrate. Reactions of 30 µMSecA, 4.6 µMSecYEG-reconstituted proteoliposomes, 20
mM phosphoenolpyruvate, 20 µM NADH, 9-14 Units of Pyruvate Kinase/Lactic De-
hydrogenase and 30 nM SecAN95 (monomer concentration) in TKM buffer (20 mM
[Tris]-HCl [pH 7.5], 50 mM KCl, 2 mM MgCl2 were incubated at 25°C with 10 µM
of the protein of interest. 1mM ATP and 0.7 µM proOmpA-myc were added sequen-
tially to each reaction and mixed by pipetting. After a 30 min in vitro translocation re-
action at 25°C, all material that had not been translocated was degraded with protease K
(SigmaAldrich), and the translocatedmaterial quantified by western blotting against the
carboxy-terminus myc-tag of pro-OmpA. Translocation bands were quantified using an
Odyssey imaging system (LICOR).
2.15 One-dimensional thin-layer chromatography
To determine the lipid content of the protein, one-dimensional thin-layer chromatogra-
phy was used according to a protocol described by Isom (2017). Thin-layer chromatogra-
phy (TLC) plates (Silica gel 60 -Merck Millipore) were used. The plates were 10 cm long
and a width that allowed 1 cm between each sample, plus 1 cm at each edge. 5 µl glass
microcapillary tubes (Sigma Aldrich) were used to load 10 µl of the sample, control and
each of the standards 1 cm from the bottomof theTLCplate. A solvent systemof 65:25:4
chloramphenecol:methanol:water was used to separate phospholipids by the polarity of
the head group. The TLC plate was placed in the solvent system, with the samples at the
bottom, until the solvent front was approximately 1 cm from the top. The TLC plate
was dried for 30 minutes. The TLC plate was stained with phosphomolybdic acid and




Protein was diluted in 10mMpotassium phosphate buffer, pH 7.2 (SigmaAldrich). The
spectra were acquired using a Jasco 1.5 spectropolarimeter. Data were collected between
200 and 260 nmwith a wavelength step of 0.2 nm. After each spectrum, the temperature
was increased incrementally from 15.55℃C to 87.4℃C.
2.16.2 Data analysis
Data were analysed using the online K2D software platform (Andrade et al., 1993).
2.17 UV-vis spectroscopy
Apo-protein was prepared by incubating the purified protein for 1 hour with 0.1 mM
EDTA to chelate divalent cations. The EDTAwas removed by dialysing the protein into
Buffer 1 (10 mM [HEPES]-NaOH [pH 7.4], 100 mM KOAc, 10 mMMg(OAc)2 using
SnakeSkin™Dialysis Tubing (10KMWCO) (ThermoFischer Scientific) overnight at 4°C.
A Cary 50 Bio UV-Vis spectrophotometer and Hellma 10 mm cuvettes were used for
scanning UV-vis spectroscopy experiments. The temperature was maintained at 22°C. A
buffer only sample was measured in triplicate. The average buffer only UV-vis spectrum
was subtracted from the experimental data. All samples were measured in triplicate.
2.18 Inductively coupled plasma optical emission spectrom-
etry
Protein at a final concentration of 50 mg/l in Buffer 1 plus 2% v/v nitric acid (Sigma-
Aldrich) was used. The nickel affinity column was cleaned with 10 ml of 0.1 M EDTA
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(Thermo Fischer Scientific). Subsequently, nitric acid was added to the EDTA solution
to a final concentration of 2% v/v. ZnSO4 (Sigma-Aldrich), FeSO4 (Sigma-Aldrich) and
MnSO4 (Sigma-Aldrich) were each prepared at 18 nM, 180 nM and 1.8 µM in sterile,
deionised H2O containing 2% v/v nitric acid.
The samples were submitted to Dr. Maria Thompson (School of Geography, Earth and
Environmental Sciences, University of Birmingham) and analysed using a Varian 725-ES
ICP-OES instrument.
The peak wavelengths for each element were determined manually. The emission inten-
sity of the standards at the respective wavelength for each element was used to derive the
calibration curves. The gradient and y-intercepts of each calibration curve were used to
calculate the concentration of each element from its emission intensity at the appropriate





where ε was the emission intensity, m was the gradient and c was the y-intercept. The
peak wavelength for Fe was 238.204 nm. The peak wavelength was 257.61 nm for Mn
and for Zn the peak wavelength was 206.1888 nm.
2.19 Electronparamagnetic resonance (EPR) spectroscopy
FeCl3 (Sigma Aldrich) was analysed in the presence and absence of an equimolar concen-
tration of apo-protein byDr. Janet Lovett and Anokhi Shah (University of St. Andrews)
on a Bruker Elexsys E580 spectrometer with an ER 5106QT-2w cylindrical resonator op-
erating at 34 GHz (Q-band) at 10 K, which was maintained by a cryogen free variable
temperature cryostat (fromCryogenic Limited). Quartz tubeswith 3mmouter diameter
were used. Both samples were analysed in Buffer 1 containing 30% v/v glycerol. Exper-
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iments were done with field sweeps from 1000 G to 17000 G with 4000 points using a
π
2−π Hahn echo sequence where the π pulse lengthwas 32 ns and the time between pulses
was 400 ns. The power level was determined by observing the maximum echo. The shot
repetition time was set at 100 µs with 50 shots per point, which was sufficient for the
iron, though caused some saturation of theMn2+ contaminant peak. The resultant echo-
detected field swept profiles were plotted taking account any video gain differences and
numbers of averages. The results were normalised to the maximal EPR intensity by Dr.
Janet Lovett. Using the formula
hv = gB0 β, (2.2)
where h is Planck’s constant, v is the frequency (in this case, at the Q band, 34 GHz), B0
is themagnetic field and β is the Bohrmagneton, the g-factor for the protein-bound iron
cofactor was determined.
2.20 Small Angle X-ray scattering (SAXS)
2.20.1 Data collection
SAXS data were collected by Dr. Tim Knowles and Dr. Mohammed Jamshad on the
BM28 beamline at ESRF, Grenoble using an in-line S200 10/300GL size exclusion chro-
matography column (GE Healthcare) to remove aggregates. The sample was run at a
concentration of 10 mg/ml and data were collected under continuous flow every second.
2.20.2 Data analysis
Two-dimensional scattering plotswere averaged automatically at the beamline. PRIMUS
software was used to analyse the scattering pattern, subtract the buffer background, gen-
erate Guinier plots and generate Kratky plots (Konarev et al., 2003). Kratky plots were
used to verify that the protein was correctly folded. The slope of the Guinier plot was
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used to calculate the radius of gyration (Rg). SAXS MoW2 was used to determine the
molecular weight of the protein from the scattering data (Fischer et al., 2010). Standard
settings in CORAL (Petoukhov et al., 2012) were used to model the SAXS data onto
the known crystal structures of YgfB (PDB ID: 1IZM, Galkin et al., 2004) and the SecA-
MeBD (PDB ID: 1TM6,Matousek and Alexandrescu, 2004). At the amino-terminus of
1IZM, 10 dummy glycine residues were modelled. At the carboxy-terminus of 1IZM a
flexible linker of 19 dummy glycine residues was modelled to link with 1TM6. The 1IZM
structure was fixed and the 1TM6 was free in solution. The spatial step was 5 Å and the
angular step was 20°. This was done in collaboration with Dr. Tim Knowles.
2.21 Phyre2 modelling
The FASTA protein sequence was uploaded to the online Phyre2 platform (Konarev et
al., 2003). Phyre2 builds a structural model of a protein using the structures of known
proteins with sequential homology as a template. Templates with a confidence of >90%
were considered to provide accurate models of the core of the protein (2-4Å rmsd from
native, true structure) (Konarev et al., 2003). Templates with <90% confidence were
considered in the absence of an alternative region. 8 residues were modelled ab initio
by Phyre2.
2.22 X-ray crystallography
After gel filtration, YecA was concentrated using a Vivaspin 500 concentrator (GE
Healthcare,MWCO 10000), to 20mg/ml. The following 96 condition screens were used
to test for crystal formation: JCSG+, ProPlex, Morpheus HT-96, Midas HT-96 (Molec-
ular Dimensions). Sitting drops were set up at a 300:300 nl protein:condition ratio man-
ually, with a 30 µl reservoir in each condition. The crystal trays were checked at regular




1H15N-labelled apo-protein was prepared by treating with 2 mM EDTA at 4°C, as
indicated. The EDTA was removed by dialysis using SnakeSkin™ Dialysis Tubing (10K
MWCO) (ThermoFischer Scientific) into 20 mM [MES]-NaOH [pH 6.5] 10 mM
NaCl. 1H15N-YecA was analysed at a concentration of 1.1 mM in 20 mM [MES]-NaOH
[pH 6.5] 10 mMNaCl. 1H15N-YecA201 was analysed at a concentration of 0.84 mM in
20mM[MES]-NaOH[pH6.5] 10mMNaCl using a 5mmShigemi tube (Shigemi Inc.).
For all experiments the temperature was set to 298 K and a Bruker 900 MHz spectrom-
eter that was equipped with a 4-channel AVANCE III HD console and a 5mm TCI z-
PFG cryogenic probe with enhanced 13C, 15N, 1H, 2H sensitivity was used. The spectral
width was set to 14 ppm in the 1H direction and 30 ppm in the 15N direction for all ex-
periments. The centre of the spectrum was 4.698 ppm in the 1Hdirection and 118 in the
15N direction. Prior to Fourier Transformation, the 1H dimension was solvent filtered
then both dimensions were apodised with a standard cosine bell function. Each dimen-
sion was then zero filled, the 1H dimension to 256 (t1) and the 15N dimension to 2048
(t2) complex points. The spectra were then phased and polynomial baseline corrected in
all dimensions to produce the spectra shown.
2.23.2 NMR Spectroscopy for backbone assignments
15N13C-labelled protein was prepared in 20 mM [MES]-NaOH [pH 6.0], 10 mMNaCl
in a 5 mm Shigemi tube (Shigemi Inc.). YecA was used at a concentration of 0.5 mM
using a 5 mm Shigemi tube (Shigemi Inc.). The 1H, 15N, and 13C resonances of the YecA
backbone were assigned using triple resonance experiments. BEST TROSY versions of
HNCA, HN(CO)CA, HNCACB, HN(CO)CACB, HNCO, HN(CA)CO were used
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for backbone assignments (Clubb et al., 1992; Grzesiek and Bax, 1992; Lescop et al.,
2007; Kay et al., 1992; Kay and G. Y. Xu, 1992; Salzmann et al., 1998, 1999; Schanda
et al., 2006). The spectral width was set to 14 ppm in the 1H direction and 30 ppm in
the 15N direction for all experiments. The centre of the spectrum was 4.698 ppm in
the 1H direction and 118 in the 15N direction. For the HN(CO)CACB and HNCACB
experiments the spectral width was 76 ppm in the 13C direction with 32% and 25%
non-uniform sampling with 64 scans per increment, respectively. For the HNCA and
the HN(CO)CA experiments the spectral width was 30 ppm and the centre of the
spectrum set to 55.9 ppm. Non-uniform sampling was set to 20 and 15% respectively,
with 32 scans per increment. The non-uniform sampling for the HNCA was 15% and
for the HN(CO)CA the non-uniform sampling was 20% with 32 scans per experiment.
HN(CA)CO and HNCO 16 ppm 176.2 centre. The HN(CO)CACB experiment
had 25% non-uniform sampling. Non-uniform sampling was used for all backbone
experiments using a Bruker 900 MHz spectrometer that was equipped with a 4-channel
AVANCE III HD console and a 5mm TCI z-PFG cryogenic probe with enhanced 13C,
15N, 1H, 2H sensitivity. The temperature was set at 298 K for all experiments.
Data were processed using QMDD software and nmrPipe, the spectra were analysed in
nmrDraw and Sparky.
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Table 2.4: E. coli cloning and expression strains
Strain Genotype and Description Reference or Source
BL21 DE3 B F- dcm ompT hsdS(rB- mB-) gal [malB+]K12(λS) Lab Stock
E. coliDE3 T7 express, protein expression strain
DH5α F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR
nupG Φ80dlacZΔM15 Δ(lacZYA-argF )U169,
hsdR17 (rK- mK+), λ–
Lab Stock
Transforms with high efficiency
MG1655 F-, lambda-, rph-1 Lab Stock
DHB6501 K12 F-, λ-, λsΔlac(MS265), mel-1, nalA2, supF58
(=suIII, tyrT58 )
Boyd et al. (2000)
DHB6521 DHB6501 λInCh1 (Kanr) Boyd et al. (2000)
Table 2.5: E. coli experimental strains
Strain Genotype and Description Reference or Source
N48 N48 [MM18 (MC4100 Φ(malE′-′lacZ))
recA1]
Bassford Jr. et al. (1979)
TCS103 DRH509 yecA::kan This study
TCS138 TCS103 attλ::yecA This study
TCS139 TCS138 attλ::yecA201 This study
DRH901 MG1655 yecA::kan D. Huber
DRH901 MG1655ΔyecA D. Huber
DRH902 MG1655 secB::kan D. Huber
DRH903 MG1655ΔyecA secB::kan D. Huber
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Table 2.6: Plasmids used in this study
Plasmid Description Source
pCA597 Kanamycin-resistance, empty plasmid vec-
tor that contains a T7-inducible promoter.
Cloned proteins will have a Strep(II)-SUMO
tag at the amino-terminus
Andréasson et al. (2008)
pCA528 Kanamycin-resistance, empty plasmid vec-
tor that contains a T7-inducible promoter.
Cloned proteins will have a His6-SUMO tag
at the amino-terminus
Andréasson et al. (2008)
pTrc99a Ampicillin-resistant, bacterial expression vec-
tor with inducible lacI promoter
Invitrogen
pCS070 pCA528-His6-SUMO-yecA This study
pCS071 pCA528-His6-SUMO-yecA201 This study
pDH963 pCA597-Strep(II)-SUMO-yecA D. Huber
pCS163 pCA528-His6-SUMO-yecA201 This study
Table 2.7: Primers used in this study
Primer Sequence (5′to 3′) and Description
YecA_for CCA-GTG-GGT-CTC-AGG-TGG-TAT-GAA-AAC-
GGG-ACC-GTT-AAA-CG
Forward primer for the amplification of yecA
YecA_rev CGC-GGA-TCC-TTA-ATG-CAG-GCA-GCA-CTG-
CTT-AAA-TTT-C
Reverse primer for the amplification of yecA
YecA201_for GCA-GAA-AAA-CGG-TAA-GAA-TTC-GAG-CTC
Forward primer to delete the YecA-MeBD by QuikChange®
mutagenesis
YecA201_rev GAG-CTC-GAA-TTC-TTA-CCG-TTT-CTC-TTC








Reverse primer to delete the YecA-MeBD by QuikChange®
mutagenesis
Chapter 3
THE ROLEOF YECA IN
SEC-DEPENDENT PROTEIN




YecA is a protein of unknown function that has a carboxy-terminal domain, the
YecA-MeBD. The YecA-MeBD has sequence similarity to the SecA-MeBD. It was
hypothesised that these two domains may be functionally homologous. SecA interacts
with SecB via the SecA-MeBD (Patel et al., 2006), an interaction that is stabilised when
the SecA-MeBD coordinates zinc (Fekkes et al., 1999). The SecA-MeBD and SecB
are not fully co-conserved (Fekkes et al., 1997). Therefore, the SecA-MeBD may have
other binding partners. Due to the role of SecA in the secretion of proteins, YecA was
investigated using techniques that were used to identify and derive the function of Sec
proteins.
One genetic strategy for investigating Sec-dependent translocation in vivo is to use
gene fusions. In the 1970s, gene fusions that were composed of the amino terminus
of a secreted protein and the carboxy-terminus of β-galactosidase (LacZ) were used to
investigate how proteins were localised to the periplasm of E. coli (Beckwith, 2013).





lacZ is an example of a gene fusion that was used to investigate how proteins
were localised to the correct subcellular compartment. Initially, it was shown that high
expression of MalE′-′LacZ was toxic due to the jamming of the cytoplasmic membrane
channel (Bassford Jr. et al., 1979). Other fusion proteins were used to identify mutations
in the signal sequence that caused the fusion protein to avoid recognition by the Sec
machinery and remain in the cytoplasm (Bassford Jr. et al., 1979). β-galactosidase is
only active when folded in the cytoplasm and subsequent studies screened for defects in
the Sec pathway that yielded increased β-galactosidase activity. Using this method secA
(Oliver and Beckwith, 1981, 1982), secB (Kumamoto and Beckwith, 1983) and secDF
(Gardel et al., 1987, 1990) were identified.
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Genetic interactions, such as synthetic lethality or suppression, can suggest that there
is a functional relationship between the gene products. For example, the relationship
between secA and secB was investigated by constructing double mutants (Kumamoto
and Beckwith, 1983). The accumulation of secretory proteins in the cytoplasm was
more severe in the double mutant strains compared with the single mutant strain. The
subsequent discovery of a direct and functional interaction between SecA and SecB
underlines the role of genetic interaction studies in understanding biological systems
(Hartl et al., 1990).
Biochemical techniques have also been invaluable for characterising the Sec machinery.
For example, the in vitro translocation system that was described by Lill et al. (1989) can
directly measure the translocation-coupled hydrolysis of ATP. Initially, radioisotope-
labelled ATP was used but the development of a coupled regeneration system allowed
spectroscopic measurement of ATP hydrolysis. This system has been used to investigate
the mechanism of protein export by investigating the effect of SecB (Wang et al., 2008;
Mao et al., 2009), lipids, SecYEG and secretory proteins (Robson et al., 2009b) on the
translocation-coupled ATPase activity of SecA.
In this chapter, a combination of in vivo assays and biochemical experiments were used to
investigate whether YecA is an auxiliary Sec protein. Initially, the effect of YecA on pro-
tein translocationwas studied using a reporter gene,malE′-′lacZ. The genetic interaction
between secB and yecA was then investigated. Further interaction partners of YecA were
investigated using a pull-down assay. Subsequently, YecA was characterised using an in
vitro assay designed to investigate whether YecA was a chaperone, and then an in vitro
translocation system was used. This chapter describes the first data to suggest that YecA
is involved with the translocation of secretory proteins in E. coli.
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3.2 Results
3.2.1 Construction of isogenic strains to investigate the role of YecA in
posttranslational translocation
The yecA gene spans the positions 1990954 to 1991619 on the E. coli K12 MG1655
genome (NC_000913.3). N48 is a K12 derivative of E. coli strain MC4100 that has a
chromosomalmalE ′-′lacZ gene fusion. To investigate the function ofYecA, a kanamycin
resistance cassette was introduced at the yecA locus of N48 by P1 transduction, thereby
creating strain TCS103. Subsequently, using λInCh, two strains were constructed that
encoded yecA (denoted TCS138) or yecA201 (denoted TCS139) at the λ locus. The ex-
pression of the yecA and yecA201 genes was under IPTG control. This resulted in four
isogenic strains that were verified bywhole genome sequencing using Illumina (Microbes
NG) and used in the following assay.
3.2.2 The effect of YecA andYecA201 on posttranslational translocation
using a β-galactosidase assay
To investigate whether YecA had a role in the Sec pathway, E. coli strain MC4100 that
contained a gene fusion between the lacZ gene, which encoded the cytoplasmic enzyme
β-galactosidase (LacZ), and the malE gene, which encoded the periplasmic maltose
binding protein (MalE, MBP), was used (Bassford Jr. et al., 1979). MBP is secreted
to the periplasm by posttranslational translocation. The activity of β-galactosidase
can be detected colourimetrically either through the hydrolysis of the substrate 5-
bromo-4-chloro-3-indolyl-D-galactopyranoside, which produces an insoluble blue
precipitate, or by the hydrolysis of ortho-nitrophenyl-β-galactoside, which is colourless,
to ortho-nitrophenol, which is yellow (Matsumara and Rowe, 2005). When LacZ
is fused to the carboxy-terminus of MalE, β-galactosidase activity is low because the
fusion protein is targeted for export and LacZ is unable to fold (Dwyer et al., 2014). A
61
mutation that decreases the efficiency of translocation of the fusion protein results in
the increased accumulation of MalE′-′LacZ in the cytoplasm and a concurrent increase
in β-galactosidase activity compared with the parent strain. This assay was used to
determine the effect of YecA and the YecA-MeBD on posttranslational translocation.
In initial experiments, the effect of the presence or absence of YecA on the β-galactosidase
activity of the fusion protein MalE′-′LacZ was determined (Figure 3.1). N48 (the
parent strain), TCS103 (yecA::kan), and TCS138 (yecA::kan λ-yecA) were grown in
M63 minimal medium supplemented with 0.2% maltose to mid-exponential phase and
induced with 1 mM IPTG for 2 hours. To investigate the importance of the YecA-MeBD
for activity of YecA in relation to the export of the MalE′-′LacZ fusion protein, strain
TCS139 (yecA::kan λ-yecA201) was assayed for β-galactosidase activity under the same
conditions. The cultures were harvested, lysed and assayed for β-galactosidase activity.
Data from three biological replicates, which were measured on separate days, were
collated and normalised to the β-galactosidase activity of TCS103. N48 had the lowest
relative β-galactosidase activity at 0.0186 ± 0.0142. The relative β-galactosidase activity of
TCS103was 1.00± 0.563 units. The deletion of the yecA gene resulted in nearly a 50-fold
increase in the relative β-galactosidase activity compared with N48, the parent strain.
The difference between the relative β-galactosidase activities of the parent strain and
TCS103 indicated that the mutation of yecA caused the accumulation ofMalE′-′LacZ in
the cytoplasm.
The relative β-galactosidase activity of strain TCS138 was 0.522 ± 0.164. The relative β-
galactosidase activity of strain TCS139 was 0.116 ± 0.0264. These results suggested that
expression of YecA from the λ locus decreased the accumulation ofMalE′-′LacZ in the cy-
toplasm compared with the yecA deletion mutant. However, the relative β-galactosidase
activity was lower when YecA201 was expressed compared with the full-length protein.




























Figure 3.1: β-galactosidase assay to show the effect of YecA and YecA201 on the targeting
of MalE′-′LacZ to the cytoplasmic membrane.
Strains were grown in M63 minimal medium supplemented with 0.2% maltose to in-
duce malE expression. At mid-log phase the cells were induced with 1 mM IPTG for 2
h. 0.5 ml of culture was added to 0.5 ml Z-Buffer and lysed using 0.1% SDS and chloro-
form. Subsequently, the β-galactosidase activity was assayed at 28°C by the addition of
ortho-Nitrophenyl-β-galactoside to the cell lysate. The hydrolysis of ortho-Nitrophenyl-
β-galactoside to ortho-Nitrophenyl-β-galactose results in a colourimetric change from
colourless to yellow. When a yellow colour had developed the reaction was stopped. To
decrease the contribution of cell debris to the light scattering, the samples were pelleted
and the colour change of the supernatant was measured spectrophotometrically at 420
nm. The contribution of cell debris to the light scattering was measured spectrophoto-
metrically at 550 nm. The β-galactosidase activity was calculated using equation 2.8.2.
Results are the mean of three independent biological replicates that were undertaken on
separate days. Data are expressed as relative to the mean of the yecA deletion strain and
analysed by one-way ANOVA (p = 0.0375). The Tukey post hoc test identifed a signif-
icant difference between the parent strain and the yecA::kan mutant strain p = 0.0434,
indicated by an asterisk) The error bars represent the standard error.
63
strain, which suggested that the truncated protein was either more active or more stable
than the full-length protein in vivo.
3.2.3 The genetic interaction between secB and yecA
The effect of deleting yecA in E. coli strain MG1655 was investigated. Defects in protein
secretion have been linked to a cold sensitive (CS) phenotype (Pogliano and Beckwith,
1993). For example, a secB::kan mutant is mildly CS (Ullers et al., 2007). SecB is a
chaperone that maintains preproteins in an unfolded state in the cytoplasm for post-
translational translocation. MalE is an example of a protein that is SecB-dependent for
export to the periplasm. The result of the β-galactosidase assay described in Section 3.2.2
indicated that YecA had an effect on the targeting and export of MalE to the periplasm.
Therefore, to investigate whether the deletion of yecA resulted in a similar CS pheno-
type, the growth of E. coli strains MG1655, DRH901 (MG1655 ΔyecA), DRH902
(MG1655 secB::kan) and DRH903 (MG1655ΔyecA secB::kan) were compared at 37°C
and 25°C (Figure 3.2). The growth of DRH901 at 37°Cwas not different fromMG1655
or DRH902 (Figure 3.2a). DRH902, the secB::kanmutant, had in a mild growth defect
at 25°C compared with the parent strain, MG1655 (Figure 3.2b). However, DRH901
grew similarly to MG1655 at 25°C (Figure 3.2b). Therefore the deletion of yecA did not
result in a CS phenotype.
DRH903, thedouble deletion strain,wasused to investigatewhether thedeletionof yecA
had an effect on the growth defect of DRH902, the secB::kanmutant strain. Growth of
DRH903 at 37°C was similar to the parent strain (MG1655), DRH901 and DRH902.
At 25°C, growth of DRH903 was severely CS compared with DRH902, the secB::kan
mutant. After 24 h, there was no observed growth of DRH903 (Figure 3.2b).
The growth of DRH903 resulted in the selection of suppressor mutations at 25°C. To





















(b) The effect of deleting yecA on growth at 25°C
Figure 3.2: The effect of deleting yecA on growth
Strains were streaked on LB agar at 37°C and grown for 24 h (3.2a) or 25°C and grown
for 36 h (3.2b). The figure is representative of six, independent biological replicates.
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deletion strain were serially diluted to 10-7, plated on LB agar and grown at 25°C and
37°C. The suppressor mutation frequency was determined by dividing the number of
mutants with the total number of colonies, which resulted in an apparent suppressor
frequency of 10-2 (n = 3).
To investigate whether expression of yecA from a plasmid could complement the mild
CS growth defect of the DRH902 and the severe CS phenotype of DRH903, the strains
MG1655, DRH902 and DRH903 were transformed with pTrc99a or pTrc99a-yecA
and grown on LB agar in the presence or absence of 1 mM IPTG at three different
temperatures: 37°C, 25°C and 22°C. The plasmid pTrc99a had no effect on the growth
of any strain in the presence or absence of IPTG at 37°C, 25°C and 22°C. The growth
of MG1655 pTrc99a-yecA was unaffected by the presence or absence of IPTG at 25 and
22°C compared with the growth of MG1655 pTrc99a, however a mild growth defect of
MG1655 pTrc99a-yecAwas observed in the presence of IPTG at 37°C comparedwith the
growth of MG1655 pTrc99a (Figure 3.3). This result suggested that the over-expression
of yecA was mildly toxic at 37°C.
The growth phenotype of DRH902 pTrc99a was the same as DRH902 pTrc99a-yecA at
each temperature in the presence of IPTG.However, in the absence of IPTG, the growth
phenotype of DRH902 pTrc99a-yecA strain was similar to that of MG1655 pTrc99a at
both 25°C and 22°C. This result indicated that the basal level of YecA expression from
the pTrc99a-yecA plasmid was sufficient to suppress the mild CS phenotype caused by
the deletion of secB. The deletion of both secB and yecA caused a severe CS phenotype
that was not suppressed in the absence of IPTG by the basal level of expression of yecA
from pTrc99a-yecA. In the presence of IPTG the production of YecA from pTrc99a-yecA
suppressed the CS phenotype of the double deletion strain at 25°C. At 22°C, the expres-
sion of yecA from pTrc99a-yecA partially suppressed the CS growth defect of the double
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(b) Cold sensitivity assay to show the inducible suppression of the CS phenotype by yecA
Figure 3.3: The expression of yecA affects the CS phenotype of a secB::kan strain
The strains were streaked from a single colony onto LB agar supplemented with ampi-
cillin and grown for for 24 hours in the presence or absence of IPTG at either 22°C, 25°C
or 37°C. Plates are representative of three independent experiments. The plate map in
3.3a shows the strain name, the genotype and the plasmid for each segment. 3.3b shows
the growth of these strains at 22°C, 25°C or 37°C in the presence or absence of 1 mM
IPTG.
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and yecA and that the suppression of the CS phenotype was affected by the expression
level of YecA.
3.2.4 Identification of the interaction partners of YecA and YecA201 us-
ing a pull-down assay
The genetic analysis suggested a role for YecA in Sec-dependent translocation. It was
reasoned that if YecA was an auxiliary Sec protein, then proteins from Sec machinery,
exported proteins or the ribosome would co-purify with YecA. A pull-down assay was
used to analyse the protein-protein interactions of YecA in vivo.
To investigate the effect of deleting the YecA-MeBD on the protein-protein
interactions of YecA, pCA597-yecA201 was first constructed using primers
Strep_YecA201_for and Strep_YecA201_rev and pCA597-yecA
(pDH963) as a DNA template. Following the PCR reaction the mixture was in-
cubated with DpnI to digest the template DNA. Subsequently, the template DNA
was incubated with BsaHI HF to linearise the DNA. The linear DNA was analysed by
agarose gel electrophoresis. Figure 3.4 compares the linearised template DNA (Lane
1) with the PCR product DNA (Lane 2). There was a small decrease in the molecular
weight of the PCR product compared with the template DNA. The difference in size
between the two samples is 60 base pairs, therefore the difference was expected to be
small. The PCR product was transformed into E. coli strain BL21 DE3 by electropora-
tion and the deletion of the YecA-MeBD was confirmed by sequencing. The resulting
plasmid was denoted pCS163 and the strain was denoted TCS163.
Three plasmid constructs were used for the pull-down assay (Figure 3.5). pCA597
contained a Strep(II)-SUMO construct. pCA597-yecA contained Strep(II)-SUMO-
yecA and pCA597-yecA201 contained Strep(II)-SUMO-yecA201. Each plasmid was
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Figure 3.4: Agarose gel electrophoresis of restriction digest products to screen for the
construction of pCA528-yecA201
Following PCR amplification of pCA597-yecA to delete 60 base pairs at the 5′ end of
yecA, the resultingPCRproductwas incubatedwithDpnI to digest the template plasmid
DNA. The PCR product and the template were digested with Bam HI HF analysed by
1% agarose gel electrophoresis. Lane 1 shows the linear template DNA, pCA597-yecA
and Lane 2 shows the PCR product, which was confirmed by sequencing to be pCA597-
yecA201.
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expression was induced by the addition of 1 mM IPTG for 2 hours. The cells were
pelleted and lysed by sonication. The lysate was centrifuged to pellet the cell debris
and then the clarified lysate was incubated with Strep(II)-Tactin beads. The beads were
washed once with Buffer 1 and washed once with High Salt Buffer to remove proteins
that were interacting non-specifically. After the washes, the supernatant was discarded.
The beads were dried in a speed vacuum and resuspended in Laemmli buffer. The
pull-down samples were analysed by SDS-PAGE and Coomassie staining.
A representative Coomassie gel of the pull-down is presented in Figure 3.6. The control,
Strep(II)-SUMO, resolved at approximately 22 kDa. Strep(II)-SUMO-YecA resolved
at 45 kDa and Strep(II)-SUMO-YecA201 resolved at 43 kDa. The full-length protein
co-purified with several protein bands with masses of between 75 and 180 kDa. YecA201
co-purified with several proteins between 63 and 245 kDa. The brackets in Figure 3.6
indicate the region for each sample that was excised from the gel and analysed by mass
spectrometry.
The pull down was repeated six times and the mass spectrometry was repeated twice.
The results of the mass spectrometry were analysed manually. Each protein identified
by the mass spectrometry was given a score that was the sum of the ion scores of all
peptides that were identified, which gave an indication of the prevalence of the protein
in the sample analysed. A minimum score of 40 was applied to each of the biological
replicates. If the protein was present in both biological replicates after the initial scoring
filter was applied, then the interaction was considered to be positive. Using this filter,
Strep(II)-SUMO did not have any positive protein-protein interactions. YecA201
interacted with CdsA, an RNADEAD helicase. The full-length protein interacted with
CdsA, EF-G, PNPase and DnaK.
The RNA helicase CdsA (also known as DeaD) co-purified with both YecA and
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Figure 3.5: Design of the constructs of recombinant proteins that were used in the pull-
down assay.
YecA has two domains, UPF0149 and the MeBD. YecA201 lacks only the MeBD. Both
YecA and YecA201 were expressed with an amino-terminal Strep(II)-SUMO tag. The
Strep(II)-SUMO tag was also expressed as a control. This figure was prepared with the
















Figure 3.6: Representative SDS-PAGE analysis of the protein-protein interactions of
YecA and YecA201
The protein-protein interactions of YecA was analysed using a pull-down assay. Expres-
sion of Strep(II)-SUMO, Strep(II)-SUMO-YecA and Strep(II)-SUMO-YecA201 was in-
ducedwith 1mMIPTG. Induced cultureswere pelleted, lysed and clarified by centrifuga-
tion. The clarified lysate was incubated with Strep(II)-Tactin beads for 5 minutes at 4°C.
The resinwaswashedwith Buffer 1 andHigh Salt Buffer, each for 1minute. The resinwas
pelleted, dried in a centrifugal evaporator and resuspended in Laemmli sample buffer. 10
µl of each sample was loaded on a 15% SDS-PAGE gel. The gel is representative of four
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Figure 3.7: Western blot analysis of the interaction of SecA with Strep(II)-SUMO-
YecA201
Thepull down sampleswere analysed for thepresence of SecAusingα-SecAantibody. 2µl
of 0.8 mM SecA was used as a control. The lane on the left shows the purified SecA and
the lane on the right shows the Strep(II)-SUMO-YecA201 pull down. SecA was resolved
at approximately 100 kDa. SecA was not detected in the Strep(II)-SUMO-YecA sample
or the Strep(II)-SUMO control sample.
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YecA201. The identification of CdsA in this assay was in agreement with other, more
stringent purifications that found that CdsA co-purified with YecA201 (Section 3.2.6).
YecA also co-purified with PNPase, an exoribonuclease (Briani et al., 2016).
DnaK co-purified with YecA. DnaK is a member of the HSP70 (Heat Shock Protein
of 70 kDa) family of ATP-dependent molecular chaperones (Bukau et al., 2006).
DnaK is a multifuctional chaperone that, in E.coli, assists with protein folding and
disaggregation and protein targeting and translocation through biological membranes.
A dnaK deletion confers a cold-sensitive phenotype. The deletion of both dnaK and
tig causes severe protein aggregation and a severe growth defect that is suppressed by the
overexpression of SecB (Ullers et al., 2007). As such, DnaK forms part of the network of
chaperones that indirectly enable the translocation of secretory proteins.
EF-G catalyses the movement of mRNA from the A to P to E sites in the ribosome,
together with the cognate tRNA molecule via the hydrolysis of GTP to GDP (Slasi et
al., 2015) and catalyses the recycling of the ribosome after the termination of translation
(Zhang et al., 43). An in vitro study found that EF-G can promote the folding of two
model substrates, citrate synthase and α-glucosidese, and that the GTPase activity of
EF-G stimulates the disaggregation of citrate synthase. EF-G is one of themost abundant
proteins in the cell (McLennan et al., 2013).
Themass spectrometry also suggested that YecA and YecA201 interacted with SecA how-
ever the score for one of the replicates for both YecA and YecA201 was below the mini-
mum. In addition, SecA was identified in the control using the same medium stringency
filter. This interaction was investigated byWestern blot, which indicated the presence of
SecA in the YecA201 sample, but not in either the control or the YecA sample (Figure
3.7).
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3.2.5 Construction of pCA528-yecA and pCA528-yecA201
To investigate the function of YecA in vitro, a plasmid that contained a gene fusion
betweenHis6-SUMO and yecA was constructed. The yecA gene sequence was amplified
by PCR using YecA_for and YecA_rev primers primers, purified and digested
with BsaI and BamHI HF. The PCR-amplified yecA was ligated into pCA528, which
expresses a T7-promoted His6-SUMO fusion tag, that had been digested with BsaI and
BamHI HF, and transformed into E. coli strain DH5α. The resulting colonies were
screened before sequencing by digesting with BamHI HF (Figure 3.8a). The plasmid
construct is designated pCA528-yecA. The plasmid was purified and transformed into
E. coli strain BL21 DE3 pCA528-yecA to create strain TCS070.
To investigate the role of the YecA-MeBD, a truncated variant of YecA that lacked
the distal 20-amino acid residues was constructed using pCA597-yecA as a template.
Residue 202 was replaced with a stop codon using the primers YecA201_for and
YecA201_rev. A diagnostic restriction digest was used to identify the loss of the
BamHI site in the construct. Plasmids that had lost the BamHI site were sequenced
using the primer T7-FP. The plasmid was transformed into E. coli strain BL21 DE3 by
electroporation to create the strain TCS071.
3.2.6 Purification of YecA and YecA201 for in vitro assays
To purify YecA and YecA201, the His6-SUMO-tagged fusion proteins were expressed
and purified as described in Section 2.5.4 and 2.6.2. Figures 3.9 and 3.10 show the
Coomassie-stained SDS-PAGE gels of the 0.5 ml imidazole elution fractions from the
nickel-affinity column. His6-SUMO-YecA resolved at approximately 37 kDa, which
approximately corresponds to the molecular weight of the fusion protein. His6-SUMO-
YecA201 also resolved at 37 kDa. Both His6-SUMO-YecA and His6-SUMO-YecA201


















(a) Agarose gel electrophoresis of Bam HI HF -
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(b) Agarose gel electrophoresis of restriction di-
gest products to screen for the construction of
pCA528-yecA201
Figure 3.8: Agarose gel electrophoresis to show the construction of pCA528-yecA and
pCA528-yecA201
3.8a shows the screen for the construction of pCA528-yecA201. YecA_for and
YecA_rev primers were used to amplify yecA from the chromosome. The result-
ing PCR product was purified and digested with BsaI and BamHI HF at 37°C. The
PCR-amplified yecA was ligated into pCA528 at 4°C overnight, which expresses a T7-
promotedHis6-SUMOfusion tag that had also been digestedwithBsaI andBamHIHF,
and transformed into E. coli strain BL21 DE3 by electroporation and plated on LB agar
supplemented with kanamycin. The resulting colonies were screened before sequencing
by digesting with BamHI HF.3.8b shows the agarose gel electrophoresis of the pCA528-
yecA following QuikChange® mutagenesis to introduce a stop codon at position 202 of
the amino acid sequence of YecA using YecA201_for and YecA201_rev primers.
The resulting PCR product was incubated with DpnI to digest the template plasmid
DNA and transformed into E. coli strain DH5α. The plasmid DNA was isolated and
incubatedwithBamHI HF andNcoI restriction digest enzymes. The templateDNA in
Lane 1 had both restriction sites because twoDNA fragments of 1000 base pairs and 5000
base pairs were resolved by agarose gel electrophoresis. The plasmid resolved in Lane 2
also had both restriction sites. Lane 3 suggested the successful insertion of the stop codon
because a single band at 6000 base pairs was resolved, which indicated that the Bam HI
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Figure 3.9: SDS-PAGE analysis of protein-containing fractions after nickel-affinity chro-
matography of YecA
YecA201 was expressed as a recombinant protein with an amino-terminal His6-SUMO
tag inE. coli strain BL21DE3. The cultureswere grown at 37°C inLB supplementedwith
kanamycin until late log phase. The temperature was dropped to 18°C and after 30 min-
utes at this temperature protein expression was induced by the addition of 1 mM IPTG.
The cells were induced overnight. The cultures were centrifuged to harvest the cells. The
cell pellet was resuspended in Buffer 1 supplemented with PMSF (to prevent protein de-
gredation) and Dnase I (to degrade DNA) and lysed by high pressure homogenisation.
The lysate was centrifuged to pellet un-lysed cells and cell debris. The supernatant passed
through a 0.45 µM filter to further clarify the lysate. The clarified lysate was applied to a
nickel-affinity column overnight at 4°C. The column was washed with five column vol-
umes of High Salt Buffer and with five column volumes of Buffer 1. The protein was
eluted from the column with 0.5 mM imidazole. After elution from the column, 10 µl
of the flow through and each protein-containing imidazole elution was mixed with 10 µl
Laemmli buffer and analysed by SDS-PAGE and Coomassie staining. * indicates a pro-
tein with a molecular weight of approximately 73 kDa that co-purified with YecA, which
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Figure 3.10: SDS-PAGE analysis of protein-containing fractions after nickel-affinity chro-
matography of YecA201
YecA201 was expressed as a recombinant protein with an amino-terminal His6-SUMO
tag inE. coli strain BL21DE3. The cultureswere grown at 37°C inLB supplementedwith
kanamycin until late log phase. The temperature was dropped to 18°C and after 30 min-
utes at this temperature protein expression was induced by the addition of 1 mM IPTG.
The cells were induced overnight. The cultures were centrifuged to harvest the cells. The
cell pellet was resuspended in Buffer 1 supplemented with PMSF (to prevent protein de-
gredation) and Dnase I (to degrade DNA) and lysed by high pressure homogenisation.
The lysate was centrifuged to pellet un-lysed cells and cell debris. The supernatant passed
through a 0.45 µM filter to further clarify the lysate. The clarified lysate was applied to a
nickel-affinity column overnight at 4°C at 0.5ml/min. The columnwas washed with five
column volumes of High Salt Buffer and with five column volumes of Buffer 1. The pro-
teinwas eluted from the columnwith 0.5mM imidazole. After elution from the column,
10 µl of the flow through and each protein-containing imidazole elution was mixed with
10 µl Laemmli buffer and analysed by SDS-PAGE and Coomassie staining. * indicates
a protein with a molecular weight of approximately 73 kDa that co-purified with YecA,





















Figure 3.11: SDS-PAGE to analyse the cleavage of the His6-SUMO tag from YecA and
YecA201 by Ulp1
After nickel-affinity chromatography, the protein was incubated with His6-Ulp1 at 4°C
overnight in the presence of 5mM β-mercaptoethanol. Ulp1 hydrolyses the peptide bond
at the carboxy-terminus of SUMO,which cleaves the amino-terminal tag from the recom-
binant protein. * indicates an unknown co-purifying protein with a molecular weight of
63 kDa.
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(b) SDS-PAGE to analyse anion exchange chromatography of YecA
Figure 3.12: Anion exchange chromatography of YecA
After the amino-terminal tag had been cleaved, YecA was applied to an anion exchange
column. The sample was applied manually to an anion exchange chromatography col-
umn that had be pre-equilibrated with Buffer 1. The flow rate was 1 ml/min. 3.12a shows
the elution trace of the anion exchange chromatography of YecA201. Right hand-side
y-axis: The concentration of KOAc was increased from 100 mM to 1 M (green). Left
hand-side y-axis: The elution of YecA from the anion exchange column was measured
spectrophotometrically at 280 nm (red) and 254 nm (blue). The elutions were collected
in 0.5 ml fractions for analysis by SDS-PAGE. 3.12b shows the SDS-PAGE analysis of
protein-containing fractions. 10 µl from every other fraction between 18.5ml and 24.5ml
was mixed with 10 µl Laemmli buffer and analysed by SDS-PAGE and Coomassie stain-
ing. * indicates an unknown co-purifying protein with a molecular weight of 135 kDa.
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(b) SDS-PAGE to analyse anion exchange chromatography of YecA201
Figure 3.13: Anion exchange chromatography of YecA201
After the amino-terminal taghadbeen cleaved, YecA201was applied to an anion exchange
column. The sample was applied manually to an anion exchange chromatography col-
umn that had be pre-equilibrated with Buffer 1. The flow rate was 1 ml/min. 3.13a shows
the elution trace of the anion exchange chromatography of YecA201. Right hand-side
y-axis: The concentration of KOAc was increased from 100 mM to 1 M (green). Left
hand-side y-axis: The elution of YecA201 from the anion exchange columnwasmeasured
spectrophotometrically at 280 nm (red) and 254 nm (blue). The elutions were collected
in 0.5 ml fractions for analysis by SDS-PAGE. 3.13b shows the SDS-PAGE analysis of
protein-containing fractions. 10 µl from every other fraction between 28 ml and 28 ml
was mixed with 10 µl Laemmli buffer and analysed by SDS-PAGE and Coomassie stain-
ing. * indicates an unknown co-purifying protein with a molecular weight of 63 kDa and
















(a) SDS-PAGE analysis of protein-containing fractions af-

















(b) SDS-PAGE analysis of protein-containing fractions af-
ter gel filtration of YecA201
Figure 3.14: SDS-PAGE analysis of YecA and YecA201 after gel filtration
Each protein was applied to an S75 10/300 GL column that had been pre-equilibrated
with Buffer 1 + 1 mMTCEP. YecA and YecA201 were concentrated and injected onto the
column. The flow rate was 0.5 ml/min and the elutions were collected in 5 ml fractions.
10 µl from each protein-containing fraction was mixed with 10 µl Laemmli buffer and
analysedby SDS-PAGEandCoomassie staining. 3.14a shows theCoomassie-stained SDS-
PAGE gel of the three protein-containing fractions of YecA after gel filtration chromatog-
raphy. YecA did not co-purify with any other protein bands. 3.14b shows the Coomassie-
stained SDS-PAGE gel of the three protein-containing fractions of YecA201 after gel fil-
tration chromatography. YecA201 co-purified with another protein. The co-purifying
band in lane 1 (elution volume 65 ml) was excised and analysed by mass spectrometry
and identified as CdsA, a RNADEADhelicase with a score of 3789 and peptide coverage
of 81%.
82
co-purified with both YecA and YecA201, as well as several bands of between 25 and 11
kDa, which were possibly ribosomal proteins.
Fractions 2-8 for both YecA and YecA201 were pooled and incubated with SUMO
protease (Ulp1) overnight at 4°C in the presence of 5 mM β-mercaptoethanol to
prevent the oxidation of cysteine residues. Figure 3.11 shows that the SUMO protease
had cleaved approximately 90% of the amino-terminal tag from YecA and YecA201.
To remove contaminating proteins, cleaved YecA was purified using anion exchange
chromatography. Figure 3.12a shows the elution trace of YecA from the anion exchange
column. The elution volume was collected in 0.5 ml fractions and fractions 28.5 to 32
ml contained protein, according to the elution trace. These fractions were analysed by
SDS-PAGE and Coomassie staining (Figure 3.12b), which showed that YecA was nearly
pure. Fractions 28 to 30 ml were pooled and concentrated. Fractions 31 to 32 ml did not
contain much YecA but an unidentified protein (marked with an asterisk) was resolved
in these fractions at a molecular weight of approximately 135 kDa.
YecA201 was also purified by anion exchange chromatography. Figure 3.13a shows
the elution trace of YecA201 from the anion exchange column. The elution volume
was collected in 0.5 ml fractions, as before, and fractions 24.5 to 28 ml contained
protein, according to the elution trace. These fractions were analysed by SDS-PAGE and
Coomassie staining (Figure 3.13b), which showed that YecA201 had co-purified with
several contaminating proteins. The prominent bands are indicated on the gel. One of
these bands was the correct molecular weight to be the His6-SUMO-YecA201. A second
band of 75 kDa and a third band of 48 kDa also co-purified with YecA201.
Size exclusion chromatography was used as a final purification step for both YecA and
YecA201 to remove co-purifying proteins or aggregates. Final elutions were analysed by
SDS-PAGE, which showed that YecA purified without any visible, contaminating pro-
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teins. The size exclusion chromatography of YecA201 is shown in Figure 3.14a. A 75
kDa protein co-purified with YecA201 in fractions 65 and 70 ml. The band in the 65 ml
fraction was excised and analysed by mass spectrometry. The co-purifying protein was
identified as DeaD, the RNA helicase that is also known as CdsA. The fractions that did
not contain CdsA were concentrated and used for in vitro assays.
3.2.7 Interaction of YecA with a model substrate
An in vitro chaperone assay was used to investigate whether YecA could function as a
chaperone in vitro. The genetic analysis of yecA suggested that yecA and secB could
be functionally similar. SecB is a molecular chaperone that has been shown to interact
with secretory substrates as well as other, more general, polypeptides in the cytoplasm
(Randall and Hardy, 2002). It is possible to investigate the chaperone activity of a
protein by measuring its ability to prevent aggregation of porcine heart citrate synthase
(citrate synthase) at 50°C (Shah et al., 2016). The assay used investigates whether a chap-
erone has holdase activity by preventing aggregation. Citrate synthase was incubated at
50°C in the presence or absence of YecA and the light scattering at 320 nm was used to
measure the aggregation of citrate synthase. The normalised light scattering of 200 nM
citrate synthase in the absence of YecA was 1.0 ± 0.3, which indicated that the protein
had aggregated. In the presence of 0.1 µM YecA, the normalised light scattering of was
0.7 ±0.2. In the presence of 1 µM YecA, the normalised light scattering was 0.4 ±0.2.
Therefore, the decreased aggregation of citrate synthase could be caused by the presence
of YecA.
To control for the aggregationofYecA, 1µMYecAwas incubated at 50°C.Thenormalised
light scattering of the control was 0.2 ± 0.1, which suggested that YecA was aggregating
at 50°C. To correct for this observation, 0.2 was subtracted from the light scattering of 1
µMYecA + 0.2 µM citrate synthase reaction, which gave a normalised light scattering of
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Figure 3.15: The effect of YecA on the aggregation of citrate synthase at 50°C
The ability of YecA to function as a holdase was assessed using a citrate synthase aggrega-
tion assay. Citrate synthase, at 200 nM, was incubated in either the presence or absence
of YecA at 50°C for 30 minutes. YecA was used at either 0.1 µM or 1 µM, which was an
equimolar concentration or a 10-fold excess of the citrate synthase dimer. The aggrega-
tion of citrate synthase was assayed at the endpoint by measuring the light scattering at
320 nm. The data represent the mean of three independent experiments normalised to
themean aggregation of the 0.2 µMcitrate synthase control. The error bars represent the
standard error. All samples were were analysed using one-way ANOVAwith a p-value of
0.05 considered to be significant. p = 0.0961 which suggested that YecA did not signifi-
cantly decrease the aggregation of citrate synthase at 50°C.
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control was determined using a two-sample T-test assuming equal variances (p = 0.05).
This result suggested that the YecA could be a holdase.
3.2.8 Lipid analysis by thin-layer chromatography of YecA
The 70-amino acid residues at the carboxy-terminus of SecA is required for the stable
interaction of SecA with phospholipids in the inner membrane (Breukink et al., 1995;
Eichler andWickner, 1997; Vrontou and Economou, 2004). To investigate whether YecA
binds to phospholipids, YecA was purified and lipid content was analysed by thin-layer
chromatography. Lipids were extracted from 2 ml of 1 mg/l YecA by the addition of 3
ml of 2:1 chloroform:methanol. To control for the cross-contamination of samples with
lipid, a buffer-only sample was also treated with the chloroform:methanol solution. The
samples were centrifuged to separate the aqueous phase (upper) from the organic phase
(lower). The aqueous phase was discarded and the organic phase was analysed by one-
dimentional thin-layer chromatography (TLC) in a 65:25:4 chloroform:methanol:water
solvent system. Phosphatidylethanolamine (PE), phosphatidylglycerol (PG) and cardi-
olipin (CL) were used as standards. The TLC plate was stained with phosphomolybdic
acid to show that YecA did not co-purify with any lipid species (Figure 3.16) and no lipid
species were visible in the buffer only control. It was not possible to conclude that YecA
interacted with lipids from this result.
3.2.9 The effect of YecA and YecA201 on the ATPase activity of SecA in
vitro
SecB stimulates the ATPase activity of SecA in vitro (Mao et al., 2009). To investigate
whether YecA had a similar effect on theATPase activity of SecA, an in vitro translocation
system was used (Schulze et al., 2014). The reaction consisted of liposomes that had
been reconstituted with SecYEG, SecAΔ95 (a variant of SecA that lacked the most distal
95 amino acid residues), ATP, proOmpA-myc, pyruvate kinase, phosphoenolpyruvate,
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Figure 3.16: One-dimentional thin-layer chromatography to analyse binding of YecA to
phospholipids
Any lipids that were associatedwith YecAwere extractedwith a 2:1 chloroform:methanol
solution. The extracted lipids and PE, PG and CL standards were separated in a 65:35:4
chloroform:methanol:water solvent system. A buffer only sample was included to con-
trol for disassociation of YecA during the purification. The TLC plate was stained with
phosphomolybdic acid.
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lactate dehydrogenase and NADH (Figure 3.17). YecA and YecA201 were purified as
described in Section 3.2.6. The in vitroATPase assaymeasures the rate of ATP hydrolysis
by SecAΔ95 through a coupled regeneration system. ATP was hydrolysed to ADP and
regenerated using phosphoenolpyruvate and pyruvate kinase. The pyruvate kinase was
reduced by NADH to lactate, a reaction that was catalysed by lactate dehydrogenase.
NADH was not regenerated. Therefore, as the assay progressed, the concentration of
NADH decreased. The oxidation of NADH was measured spectrophotometrically at
340 nm.
The carboxy-tail of SecA, which includes the SecA-MeBD, occludes binding of the sig-
nal peptide to the peptide-binding groove (Gelis et al., 2007). The ATPase activity of
SecAΔ95 increases in the presence of preprotein (Robson et al., 2009a; Corey et al., 2016)
and has decreased variability ofATPase activity comparedwith full-length YecA (Robson
et al., 2009a; Corey et al., 2016). The preprotein proOmpA-myc was added to each reac-
tion to stimulate theATPase activity of SecAΔ95. ProOmpA-mycwas used as a substrate
because several other studies have used proOmpA, an outer membrane protein, to inves-
tigate Sec-dependent translocation in vitro and in vivo (Geller and Green, 1989; Robson
et al., 2009a; Corey et al., 2016; Lee and Bernstein, 2001).
The positive control included all components of the in vitro translocation system, except
YecA or YecA201. The first negative control lacked only ATP from the reaction to
control for background oxidation of NADH to NAD+. The second negative control
included ATP and YecA but lacked SecYEG and SecA from the in vitro translocation
system. This control was included to investigate the ATPase activity of YecA. The
effect of YecA and YecA201 on the ATPase activity of SecAΔ95 was measured be-
fore and after addition of proOmpA-myc. The rate of ATP hydrolysis, as measured
by the change in NADH concentration, was normalised to the positive control after








Figure 3.17: Illustration of the coupled regeneration system of the in vitroATPase assay
ATP hydrolysis to ADP by SecA is coupled to the conversion of pyruvate to phospho-
enolpyruvate by pyruvate kinase. Pyruvate is reduced to lactate by lactate dehydrogenase
by the oxidation ofNADHtoNAD+. The depletion ofNADH ismeasured spectropho-
tometrically at a wavelength of 390 nm.
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Before proOmpA-myc was added to the system, the rate of ATP hydrolysis was mea-
sured. For the control that lacked ATP, the rate of ATP hydrolysis was 0.03 ± 0.01 min-1.
The normalised rate of ATP hydrolysis for the control that lacked SecYEG and SecAΔ95
but contained YecA (minus SecYEGA + YecA) was 0.01 ± 0.006 min-1. The normalised
rate of the control reaction that contained all components of the system except YecA or
YecA201 (minus YecA) was 0.07 ± 0.009 min-1. The rate of ATP hydrolysis when YecA
was included in the reaction was 0.08 ± 0.009 min-1. When YecA201 was included in
the reaction, the normalised rate of ATP hydrolysis was 0.07 ± 0.002 min-1. One-way
ANOVA analysis of the data indicated that there was a significant difference between the
reactions (p = 0.002). A post hoc Tukey test showed that neither YecA nor YecA201 af-
fected the rate of ATP hydrolysis compared with the reaction in the absence of YecA (p =
0.9 and p = 0.9, respectively). Therefore, it is not possible to conclude from this data that
YecA increased ATPase activity of SecA in the absence of preprotein in vitro.
The rate of ATP hydrolysis was measured after the addition of the preprotein to
investigate whether YecA or YecA201 had an effect on the ATPase activity of SecAΔ95
in vitro in the presence of proOmpA-myc. The rate of ATP hydrolysis by SecAΔ95 in
the control reaction that lacked only YecA was normalised to 1 for each replicate. The
normalised rate of ATP hydrolysis in the absence of ATP was 0.02 ± 0.01 min-1. The
normalised rate of ATP hydrolysis was 0.02 ± 0.005 min-1 for the control that lacked
SecYEG and SecAΔ95 but contained YecA. The two negative controls both had a similar
rate of ATP hydrolysis in the presence or absence of proOmpA-myc. The latter control
indicated that YecA did not have in vitroATPase activity.
When proOmpA-myc was added to the system that contained YecA, the normalised rate
of ATP hydrolysis by SecAΔ95 was 1.4 ± 0.1 min-1, which is nearly a 40% increase com-
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Figure 3.18: Relative ATPase activity of SecAΔ95 in the presence or absence of YecA or
YecA201 in vitro
The effect of YecA or YecA201 on the ATPase activity of SecAΔ95 was measured using
a coupled regeneration reaction that measures the hydrolysis of ATP via the decrease in
NADH over time spectrophotometrically. The rate of ATP hydrolysis by 0.3 µM Se-
cAN95 in the presence of 0.3 µM proteoliposomes and 10 µM YecA or YecA201 was
measured before and after the addition of 1 µMproOmpA-myc. The ratewas normalised
within each replicate to the positive control, which was the reaction that contained all of
the reagents exceptYecA.The error bars are the standard error of thenormaliseddata. Sta-
tistical analysis indicated that therewas a significant difference between the rate ofATPase
hydrolysis after proOmpA-myc had been added to the reactions (p = 5.64x10-8). Further
analysis using a post hoc Tukey investigate revealed that there was a significant difference
when YecA was included in the assay compared with the minus YecA control (p = 0.01,
indicated by an asterisk). Inclusion of YecA201 also caused a significant increase in the
rate of ATP hydrolysis compared the rate of ATP hydrolysis in the absence of YecA (p =
0.01). There was no statistical difference between YecA and YecA201 on the normalised
rate of ATP hydrolysis (p = 0.7). n = 3.
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that contained the full system and YecA201, the normalised rate of ATP hydrolysis was
1.2 ± 0.1 min-1. After proOmpA-myc had been added, the inclusion of YecA201 in the
reaction resulted in a 30% increase in the rate of ATP hydrolysis compared with the mi-
nus YecA control. Both YecA and YecA201 stimulated the ATPase activity of SecAΔ95,
however the activity of the full-length protein was higher than that of YecA201.
3.2.10 The effect of YecA and YecA201 on the rate of translocation in
vitro
The assay described in Section 3.2.9 indicated that YecA and YecA201 had increased the
ATPase activity of SecAΔ95. TheATPase activity of SecA is required for translocation of
preproteins through the SecYEGmembrane channel in vivo. In the in vitro translocation
assay, successfully translocated proOmpA is sequestered inside the SecYEG proteolipo-
somes. A protein protection digest assay was used to investigate the effect of YecA on the
translocation of proOmpA. This assay results in the digestion of all proteinaceous mat-
ter that was not translocated into the proteoliposomes. After treatment with protease
K, the liposomes were analysed by SDS-PAGE. The in vitro translocation efficiency of
each reaction was determined by immunoblotting against the carboxy-terminal myc-tag
of proOmpA-myc (Figure 3.19). After the reaction that lacked ATP was incubated with
protease K, no proOmpA-myc was detected by immunoblot. All reactions successfully
coupled ATP hydrolysis with the translocation of proOmpA-myc (Figure 3.19).
The total mean proOmpA-myc (before protease K digestion) of 10% of each sample was
0.1 ±0.03. This result shows the error associated with this assay. Although there was a
small increase in the translocation activity of YecA (0.2) and YecA201 (0.2) compared the
translocation activity in the absence of YecA (0.1), it was reasoned that this was within
the error of this experiment and the translocation assay was repeated only once.
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(b) Quantified translocation activity of SecAΔ95
Figure 3.19: Translocation activity of SecAΔ95 in the presence and absence of YecA or
YecA201
The translocation activity of SecAΔ95 was investigated through the detection of
proOmpA-myc by α-myc immunoblotting. 3.19a shows theWestern blot of samples that
had been incubated with protease K. The samples were treated with protease K to digest
the proOmpA-myc that had not been translocated into the proteoliposomes. 10% of the
sample was not treatedwith protease K and represents the total input of proOmpA-myc.
n = 1. 3.19b shows the quantified translocation activity (a.u.) of the in vitro translocation
system. The signals shown in 3.19a were quantified using ImageJ software. The mean
quantified signal of 10% each sample that was not treated with protease K represents the
total input of proOmpA-myc. The error bar is the standard error of the total input con-
trols. n = 4. The detection of proOmpA-myc after the samples had been treated with
protease K represented the translocation activity of each sample. n =1.
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3.3 Discussion
In this chapter, three novel observations were described that together suggest that YecA,
a protein of unknown function, is involved in Sec-dependent translocation of secretory
proteins inE. coli. Firstly, it was shown that YecAwas involvedwith the export of a fusion
protein that has been used to identify components of the Sec machinery. Secondly, the
genetic interaction between secB, which encodes a cytoplasmic chaperone, and yecA was
identified. Thirdly, YecA interacted with SecA to increase the translocation-coupled
ATPase activity of SecA. It is possible that YecA functions as a cytoplasmic chaperone of
secretory substrates.
The first aim of this chapter was to investigate the effect of deleting yecA on the
Sec-dependent translocation of MalE′-′LacZ in vivo. The β-galactosidase assay showed
that the deletion of yecA resulted in a secretion defect. It was not possible to fully
complement the deletion of yecA by expressing yecA from another locus, however
the expression of yecA201 did alleviate the observed secretion defect. There are several
possible explanations for this. The first explanation is that YecA201 is more stable in
vivo than YecA, which could be investigated using a Western blot to visualise the relative
concentrations of each protein. It is also possible that YecA is required at a specific
subcellular concentration that was not achieved under the experimental conditions of
this assay. The CS assay suggested that, under similar conditions to the β-galactosidase
assay, the over-expression of yecA caused a mild growth defect. This growth defect was
not observedwhen expression of yecAwas not induced. In the future, the β-galactosidase
assay will be repeated with different levels of induced expression of yecA. The result of
the β-galactosidase assay described in this chapter could also indicate that YecA201 is
more active than YecA. YecA interacts with the ribosome and this interaction is depen-
dent on the YecA-MeBD (Dr. D. Huber, personal communication). It is possible that
a proportion of YecA that interacted with the ribosome was diverted from interacting
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with the fusion protein, which resulted in a higher β-galactosidase activity compared
with YecA201.
The connection between YecA and SecB was investigated in this chapter. SecB is a
cytoplasmic chaperone that maintains preproteins in an unfolded state for posttransla-
tional translocation and MalE is dependent on SecB for export (Collier et al., 1988). To
investigate this, single gene deletions of yecA and secB in E. coli strain MG1655 were
compared with the parent strain and a double deletion strain that lacked both yecA
and secB. The enhanced CS phenotype of the double mutant compared with the secB
deletion strain indicated that yecA and secB could be functionally redundant. Studies
have shown that, like yecA deletion strains, increased basal β-galactosidase activity is
observed in secB deletion strains that express malE′-′lacZ (Kumamoto and Beckwith,
1983) because SecB increases the concentration of preprotein at the translocation site by
interacting with full-length SecA. A SecB-induced conformational change increases the
affinity of SecA for unfolded secretory proteins, and it is this interaction that increases
the rate of ATP hydrolysis by SecA (Miller et al., 2002; Gelis et al., 2007; Mao et al.,
2009). In the in vitro system described in this chapter to investigate the rate of ATP
hydrolysis by SecA, SecAΔ95 and not full-length SecA was used. Inclusion of SecB in
this in vitro system resulted in a decrease in the ATPase activity of SecAΔ95 (Prof. I.
Collinson and Dr. W. Allen, personal communication). It is possible that the decrease
in ATP hydrolysis was caused by the inability of SecB to bind SecAΔ95. Therefore, it
is possible that the mechanism by which YecA increased the ATPase activity of SecA
involved a direct interaction between YecA and SecAΔ95. Furthermore, the pull down
assay suggested that YecA co-purified with SecA. In the future, an immunoprecipitation
assay will be used to confirm these data.
The observed phenotypes described in this chapter could be linked to the stimulation
of the ATPase activity of SecA by YecA and YecA201. ATP hydrolysis by SecA provides
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the energy for the translocation of secretory proteins through SecYEG. YecA was shown
to increase the ATPase activity of SecAΔ95 in vitro. However, it was not clear whether
the increased ATPase activity was the result of a direct interaction between SecAΔ95
and YecA. The increase in ATPase activity of SecAΔ95 in the presence of YecA could
be caused by YecA functioning as a chaperone to effectively increase the preprotein
concentration at the SecYEG channel.
The protein-protein interactions of YecA that were identified using the pull-down assay
and the mass spectrometry analysis indicated that YecA interacted with CdsA. The
expression of cdsA is induced by cold-shock (Jones et al., 1996). Like SecA, CdsA is an
ATP-dependent DEAD-box protein. While SecA hydrolyses ATP to drive translocation
of secretory proteins, CdsA is a RNA helicase that is thought to assist with several
processes that include the initiation of translation, cold-shock induced gene regulation,
mRNA decay and biogenesis of the large ribosomal subunit (Charollais et al., 2004).
Deletion of the cdsA gene in E. coli causes a cold-sensitive growth phenotype due
to aberrant biogenesis of the large ribosomal subunit (Charollais et al., 2004). CdsA
interacts with RNase E, which is known to associate with PNPase and the DEAD-box
protein RhlB to form an “RNA degradosome” (Regonesi et al., 2006). RhlB and
RNase E were both identified by mass spectrometry as a co-purifying with YecA and
YecA201. However, the parameters of the manual filter meant that these proteins were
not considered to have a positive interaction with either YecA or YecA201. PNPase was,
however, positively identified as interacting with YecA. In the future, the interaction of
YecA with the RNA degradosome will be investigated.
The possibility that YecA was a chaperone was investigated in vitro using a non-native
substrate, citrate synthase. YecA decreased the aggregation of citrate synthase by ap-
proximately 50%, although this result was not statistically significant. The experimental
conditions that were used during this assay were observed to cause the aggregation of
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YecA. The aggregation of secretory substrate proOmpA has be used to investigate the
chaperone activity of SecB at room temperature (Lecker et al., 1990). In the future,
a different model substrate, such as the precursor protein proOmpA, will be used to
investigate the holdase activity of YecA.
It not is possible to conclude whether YecA interacted with lipids from the investigation
presented in this chapter. YecAwas purified to homogeneity prior to theTLC assay. Sub-
sequent discussion revealed that similar levels of purification can disrupt the interaction
between SecA and lipids (Dr. M. Jamshad, personal communication). SecA interacts
with lipids and SecB via the SecA-MeBD. To investigate whether YecA interacts with
lipids, the TLC assay could be repeated with a less stringently purified YecA sample. If
YecA interacts with lipids, the role of the YecA-MeBD could be investigated by repeating
the TLC assay with YecA201. If YecA does not interact with lipid, the MeBDs of YecA
and SecA could be swapped to investigate whether the SecA requires the specific amino
acid residues in the SecA-MeBD to interact with lipid.
The role of the YecA-MeBD was investigated by comparing the full-length protein with
YecA201, a truncated variant of YecA that lacked the most distal 20-amino acid residues.
The expression of yecA201 complemented the effect of deleting yecA on the export of
MalE′-′LacZ in vivo, unlike the expression of yecA, which only partially complemented
the deletion. The partial complementationby yecA201 of this phenotype could be caused
by differential expression of yecA compared with the parent strain. It is possible that
YecAwas required at a specific cellular concentration, or under a particular environmental
condition that was not achieved under the experimental conditions that were used. The
MeBD of SecA can prevent binding of signal peptides to the peptide-binding groove of
SecA (Gelis et al., 2007). It is possible that the YecA-MeBD has an auto-inhibitory role,
like the SecA-MeBD. Therefore, it is possible that the partial complementation of the
yecA deletion by the full-length protein could be explained by the inhibition of YecA by
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its MeBD. In the next chapter the investigation of the structure of YecA to analyse both






The results presented in Chapter 3 suggested a role for YecA in the Sec pathway of E.
coli. These investigations were predicated on the hypothesis that the YecA-MeBD and
the SecA-MeBD were functionally homologous. The structure of YecA was investigated
to gain insight into the molecular mechanism of the protein. Structures of sequence
homologues of both domains of YecA have been resolved, however it is not known how
the two domains interact to form the tertiary structure of YecA.
UPF0149 is an 192-amino acid residue domain that is situated at the amino terminus of
YecA. In E. coli, the only other protein that contains UPF0149 is YgfB, which is a 20.3
kDa protein of unknown function. A 1.95 Å crystal structure of the dimer of YgfB from
H. influenzae has been resolved (Galkin et al., 2004). The monomer has a two structural
regions formed of four and three α-helices, respectively. The carboxy-terminal 3-helix
bundle is similar to the “lid” of the substrate binding domain of DnaK, a chaperone
(Galkin et al., 2004). The sequence similarity between YgfB and the 3-helix bundle of
DnaK is low. The two α-helices of YgfB fold to form a novel fold that could be formed by
YecA but the function of this fold has not been investigated. UPF0149 remains a domain
of unknown function, however studies have suggested a role for YgfB in DNA-binding
and the regulation of gene expression in E. coli (Ishihama et al., 2016).
The SecA-MeBD binds to lipid and SecB (Breukink et al., 1995; Zhou and Xu, 2003).
When bound to zinc the SecA-MeBD forms a ββα structural motif that is similar to the
classical zinc finger motif (Zhou and Xu, 2003; Dempsey et al., 2004; Matousek and
Alexandrescu, 2004). A single zinc ion is coordinated via three cysteine residues and a
histidine residue, which is sometimes replaced by a fourth cysteine residue (Zhou and
Xu, 2003). The interaction between SecA and SecB is stabilised by the presence of zinc
(Fekkes et al., 1997), possibly because the coordination of zinc creates a positively charged
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interface on the SecA-MeBD (Zhou and Xu, 2003). The positively charge residues and
the zinc-binding residues are conserved between the SecA-MeBD and the YecA-MeBD.
To investigate the structure of YecA, several techniques were used. These techniques (X-
ray crystallography, NMR spectroscopy, small-angle X-ray scattering and circular dichro-
ism) are described below.
X-ray crystallography
The objective of X-ray crystallography is to resolve the three-dimensional structure of the
desired complex from its crystal (Smyth and Martin, 2000). To form crystals, protein is
encouraged to come out of solution by vapour diffusion (Figure 4.1). For example, the
SecA-polypeptide-binding domain from different organisms has been crystallised in two
different conformations, with the PPXD close to the HWD, or rotated away from the
HWD (Hunt et al., 2002; Osborne et al., 2004). The crystal structure of a single SecA
bound to a single SecY indicates that the PPXD rotates further away from the HWD to
create an interface between the PPXD and the nucleotide binding domain 2 to interact
with SecY (Zimmer et al., 2008). The observed conformational changes provide the foun-
dations for further mechanistic studies. Structural information can provide the basis for
focussed downstream research, therefore X-ray crystallography has a role in many areas
of biology.
NMR spectroscopy
NMR spectroscopy is an analytical technique that is used to determine the molecular
structure of proteins in solution. After the molecular structure has been determined,
interactions and other physical properties can be ascertained through conformational
changes. NMR allows the study of proteins in solution, unlike X-ray crystallography,



















Figure 4.1: Sitting drop and hanging drop methods of protein crystallisation.
Vapour diffusion is used to encourage protein to come out of solution and crystallise.
There are two types of vapour diffusion: sitting drop and hanging drop. In both set-ups,
a sample reservoir containing purified protein, buffer and precipitant is placed within a
sealed well with a reservoir of similar buffers. Water moves from the sample reservoir
and collects in the buffer reservoir by vapour diffusion over time. This promotes protein
crystallisation because the protein and precipitant concentrations both increase slowly.
The only difference between the two methods of vapour diffusion is the orientation of
the sample reservoir to the buffer reservoir.
102
approximate the physiological environment. Full-length SecA remains unresolved by
X-ray crystallography due to the flexibility of the carboxy-tail. NMR spectroscopy has
revealed that the carboxy-tail interacts with the PPXD in the main body of the protein
(Keramisanou et al., 2006; Gelis et al., 2007), which could regulate the interaction of
SecA with polypeptides in the cytoplasm.
Protons, neutrons and electrons are sometimes referred to in the literature as quantum
mechanically subatomic particles. Collectively, these particles have nuclear spin (Keeler,
2002). A nucleus with spin is a charged particle that rotates about a given axis, which
creates a magnetic field. The overall spin of the nucleus is determined by the number and
ratio of protons and neutrons. If a nucleus has an even number of protons and an even
number of neutrons then the paired spins often cancel each other out such that the spin
of the nucleus is equal to zero. If the number of neutrons plus the number of protons is






2 . Anucleus has an integer spin if
the number of neutrons and protons are both odd. The magnetic field around a nucleus
with spin is the nuclear magnetic moment. NMR spectroscopy applies a magnetic field
(B0) to the sample. The nuclear magnetic moment of the nucleus causes the nucleus to
align with or against the external magnetic field. The rotational axis of a nucleus cannot
be exactly parallel or antiparallel to the external magnetic field but must precess at an
angle (Figure 4.2a). This precession is known as the Larmor precession. The frequency
of the Larmor precession is proportional to the strength of the external magnetic field:
the greater the strength of the external magnetic field, the greater the frequency.
In an example compound with two populations of hydrogen atoms there will be two
precessional frequencies. A little more than half of the protons align with B0 and the
rest align against B0. Electromagnetic radiation in the radio frequency range is applied
to the sample. The frequency that is equivalent to the precessional frequencies causes
the corresponding hydrogen populations to absorb radiation and “flip” so that both are
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precession B0


















(b) The effective magnetic field
Figure 4.2: The effect of an external magnetic field on a sample with spin
4.2a shows that when a magnetic field (B0) is applied to a nucleus with spin, the nucleus
precesses at an angle. 4.2b compares the effective magnetic field strength experienced by
protons in methane and methyl fluoride. When an external magnetic field B0 is applied
to methane, the electrons that belong to the methyl carbon create their own magnetic
field that opposes B0. The magnetic field that is created by the electrons is known as the
induced magnetic field. The induced magnetic field shields the protons of the methane
from B0 such that they experience an effective magnetic field that is B0 less the induced
magnetic field. In the case of methyl fluoride, the fluorine has a greater electromagnetic
strength than carbon. This means that the electrons that belong to the carbon are pulled
towards the fluorine and the protons are not shielded to the same extent as the protons
in methane. Therefore the effective magnetic field experienced by the protons in methyl
fluoride is greater than the effectivemagnetic field experiencedby the protons inmethane.
As a result, the chemical shift of theprotons ofmethyl fluoride is greater than the chemical
shift of the protons of methane. Figure adapted from Soderberg (2016).
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aligned against B0. The absorbance of the radiation, and the intensity of the absorbance,
is recorded by the NMR instrument. The frequency information is converted to
chemical shift to standardise recordings of samples across different NMR instruments
with different field strengths.
When a compound is placed inside a magnetic field (B0), non-equivalent protons will
resonate with a different frequency. The chemical shift of a proton is determined pri-
marily by the neighbouring electronic environment. Methane (CH4) has four equivalent
protons. When B0 is applied to methane the electrons of the carbon atom circulate and
create an induced magnetic field that opposes B0. The induced magnetic field reduces
the strength of the magnetic field that the four protons experience. This is known as
local diamagnetic shielding and results in a lower resonance frequency of the protons
(Soderberg, 2016). Methyl fluoride (CH3F) is an example of a compound with three
protons that experience a deshielding effect because the fluorine is more electronegative
than carbon so the carbon’s electrons are pulled towards the fluorine and away from
the hydrogens. This means that the three protons of methyl fluoride experience a
larger effective magnetic field strength than methane (Figure 4.2b). This means that
the chemical shift of the protons of methyl fluoride is greater than the chemical shift
of the protons of methane (Soderberg, 2016). The strength of the deshielding effect of
electronegative moiety is correlated with the proximity to the proton, i.e. the closer the
proton to the electronegative moiety, the stronger the deshielding effect and the greater
the chemical shift will be.
Heteronuclear Single Quantum Coherence (HSQC) is a simple 2D NMR spectrum
that maps cross peaks of correlating 1H and heteronuclei (for example 15N and 13C). The
1H-15N-HSQC spectrum of a protein will show peaks with slightly different frequencies
depending on the amino acid composition and the folding of a protein. In the case of a

















































































































Figure 4.3: Diagram to show the NMR experiments used for the assignment of YecA
The red arrows show the direction of magnetisation transfer. For each experiment, the
chemical shift information that can be determined from each experiment is indicated by
the red atoms. HNCAprovides information about the amide proton of a residue, theCA
of the same residue and theCAof the neighbouring residue. HN(CO)CAprovides infor-
mation about the the amide proton of a residue and both the carbon atoms of the preced-
ing residue. HNCACB correlates the chemical shifts of the amide bond of a residue and
the CA and the CB of both that residue and the neighbouring residue. HN(CO)CACB
provides information about the amide proton and the CA, CB and the CO of the neigh-
bouring residue, as well as providing information about the CO of its residue. HNCO
correlates the amide proton with the CO of the neighbouring residue. HN(CA)CO cor-
relates the amide bondwith the CO (and the CA) of the same residue and the neighbour-
ing residue. Figure adapted from Knowles (2005).
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in an unfolded protein resonance peaks are poorly dispersed. This is due to the high
sensitivity of the chemical shift to the chemical environment. Each 1H-15N cross peak in
the 1H-15N-HSQC spectrum represents a resonance peak from a single N-H. Therefore,
in an 1H-15N-HSQC, the number of residues of the protein should be roughly equal to
the number of peaks. Proline lacks an NH-backbone moiety so is not observed in an
1H-15N-HSQC experiment. 1H-15N-HSQC spectra also contain signals from the NH2
groups of the side chains of asparagine and glutamine and of the aromatic HN protons
of tryptophan. The 1H-15N-HSQC experiment is a useful tool in detecting and studying
interactions with ligands, such as other proteins or drugs. When a protein binds a ligand,
the chemical shifts of the co-ordinating and nearby residues are perturbed (Williamson,
2013).
Isotope-labelling of a protein is necessary for the assignment of the backbone amino
acid sequence. The isotopes used are 15N and 13C and the double isotope-labelled
proteins can be investigated using three-dimensional assignment experiments. The
three dimensional experiments together correlate the amide proton with the CA and
the CB and the CO for a given residue and the adjacent residue, depending on the
experiment. By sequentially assigning adjacent amino acid residues to the resonances of
these chemical shifts it is possible to assign the backbone of the protein (Knowles, 2005).
There are several experiments that are required to achieve this, which are described below
(Figure 4.3).
The HNCA experiment correlates the resonances of the amide proton, the nitrogen
and the CA for a residue and CA for the adjacent residue can also been derived from
this experiment. The partner experiment, HN(CO)CA experiment correlates the
amide proton and the nitrogen of a residue, with the adjacent residue. Therefore, the
HN(CO)CA experiment allows the distinction between the two CA carbons.
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TheHNCACB experiment correlates amide proton, the nitrogen, the CA and CB chem-
ical shifts for residue. The HNCACB experiment can be used to observe and correlate
the resonances of the CA and CB of residue. The 13C dimension of the HNCACB
spectrum has additional CB chemical shifts compared with the HNCA spectrum but
is otherwise similar to the HNCA experiment. The HN(CO)CACB correlates amide
proton and nitrogen chemical shifts for a residue, with those of the CA and CB for the
adjacent residue. The spectrum of the HN(CO)CACB spectrum is therefore similar to
theHN(CO)CACB spectrum but in the 13C dimension there are additional CB chemical
shifts.
The HNCO and HN(CA)CO experiments both correlate the amide proton and
nitrogen with that of the CO. The HNCO experiment correlates the amide proton and
nitrogen with that of the CO of the adjacent residue and the HN(CA)CO experiment
correlates the chemical shifts of the amide proton and nitrogen of a residue with the CO
of the same residue with the adjacent residue.
Small-angle X-ray scattering
Small-angle X-ray scattering (SAXS) is a low resolution technique that can be used to
study the overall shape and conformation of a biological macromolecules in solution. A
protein sample in solution is illuminated with an X-ray beam. The sample scatters scat-
tered X-ray intensity is measured by a detector (Figure 4.4a). The scattering pattern is re-
lated to the overall shape and size of the particles (Figure 4.4b). The scattering intensity,
I is represented as a function of momentum transfer q, or the distance from zero that an
X-ray is scattered. Using SAXS data, it is possible to model the structure of a protein us-
ing a program calledCORAL (Petoukhov et al., 2012). CORALuses template structures
and dummy residues to model multidomain proteins. Template domains are moved by
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(b) The pattern of the scattering is related to the shape and size of the analysed particles
Figure 4.4: Overview of the SAXS experiment
During a SAXS experiment, the sample is illuminated by a monochromatic X-ray beam
and the intensity of the scattered X-rays (K2) is recorded by an X-ray detector. The scat-
tering pattern of the pure solvent (K1) is collected as well and subtracted from the sample
solution scattering leaving only the signal from the particles of interest. The resulting
scattering pattern is related to the overall shape and size of the particles under investiga-
tion (q = K1 − K2).
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structure of the protein is generated from these computationally-generated SAXS pro-
files.
Circular dichroism
Circular dichroism spectroscopy (CD) measures the difference in absorption between
left-hand and right-hand circularly polarised light by a chiral molecule (Kelly et al.,
2005). Chiral molecules are mirror-image isomers and all amino acids, apart from
glycine, have chirality. The far-UV range (160 - 260 nm) is often used to investigate
the secondary structure of proteins because the peptide bond, the side chains and the
disulphide bonds absorb light in this region (Kelly et al., 2005). One of the strengths of
CD is that it is can be to investigate structural changes of a protein in response to dena-
turing conditions, pH,mutations in the amino acid sequence or even binding of a ligand.
In this chapter, a combinationof structural techniqueswere used to study the structure of
YecA.The data that is presented in this chapter suggests that YecA is amonomeric protein
that has two distinct domains, which do not interact directly. In addition, using NMR
spectroscopy, two conformations of the YecA-MeBDwere identified. While the structure
of YecAwas not fully resolved, insight into the thermostability and the orientation of the
two domains was gained, this chapter provides the basis for further structural analysis of
YecA.
4.2 Results
4.2.1 A prediction model of the structure of YecA
Initially, the structure of YecA was investigated using Phyre2. Phyre2 is an online
platform that builds a structural model of a protein using sequence alignments to
proteins with known structures (Kelley et al., 2015). The amino acid sequence of the E.
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coli YecA (UniProt ID: P0AD05) was submitted to Phyre2. 90% of YecA was modelled
with 90% confidence. The template structures that were used to model YecA are listed
in Table 4.1. Phyre2 predicted that 71% of YecA would be α-helical and the remaining
portion would be random coil. Figure 4.5 shows the predicted structure of YecA. The
model has 7-αhelices that form the UPF0149 domain and a random coil that links the
main body of the protein with the YecA-MeBD.
The templates that were used to model YecA are indicated in Table 4.1. The UPF0149
domain wasmodelled to a confidence of >90% using protein data bank structures 4GYT
(Michalska et al., 2012) and 1IZM (Galkin et al., 2004). The YecA-MeBD was modelled
to a confidence of >90%using protein data bank structures 2I9W (Joint Center for Struc-
tural Genomics, 2006), 1SX0 (Dempsey et al., 2004), 1SX1 (Dempsey et al., 2004), 1OZB
(Zhou and Xu, 2003) and 1TM6 (Matousek and Alexandrescu, 2004). Residues 186 to
200 were modelled to a confidence of >80% using the protein data bank structure 1NNJ
(Pereira de Jesus et al., 2005).
Phyre2 aligned residues 69 - 154 of YecA to residues 721 - 880 of SecA from Thermatoga
maritima (14% identity; PDB ID: 3JUX; Zimmer and Rapoport, 2009) and residues 51 -
154 of YecA to residues 703 - 825 of SecA fromMycobacterium tuberculosis (12% identity;
1NKT; Sharma et al., 2003) and residues 8 - 154 of YecA to residues 790 - 928 SecA from
Thermus thermophilus (13% identity; PDB ID: 2IPC; Vassylyev et al., 2006) and residues
8 - 154 of YecA to residues 632 -770 of SecA from B. subtilis (15% identity; PDB ID:
1TF5; Osborne et al., 2004). This region of SecA forms part of the SD andHWD. Phyre
aligned residues 12 to 154 of YecA to residues 628 - 808 of SecA fromB. subtilis (13% iden-
tity; PDB ID: 3DIN; Zimmer et al., 2008), which corresponds to the flexible linker. The
carboxy-terminal domain of SecA is exclusively α-helical. The sequence identity between
these templates and the UPF0149 of YecA is between 12 and 15% but the confidence of
homology for all alignments was >90%. This result suggested that the UPF0149 domain
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Table 4.1: Phyre2 sequence alignment of high confidence proteins to YecA
The amino acid sequence of E. coli YecA was submitted to Phyre2 for structural mod-
elling. ? indicates a template that was used to model the structure of YecA. The confi-









4GYTB? Lpg0076 6 - 185 99.9 (Michalska et al., 2012)
1IZMa? YgfB-like 10 - 183 99.9 (Galkin et al., 2004)
2I9WA Psyc_2064 199-219 99.6 (Joint Center for Struc-
tural Genomics, 2006)
1SX0A? SecA 200 - 219 99.4 (Dempsey et al., 2004)
SX1A? SecA 200 - 219 99.4 (Dempsey et al., 2004)
1OZBI SecA 201 - 219 99.3 (Zhou and Xu, 2003)
1OZBi SecA 201 - 219 99.3 (Zhou and Xu, 2003)
1OZBJ SecA 201 - 219 99.3 (Zhou and Xu, 2003)
1TM6A? SecA 201 - 219 99.3 (Matousek and Alexan-
drescu, 2004)
1TM6B? SecA 201 - 219 99.3 (Matousek and Alexan-
drescu, 2004)
2I9A3 uPA 148 - 211 97.7 (Lubkowski andBarinka,
2006)
2IPCB SecA 8 - 154 95.4 (Vassylyev et al., 2006)
3DINB SecA 12 -154 95.3 (Zimmer et al., 2008)
1TF5A2 SecA 8 - 154 95.3 (Osborne et al., 2004)
1NKTA2 SecA 51 - 154 93.5 (Sharma et al., 2003)
3JUXA SecA 69 - 154 92.8 (Zimmer and Rapoport,
2009)












(b) Predicted model of YecA using Phyre2
NH2
COOH
(c) Predicted model of YecA using Phyre2
Figure 4.5: Phyre 2 structural model to show the predicted orientation of the two do-
mains of YecA
The amino acid sequence of YecA was submitted to Phyre 2 (Kelley et al., 2015) to pre-
dict a structuralmodel using homologous sequences with known structures as templates.
8 templates were used to predict the structure of YecA (Table 4.1). In Subfigure 4.5a
UPF0149 (11 - 189) is shown in green and the YecA-MeBD (201 - 221) is shown in yellow
and other residues (1 - 10; 190 - 200) are shown in grey. In Subfigures 4.5c and 4.5b red
indicates that the structure wasmodelled with confidence of >90%, orange indicates that
the structurewasmodelledwith confidence of >80% and blue indicates that the structure
was modelled ab initio and is unreliable (Kelley et al., 2015). 8 residues were modelled ab
initio. 90% of YecAwasmodelled with confidence of >90%. Subfigures 4.5c and 4.5b are
180° rotations of the predictedmodel of YecA. Subfigure 4.5a shows the predictedmodel
of YecA in the same orientation as Subfigure 4.5b.
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of YecA might be structurally similar to the C-domain of SecA.
4.2.2 Purification of full-length YecA for X-ray crystallography
To obtain a crystal structure of YecA, full-length YecA was expressed and purified for X-
ray crystallography screen trials. The yecA gene sequence was amplified by PCR using
yecA_for and yecA_rev and ligated into pCA528 using BsaI and BamHI restric-
tion sites, and transformed into E. coli strain BL21 DE3. Bacteria were cultured as de-
scribed in Section 2.5.4. The cells were lysed using high pressure homogenisation. The
lysatewas centrifuged to remove cell debris and subsequently incubatedwith ProtinoNi-
TEDresin,which chelates theHis6moiety of the amino-terminal tag ofYecA.The recom-
binant YecA bound to the resin, although a small fraction was eluted by the wash steps
(Figure 4.6). His6-Ulp1 (SUMO protease) was added to the resin to cleave the amino-
terminal tag fromYecA.Ulp1 is a protease that recognises the tertiary structure of SUMO.
Subsequently, the proteins were eluted using imidazole. The protein-containing frac-
tions were analysed by SDS-PAGE, which showed that cleaved YecA, the His6-SUMO
tagged YecA and the cleaved tag all eluted together (Figure 4.6). SDS-PAGE analysis of
these fractions also indicated the presence of contaminating proteins. Fractions E2 to E7
were pooled and concentrated for further purification.
Anion exchange chromatography was used to separate proteins according to their net
surface charge. YecA eluted when the concentration of KOAc was between 600 and 700
mM (Figure 4.7a). Analysis of the elution fractions indicated that YecA co-purified with
the His6-SUMO tagged YecA (Figure 4.7b). Therefore, size exclusion chromatography
was used to separate YecA from the recombinant variant of YecA. The gel filtration col-
umnwas pre-equilibratedwithBuffer 1 + 1mMTCEP and the protein samplewas loaded
manually. The protein eluted in 5 ml fractions between 60 and 75 ml (Figure 4.8. The
fractionswere pooled after analysis by SDS-PAGE and concentrated to 10mg/ml for crys-
tallography screen trials.
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Figure 4.6: SDS-PAGE of YecA expression (E. coli strain BL21 DE3 pCA528-His6-
SUMO-YecA) and purification using Protino Ni-TED resin.
His6-SUMO-YecA was expressed from a plasmid in E. coli strain BL21 DE3 that was
grown in LB supplemented with kanamycin. The IPTG-induced cells were harvested
and lysed. The lysate was clarified by centrifugation and filtration before incubationwith
Protino resin. The lysate was equilibrated with the lysate for 1 hour and subsequently
washed with Buffer 1 (LW). Subsequently, the resin was washed with five column vol-
umes of High Salt Buffer (HW). YecA was eluted in 1 ml fractions with 0.5 mM imida-
zole. The washes and imidazole elutions were analysed by SDS-PAGE and Coomassie
staining. R: raw lysate, L: clarified lysate, H1-2: washes with Buffer 1 + 900 mM KOAc,
L1-2: washes with Buffer 1, E1-7: 1 ml elutions with 500 mM imidazole from the Protino
resin after incubation with SUMO protease. * indicates a protein of 75 kDa that copuri-
fied with YecA, which is possibly CdsA.
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(b) SDS-PAGE analysis of anion exchange chromatography elutions.
Figure 4.7: Anion exchange chromatography of YecA for crystal screens
After the amino-terminal tag had been cleaved, YecA was applied to an anion exchange
column. The sample was applied manually to an anion exchange chromatography col-
umn that had be pre-equilibrated with Buffer 1. The flow rate was 1 ml/min. 4.7a shows
the elution trace of the anion exchange chromatography of YecA201. Right hand-side
y-axis: The concentration of KOAc was increased from 100 mM to 1 M (green). Left
hand-side y-axis: The elution of YecA from the anion exchange column was measured
spectrophotometrically at 280nm(red) and254nm(blue). The elutionswere collected in
0.5ml fractions for analysis by SDS-PAGE. 4.7b shows the SDS-PAGEanalysis of protein-
containing fractions. 10 µl from each fraction between 19 and 21.5 ml was mixed with 10
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Figure 4.8: Size exclusion chromatography of YecA for crystal screens
Each protein was applied to an S75 10/300 GL column that had been pre-equilibrated
with Buffer 1 + 1 mM TCEP. YecA and YecA201 were concentrated and injected onto
the column. The flow rate was 0.5 ml/min and the elutions were collected in 5 ml frac-
tions. 10 µl from each protein-containing fraction was mixed with 10 µl Laemmli buffer
and analysed by SDS-PAGE and Coomassie staining. YecA resolved at approximately 25
kDa, which corresponds to its molecular weight. No contaminating bands or degrada-
tion products were resolved by SDS-PAGE. Fractions 60 to 70 ml were pooled and con-
centrated to 10 mg/ml for crystal screen trials.
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4.2.3 X-ray Crystallography of full-length YecA
Purified YecA was screened in crystal screen matrices designed for soluble protein
crystallisation. The commercial screens that were used were JCSG+, ProPlex, Morpheus
HT-96, and Midas HT-96. Each screen consisted of 96 conditions. YecA was used at
a concentration of 10 mg/ml. The protein sample was diluted in condition buffer at a
ratio of 1:1 to form a sitting drop of 600 nl in 96-well crystallisation plates. After 1 month
no crystals were observed.
A brown-red precipitate was observed in several conditions in the JCSG+ screen: 0.1
MCAPS, pH 10.5, 40% v/v MPD (E5), 0.2M zinc acetate dihydrate, 0.0.5 mM imida-
zole, pH 8.0, 20% v/v PEG 3000 (E6) and 0.2 M zinc acetate dihydrate, 0.1 M sodium
cacodylate, pH 6.5, 10% v/v 2-propanol (E7). A similarly brown-red precipitate was ob-
served in 0.1 Mmagnesium acetate, 0.1 MMOPS, pH 7.5, 12% w/v PEG 8000 (E8), pH
7.0, 1.3 M Na/K hydrogen phosphate (G9), 0.1 M Na HEPES, pH 7.5, 1 M sodium ac-
etate (G11), 0.1 M Na HEPES, pH 7.0, 1.5 M ammonium sulphate (F12) in the ProPlex
screen. YecA is not predicted to bind any chemicals that would result in crystals of this
colour and so it was thought that these precipitates were contaminants. Further analysis
of these conditions was not pursued.
4.2.4 Analysis of the secondary structure of YecA as a function of tem-
perature by circular dichroism
Circular dichroism spectroscopy (CD) can be used analyse changes to the secondary struc-
ture of protein in response to changes in temperature. NMR spectroscopy can be used to
investigate the structure of macromolecules in solution. However, the temperature used
forNMRspectroscopy experiments, which is 298K (24.85°C), can affect protein stability
(Kozak et al., 2016). CD was used to investigate the thermal stability of YecA prior
toNMRspectroscopy, and to gain an insight into the secondary structure of foldedYecA.
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Purified YecA was dialysed into 10 mM potassium phosphate buffer (pH 7.4) and anal-
ysed by CD. A buffer only control was also analysed. The buffer only control was sub-
tracted from the CD spectra of YecA at each temperature and analysed byK2D (Andrade
et al., 1993;Whitmore andWallace, 2004, 2008). K2D is an online resource that estimates
the secondary structure content of a protein from the rawCDdata. The buffer-corrected,
K2D back-calculated CD spectra of YecA as a function of temperature is shown in Figure
4.9 (Andrade et al., 1993). The NRMSD is a measure of the difference between the ex-
perimental ellipticities and the ellipticities of the back-calculated spectra for the derived
structure (Table 4.3). NRMSD values ≤0.05 were considered to be a good fit. Table 4.3
shows that the back-calculated spectra for temperatures up to 58.98°C had NRMSD val-
ues that were ≤0.05. The back-calculated spectra of YecA at 58.98 and 78.08°C did not
have such a good fit, according to theNRMSD value, which could be due to the aggrega-
tion of YecA at the higher temperatures.
The CD spectra of YecA for the temperatures 15.55, 25.09, 29.91 and 39.6°Cwere similar
with negative ellipticity peaks at 221 nm and 210 nm (Figure 4.9a). Analysis of these
CD spectra by K2d indicated that the secondary structure of YecA was stable to 39.6°C
because there was little change in the proportion of α-helical, β-sheet or random coil
(Figure 4.9c). Figure 4.9a shows that the intensity of the negative ellipticity peak at 221
nm was decreased when the temperature was increased to 44.46°C. Figure 4.9b shows
that between 39.6 and 49.31°C there a large decrease in the molar ellipticity at 221 nm,
which indicated protein unfolding. The observed decrease in the negative ellipticity peak
at 221 nm suggested that the α-helical portion of the YecAmolecule was either decreased
or destabilised or both as the temperature was increased to 44.46°C. Analysis of the
CD spectrum of YecA at 44.46°C by K2D indicated that the proportion of α-helical
structure had decreased and the β-sheet secondary structure had increased compared
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(a) Buffer-corrected and back-calculated CD spectra of 0.8 µM YecA in 10 mM potassium phos-






















(b) The change in mean residue molar elliptic-









































(c) The proportion of the secondary structures
of YecA, as calculated by K2D
Figure 4.9: Circular dichroism to analyse the thermostability of YecA
Purified YecA was dialysed into 10 mMpotassium phosphate buffer and analysed by CD
at different temperatures. The spectra were analysed by K2D (Andrade et al., 1993) and
the back-calculated results are shown in Subfigure 4.9a. The y-axis shows intensity as the
mean residue molar ellipticity, [θ] (degrees.cm2.decimole-1). Subfigure 4.9b shows the
change in molar ellipticity, [θ] (degrees.cm2.decimole-1), at 221 nm of the K2D analysis
as a function of temperature. Subfigure 4.9c shows an analysis of the CD spectra of YecA
as a function of temperature by K2D. The percentage of α-helix secondary structure is
shown in black, while the percentage of β-sheet structure is shown in dark grey. The
percentage content of random coil is shown in grey.
120
Table 4.3: Calculated NRMSD parameters of YecA CD spectra (Micsonai et al., 2015)











peak at 221 nm was most decreased in intensity for the four highest temperatures. The
CD spectra of YecA at 49.31, 54.15, 58.98 and 78.08°C have lost most of the secondary
structure of YecA compared with the protein at lower temperatures. The spectra of YecA
at the four highest temperatures were similar.
The α-helical secondary structure of YecA was stable between 15..55°C and 39.6°C.
The melting temperature of YecA was determined as 46.9°C and the results of the CD
spectroscopy suggested that YecA was likely to be stable at 298 K (24.85°C) for analysis
by NMR spectroscopy.
4.2.5 Preparation of 1H-15N-YecA
NMR spectroscopy was used to investigate the structure of YecA. To analyse the struc-
ture of a protein by NMR it is often necessary to isotopically label the protein with two
isotopes, 13C and 15N, by growing the strain that expresses the gene of interest inminimal
medium supplemented with 15NH4Cl and 13C-glucose. 13C-glucose is expensive and, at
25 kDa, YecA is close to themolecular weight limit ofNMR spectroscopy. Therefore 1H-
15N-YecAwas purified for analysis by 1H-15N-HSQC to test the suitability of this protein
for structural analysis by NMR spectroscopy (McIntosh and Dahlquist, 1990).
Initially, YecA was produced as a recombinant protein with a His6-SUMO tag at the
amino-terminus inE. coli strain BL21 DE3. The strain was grown inminimal media that
was supplemented with 15NH4Cl. The first purification step required the application
of the cell lysate to a nickel-affinity column. The recombinant YecA bound to the
column via the amino-terminal His6-SUMO tag. YecA was eluted from the column
using imidazole, which competes with the His6 tag for binding to the nickel column.
The imidazole elutions were analysed by SDS-PAGE, which showed that the recombi-















1 2 3 4 5 6
1 ml imidazole elution fractions
7
Figure 4.10: SDS-PAGE analysis of the nickel-affinity chromatography of 1H-15-N-His6-
SUMO-YecA
His6-SUMO-YecA was expressed in E. coli strain BL21 DE3 in M9 media that was sup-
plemented with 15NH4Cl and kanamycin. The IPTG-induced cells were harvested and
lysed. The lysate was clarified by centrifugation and filtration before application to a
nickel affinity column. The lysate was equilibrated with the lysate for 1 hour and subse-
quently washed with Buffer 1. YecA was eluted in 1 ml fractions with 0.5 mM imidazole.
The imidazole elutions were analysed by SDS-PAGE and Coomassie staining. A signif-
icant amount of His6-SUMO-YecA eluted in imidazole elution fractions 2-4 and these
fractions were pooled and concentrated incubation with SUMO protease to remove the
His6-SUMO tag.
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(b) Anion exchange chromatography elution trace of 1H-15N-YecA
Figure 4.11: Anion exchange chromatography of 1H-15N-YecA for NMR spectroscopy
Topurify cleavedYecA after the incubationwith SUMOprotease, 1H-15N-YecAwas con-
centrated and applied to an anion exchange column. 4.11a: shows the elution trace of
YecA. The anion exchange column was pre-equilibrated with Buffer 1, which contains
100 mM KOAc, and the protein sample was injected on to the column manually. A salt
gradient from 100 mM KOAc to 1 M KOAc was used to elute the proteins according to
their net charge and is shown in green (right y-axis).The absorbance (left y-axis) at 280
nm is in red and the absorbance at 254 nm is in blue. 1H-15N-YecA was eluted in 500
µl fractions from the anion exchange column between 23 and 28 ml when the concen-
tration of KOAc in buffer 1 was 680 mM. 4.11b: shows the SDS-PAGE analysis of every
other protein-containing fraction. Fraction 23 and 24 contained a small amount of YecA
and several contaminating bands. Most of YecA eluted between 25 and 27 ml and these


















Figure 4.12: SDS-PAGE analysis of the size exclusion chromatography of 1H-15N-YecA
Size exclusion chromatography was used as a final purification step to remove co-
purifying proteins and remove aggregates prior to NMR spectroscopy experiments. 1H-
15N-YecA applied manually to a S75 10/300 GL column that had been pre-equilibrated
with Buffer 1 supplemented with 1 mM TCEP. The flow rate was 0.5 ml/min and the
elutions were collected in 5ml fractions. 10 µl from each protein-containing fraction was
mixed with 10 µl Laemmli buffer and analysed by SDS-PAGE and Coomassie staining.
10 µl of each protein-containing fraction was analysed for purity by SDS-PAGE. A final
concentration of 1.1 mM 13C-15N-YecA was achieved.
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The nickel-affinity column is normally blue due to the presence of nickel. After the appli-
cation of His6-SUMO-YecA to the column, the blue was replaced with a yellow-brown
colour that remained after the elution of the protein (Figure 4.13). The crystallography
screen had suggested the potential presence of ametal cofactor due to the brown-red pre-
cipitates formed in some of the crystal screen conditions. The colours associated with
YecA suggested that this metal cofactor could be iron.
The amino-terminal tag was cleaved by incubating the pooled protein fractions with
SUMO protease (His6-Ulp1). The cleaved YecA was separated from the tagged YecA
and the protease by applying the sample to a nickel-affinity column. The cleaved YecA
cannot not bind to the column and flows through the column. The flow through was
applied to an anion exchange chromatography column. YecA eluted from the column as
the concentration of KOAc increased from 300 to 450 mM (Figure 4.11a) and these frac-
tions were analysed by SDS-PAGE analysis, which showed that most of YecA had eluted
between 23 -27 ml but several contaminating proteins were also resolved (Figure 4.11b).
The protein-containing fractions were pooled and applied to a size-exclusion chromatog-
raphy column. Figure 4.12 shows that YecA eluted between 60 and 70 ml with a small
amount of contaminating protein that only resolved after 48 h in Coomassie stain. This
result shows that YecAwas >90%pure for analysis by 1H-15N-HSQCNMRspectroscopy
experiments. Subsequently, the protein was concentrated to 1.1 mM in 20 mM [MES]-
NaOH [pH 6.5] 10 mMNaCl.
4.2.6 NMR 1H-15N-HSQC of YecA
NMR 1H-15N-HSQC experiments were used to assess whether YecA was folded and to
asses the quality of the spectrum prior to pursuing more expensive techniques. The 1H-
15N-HSQC spectrum of 1.1 mM YecA showed that YecA was folded because the reso-
nances are well-dispersed (Figure 4.14). 170 resonance peaks were identified. YecA con-
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Figure 4.13: The 1 ml HisTrap column before and after nickel affinity chromatography
of YecA
His6-SUMO-YecAwas purified initially by nickel affinity chromatography. Panel A: 1 ml
HisTrap column before application of YecA. Panel B: 1 ml HisTrap column after YecA
was eluted from the column with 0.5 mM imidazole.
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Figure 4.14: 1H-15N-HSQC spectrum of YecA
1H-15N-YecA was dialysed into 20 mM [MES]-NaOH [pH 6.5], 10 mM NaCl and concentrated to 1.1 mM for analysis by 1H-15N-HSQC NMR
spectroscopy using the Bruker 900 mHz instrument. Each peak represents a 1H attached to a 15N.
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tains 221 amino acid residues of which there are 24 with a NH2 in the side chain and
14 prolines, which means that approximately 70% of the protein was visible. This result
suggested that the structure of YecA could be investigated using NMR spectroscopy.
4.2.7 Preparation of 13C-15N-YecA for structural analysis byNMR spec-
troscopy
To analyse the structure of YecA, 13C-15N-YecA was prepared as described in Section
2.5.4 and 2.6.2 for analysis byNMR spectroscopy. Briefly,M9media supplementedwith
15NH4Cl and 13C-D-glucose was used to grow E. coli strain BL21 DE3 that expressed
recombinant YecA with a His6-SUMO tag at its amino-terminus. Cells were grown to
an OD600 of 0.8 and induced with IPTG overnight at 18°C. The cells were lysed using
high pressure homogenisation. The lysate was centrifuged and filtered to remove cell
debris and protein aggregates and applied to a nickel-affinity column that had been
pre-equilibrated with Buffer 1. The column was washed and 1H-15N-His6-SUMO-YecA
was eluted from the column with imidazole. The washes and the imidazole elutions
were analysed by SDS-PAGE and Coomassie staining (Figure 4.16). The gel showed that
a major band resolved between 35 and 48 kDa, which corresponded to the molecular
weight of recombinant YecA (37 kDa). The His6-SUMO tag was cleaved by incubating
overnight with His6-Ulp1, a SUMO protease.
After the protein had been incubated with His6-Ulp1, the sample was concentrated and
anion exchange chromatography was used to separate the proteins according to their
net surface change. The anion exchange column was pre-equilibrated with Buffer 1,
which contains 100 mM KOAc, and the protein sample was injected on to the column
manually. The concentration of KOAc in Buffer 1 was increased linearly to 1 M. YecA
was eluted in 500 µl fractions from the column when the concentration of KOAc in
buffer 1 was 680 mM (Figure 4.15a). The protein-containing fractions were analysed
by SDS-PAGE and Coomassie staining (Figure 4.15b). Lanes 1 and 2 (elution volume
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(b) SDS-PAGEanalysis of 13C-15N-YecAafter anion exchange chromatog-
raphy
Figure 4.15: Anion exchange chromatography of 13C-15N-His6-YecA for structural anal-
ysis by NMR spectroscopy
Topurify cleavedYecAafter the incubationwith SUMOprotease, 13C-15N-YecAwas con-
centrated and applied to an anion exchange column. The anion exchange column was
pre-equilibrated with Buffer 1, which contains 100 mM KOAc, and the protein sample
was injected on to the column manually. 4.15a shows the elution trace of YecA from the
anion exchange column as the concentration of KOAc increased 100 mM KOAc to 1 M
KOAc. The salt gradient that was used to elute the proteins according to their charge and
is shown in green (right y-axis). The absorbance (left y-axis) at 280 nm is in red and the
absorbance at 254 nm is in blue. 13C-15N-YecAwas eluted in 500 µl fractions from the an-
ion exchange column between 19.5 and 22ml when the concentration of KOAc in buffer
1 was 680 mM. 4.15b: The protein-containing fractions (19.5 - 24 ml) were analysed by
SDS-PAGE and Coomassie staining. YecA co-purified with a protein of approximately
100 kDa (Fraction 19.5 ml and 20 ml). YecA co-purified with a protein of approximately
63 kDa (Fraction 23 ml and 24 ml). Fractions that eluted between 20 ml and 22 ml were
pooled and concentrated for further purification. * indicates an unknown protein of ap-
proximately 100 kDa that co-purified with YecA and ** indicates a protein an unknown
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Figure 4.16: Nickel affinity chromatography of 13C-15N-His6-SUMO-YecA for structural
analysis by NMR spectroscopy
His6-SUMO-YecA was expressed in E. coli strain BL21 DE3 in M9 media that was sup-
plemented with 15NH4Cl and 13C-D-glucose. Expression was induced overnight at 18°C.
The IPTG-induced cells were harvested and lysed by high pressure homogenisation. The
lysate was clarified by centrifugation and filtration to remove cell debris and aggregates
before application to a nickel affinity column. A flow rate of 0.5 ml/min was used and
the lysate passed over the column five times before the column was washed with five col-
umn volumes of Buffer 1 and five column volumes of High Salt Buffer. 13C-15N-His6-
SUMO-YecA was eluted with 0.5 mM imidazole in 0.5 ml fractions. The imidazole elu-
tions were analysed by SDS-PAGE and Coomassie staining. 13C-15N-His6-SUMO-YecA
eluted in fractions 3 to 11, which was equivalent to an elution volume of between 1.5 and
8.5 ml. These fractions were pooled and incubated with SUMO protease to cleave the
His6-SUMO tag. Several co-purifying proteins also eluted with 13C-15N-His6-SUMO-
YecA. * indicates a co-purifying protein that resolved at approximately 75 kDa, which is
possibly CdsA.
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19.5 and 20 ml) of Figure 4.15b show that YecA had co-purified with a protein of
approximately 100 kDa. Lanes 5 and 6 (Fraction 23 ml and 24 ml) of Figure 4.15b show
that YecA had co-purified with a protein of approximately 63 kDa. The fractions that
collected the elution volume of between 20 and 22 ml were pooled and concentrated
and applied to a size exclusion column. After size exclusion chromatography, the
protein-containing fractions were analysed by SDS-PAGE and Coomassie staining.
Figure 4.17 shows that 13C-15N-YecA eluted between 55 and 80 ml, with the majority
of the protein eluting in one fraction at 60 ml. Two co-purifying bands were resolved
only after 48 h in Coomassie stain. One of the bands resolved at 37 kDa and it is possible
that this protein was 13C-15N-His6-SUMO-YecA. The other protein resolved at 48 kDa
and is unidentified. The 13C-15N-YecA was approximately 95% pure and the protein
was dialysed into 20 mM [MES]-NaOH [pH 6], 10 mM NaCl for analysis by NMR
spectroscopy.
4.2.8 Assignment of the backbone of 13C-15N-YecA
To investigate the structure of the YecA-MeBD from NMR spectroscopy experiments,
each of the resonances1 were assigned to the backbone sequence of the protein. The
first stage of the assignment process is clustering, which involves tracing each of the res-
onances that correspond to a particular residue. The HNCA, HN(CO)CA, HNCACB,
CBCA(CO)NH, HNCO, and HN(CA)CO provide information about the chemical
shifts of carbon atoms of the amino acid residue (CA, CB and CO) with respect to
the hydrogen and the nitrogen of the backbone amide group. It is then necessary to
identify the sequential arrangement of the amino acid residues. Each cluster provides
information about the adjacent cluster, which facilitates the mapping of the residues.
Using the program Sparky, it was possible to align the inter-residue carbon shifts of one
1The 1H15N-HSQC NMR spectrum of apo-YecA201 shown in Figure 5.8 was used to identify reso-
















MW (kDa) 60 65 70 7555 80
Elution volume (ml)
*
Figure 4.17: SDS-PAGE analysis of 13C-15N-YecA after gel filtration
Size exclusion chromatography was used as a final purification step to remove co-
purifying proteins and remove aggregates prior to NMR spectroscopy experiments. 13C-
15N-YecA applied manually to a S75 10/300 GL column that had been pre-equilibrated
with Buffer 1 supplemented with 1 mM TCEP. The flow rate was 0.5 ml/min and the
elutions were collected in 5ml fractions. 10 µl from each protein-containing fraction was
mixed with 10 µl Laemmli buffer and analysed by SDS-PAGE and Coomassie staining.
10 µl of each protein-containing fraction was analysed for purity by SDS-PAGE. A final
concentration of 0.5 mM 13C-15N-YecA was achieved. *indicates two co-purifying pro-
teins that resolved at 48 kDa and at 37 kDa. It is possible that the 37 kDa protein was
His6-SUMO-YecA, which is 37 kDa, while the other is unknown.
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Figure 4.18: 1H-15N backbone assignments of 13C-15N-YecA
13C-15N-YecA, at a concentration of 0.5 mM in 20 mM [MES]-NaOH [pH 6.0], was analysed by 1H-15N-HSQC. The spectrum was recorded on a
Bruker 900mHz spectrometer. The chemical shift information fromtheHNCA,HN(CO)CA,HNCACB,HN(CO)CACB,HNCOandHN(CA)CO
experiments was correlated using clustering and then sequentially assigned using Sparky software. Black labels indicate the fully assigned conformation
of the YecA-MeBD and the green labels indicate the second, partially assigned conformation of the YecA-MeBD.
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cluster to the intra-residue carbon shifts of the adjacent cluster. Afterwards, the next
cluster in the sequence was identified in the same way. In theory, this process can be
repeated by assigning adjacent clusters to a residue until the full back-bone of the protein
is assigned. However, proline is invisible because it does not have an amide proton
in its backbone and some resonances are very poorly resolved. It is common to have
fragments of backbone assignments (Knowles, 2005). After a sequence of resonances
have been assigned, it is necessary to position the fragment to the correct location on
the polypeptide sequence. The reposition function within Sparky was used identify the
likely locations in the protein backbone for the fragment. The amino acid residues with
characteristic chemical shift patterns were used to manually check the recommended
position. Examples of amino acid residues with distinctive chemical shift patterns
include serine (CA 63 ppm, CB, 67 ppm), threonine (CA 63 ppm, Cb 70ppm), alanine
(CB 18 ppm) and glycine (CA 45 ppm).
The 1H-15N-HSQC spectrum of 1H-15N-YecA is shown in Figure 4.18. The aim of this
process was to assign the backbone of the YecA-MeBD. 24 assignments were mapped to
this region of YecA, which is only 20-amino acid residues long and contains two proline
residues. These assignments were independently checked2 and would not fit anywhere
else in the protein backbone of YecA. The assignments suggested there were two YecA-
MeBD species present in the sample. The entire YecA-MeBD was fully assigned in one
of these conformations (G202-D205; C207; C209-H221), while the other conformation
was only partially assigned (G202-D205; C219-H221). The two species showed consid-
erable differences between their chemical shift patterns.
4.2.9 Small angle X-ray scattering
Small angle X-ray scattering (SAXS) was used to develop an understanding of the
conformation of YecA in solution. The BM29 beamline at ESRF, Grenoble was used
2With many thanks to Dr. T. Knowles
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to collect all SAXS data3. Data was collected every second from samples as they eluted
from an in-line size exclusion chromatography column. YecA eluted from the column
between 1080 and 1150 s (Figure 4.19). This was consistent with the elution of a protein
of 25 kDa, which suggested that YecA was a monomer under these conditions (Dr. T.
Knowles, personal communication). The SAXS profiles between 1087 and 1108 s were
selected for further analysis to ensure the data was consistent. These profiles were buffer
subtracted and the resulting SAXS profiles were averaged for further analysis (Figure
4.20).
Guinier analysis of the SAXS data was used to investigate whether the protein was
aggregated or homogenous. The Guinier analysis is the scattering intensity curve in the
low q region, which can be used to determine the radius of gyration (Rg). The linearity
of the Guinier plot (Figure 4.21) indicated that the protein was not aggregated, which
indicated that the data was of good quality and could be used for further analysis. The
Rg was 2.16 ± 0.03 nm, which was determined automatically from the Guinier analysis
using PRIMUS software (Konarev et al., 2003).
SAXS MoW2 is an online, open-source platform that can be used to estimate the
molecular weight of a protein from its SAXS data (Fischer et al., 2010). SAXS MoW2
analysis of the averaged SAXS data of YecA indicated that the protein had a molecular
weight of 33.217 kDa. The molecular weight of YecA is 25 kDa and this analysis was
consistent with the elution profile that also suggested that YecA was monomeric.
Kratky analysis was used to determine whether YecA was folded. If a protein is folded,
a bell-shaped peak in the low q region that converges to the q axis in the high q region
(Mertens and Svergun, 2010). A protein that has high flexibility lacks this bell-shaped
peak and instead has a plateau in the high q region. Multi-domain proteins sometimes
3Data was collected by Dr. Tim Knowles and Dr. Mohammed Jamshad
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Figure 4.19: In-line gel filtration profile of YecA as a function of time
The total scattering (a.u.) of YecA as a function of time (s) was used to identify the elu-
tion of YecA. The scattering intensity between 1080 s and 1150 s was collated and used
for further analysis. The radius of gyration (Rg) as a function of time was determined













Figure 4.20: Average SAXS profile of YecA
The average log scattering intensity as a function of q of YecA. q is the vector of momen-














Figure 4.21: Guinier analysis of the low q region of the SAXS scattering curve of YecA
TheGuinier plotwas determined automatically using PRIMUS software (Konarev et al.,
2003). The linearity of theGuinier plot indicated that YecAwas folded and not aggregat-














Figure 4.22: Kratky plot of the SAXS scattering curve of YecA
PRIMUS was used to generate a Kratky plot to ensure that YecA was folded. The q2 ×
I (q) emphasised the shape at low intensities. A bell-shaped curve is indicative of a folded
protein.
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(a) Test 1: Chi2 = 0.89 (b) Test 2: Chi2 = 0.87 (c) Test 3: Chi2 = 0.86
(d) Test 4: Chi2 = 0.84 (e) Test 5: Chi2 = 0.87 (f) Test 6: Chi2 = 0.90
(g) Test 7: Chi2 = 0.82 (h) Test 8: Chi2 = 0.83 (i) Test 9: Chi2 = 0.88
(j) Test 10: Chi2 = 0.88
Figure 4.23: The fits of 10 independent CORALmodels
YecAwas analysed by SAXSusing an in-line size exclusion chromatography column. The
orientation of the two domains of YecAwas modelled using the structures of two homo-
logues, PDB ID: 1IZM (Galkin et al., 2004) and PDB ID: 1TM6 (Matousek and Alexan-
drescu, 2004). Residues 11 to 192 were modelled using 1IZM and residues 201 to 221
were modelled using 1TM6. The remainder of the protein was modelled using dummy
molecules. CORAL was to compare the scattering profile of YecA with the theoretical
scattering profile of the model. The comparison of the experimental data with the theo-
retical fit is shown for ten models created with CORAL (a - j) where I is the intensity of
scattering in arbitrary units and q is the scattering vector (Å-1). The Chi2 shows a good fit
for all of the test fits (Chi2 = 0.82-0.90).
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Figure 4.24: Ten structural models of YecA
The orientation of the YecA-MeBD in relation to theUPF0149 domain (blue) was recon-
structed from the SAXS analysis using rigid body modelling in CORAL. The UPF0149
domain was modelled using the crystal structure of YgfB (PDB ID: 1IZM Galkin et al.,
2004) and theYecA-MeBDwasmodelled on the SecA-MeBD (PDB ID: 1TM6Matousek
and Alexandrescu, 2004). The two domains were rigid and flexible dummy molecules
(dots) were used tomodel the linker region between the two domains and the amino ter-
minus. The ten orientations of the YecA-MeBD, flexible linker and amino-terminus in
relation to the UPF0149 domain are shown in red, green, blue, yellow, light blue, orange,
tangerine, light green, dark orange and turquoise.
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have a shoulder on the bell-shaped peak in the low q region but still converge to the q
axis in the high q region, unless the domains are linked by a flexible region. The SAXS
data was transformed automatically using PRIMUS software (Konarev et al., 2003).
The Kratky analysis of the averaged SAXS data of YecA showed the bell-shape peak in
the low q that converged to the q axis in the high q region. This result indicated that
YecA was in a folded, globular conformation (Figure 4.22).
CORAL is a program that is used to model complexes from SAXS data (Petoukhov
et al., 2012). Using CORAL, the averaged measured scattering profile of YecA was
compared to theoretical profiles of a template molecule. The template molecule was
composed of two domain homologues of YecA and dummy molecules (Petoukhov et
al., 2012). Dummy glycine residues were used to model the first 10-amino acid residues
of the YecA molecule. Amino acid residues 11 to 189 of YecA were modelled using the
crystal structure of YgfB (PDB ID: 1IZMGalkin et al., 2004)Residues 201 to 221 of YecA
were modelled using the NMR solution structure of the SecA-MeBD (PDB ID: 1TM6
Matousek and Alexandrescu, 2004). A flexible linker of 19 dummy glycine residues was
used to attach the carboxy-terminus of 1IZM to the amino terminus of 1TM6. 1IZMwas
fixed in the template model, and the rest of the molecule was given freedom to move. 10
theoretical models were generated by CORAL (Chi2 = 0.82-0.90). The simulated SAXS
data for each model generated by CORAL is shown in Figure 4.23.
Figure 4.24 shows that the modelled YecA-MeBD was independent of the UPF0149 do-
mainbut had limitedmovement in solution. Themodel structures showed that theYecA-
MeBD could rotate approximately 100° around theUPF0149 domain. The amino termi-
nus of YecA, which was modelled using dummy molecules, showed large flexibility. The
models were in agreement with the structural model of YecA that was generated using
Phyre2. The models showed that the UPF0149 domain formed 7 α-helices, that were
grouped in a 3-helix and a 4-helix bundle, like YgfB.
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4.3 Discussion
The aim of this chapter was to investigate the structure of YecA. Although the structure
of YecA was not resolved, progress towards this aim was made. The data presented in
this chapter suggested that YecA was a monomer in solution under the experimental
conditions used. Model structures of YecA that were generated suggested that YecA
forms 7 α-helices. The CD spectra also suggested that YecA was mostly α-helical. The
Phyre2 predicted model and the SAXS analysis suggested that the YecA-MeBD was
independent of UPF0149. The two domains were predicted to be linked by residues
with limited flexibility, which suggested that an interaction between the linker region
and UPF0149 was possible. Assignment of residues from the NMR data suggested that
the YecA-MeBD existed in two conformations.
The thermostability of YecAwas investigated by CD spectroscopy to investigate whether
YecA was stable at the temperature required for NMR spectroscopy. The CD analysis
suggested that the melting temperature of YecA was 46.9°C. Above these temperatures,
protein aggregation was observed by the increased absorbance at 200 nm. This data
suggested that YecA was stable only to 39.6°C. The K2D analysis suggested that folded
YecA was approximately 31% α-helical and approximately 10% β-sheet. The structural
models of YecA both indicate that YecA is mostly α-helical. The SecA-MeBD has a
ββα-fold when bound to zinc (Zhou and Xu, 2003; Dempsey et al., 2004; Matousek
and Alexandrescu, 2004) and it is possible that the YecA-MeBD forms the same fold.
Additionally, the CD analysis provided the basis for repeating the citrate synthase assay
that was described in Section 3.3 at 40°C in the future.
The investigation of the solution structure of YecA by 1H-15N-HSQC NMR spec-
troscopy revealed that the proton resonances were well-dispersed. The backbone
assignments of YecA showed that the YecA-MeBD existed in two, distinct conformations
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that were independent of the main body of the protein. The two species could be the
result of disulphide bond formation because reducing agent was not included in the
buffer that was used for the NMR experiments. However, it is also possible that the
YecA-MeBD was structurally affected by iron. Fe2+ is a paramagnetic ion, which causes
the intensity of the coordinating or neighbouring amide bonds to decrease. Therefore, it
is possible that the absence of resonances that correspond to residues 206 to 216 (except
proline) was caused by the proximity of an iron cofactor to these residues. The presence
of iron could also explain the large changes in chemical shift of other residues. Studies
of the SecA-MeBD indicated that the domain was unfolded in the absence of zinc and
folded in the presence of zinc (Matousek and Alexandrescu, 2004). To determine the
structure of YecA using NMR spectroscopy, the apo-protein will be prepared under
reducing conditions to prevent the oxidisation of the cysteine residues. It is hoped that
this method will allow the assignment of the YecA-MeBD in a single conformation.
The structural model of YecA that was determined using SAXS and CORAL indicated
that the two domains, UPF0149 and YecA-MeBD, were independent of each other.
This result suggested that the YecA-MeBD does not function as an auto-inhibitor. The
carboxy-tail of SecA, which includes the SecA-MeBD and the flexible linker, has been
shown to occlude the PPXD (Gelis et al., 2007). In the future, the orientation of the
YecA-MeBD with respect to the UPF0149 domain in response to ligands will be investi-
gated. Similarly, determining whether YecA can dimerise, like the sequence homologues
Lpg0076, YgfB and SecA, will provide an insight into the structural mechanisms that
underlie the function of YecA.
YecA was submitted to crystal screen trials but no protein crystals were observed in any
of the conditions. However, in some conditions brown or brown-red precipitates were
formed. At the time, these precipitates were considered to be contaminants. However,
subsequent purifications of YecA by nickel affinity chromatography resulted in the
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nickel affinity column turning from turquoise-blue to brown, and the protein sample
was yellow. Fe2+ is soluble but oxidation of this ion to Fe3+ frequently results in the
formation a brown precipitates. It was hypothesised that the colours observed in the
crystal screen trials and during the nickel affinity chromatography was caused by iron.
The independent observations also suggested that the cognate cofactor of YecA could
be iron and not zinc, as predicted by sequence similarity between the YecA-MeBD and
the zinc-binding SecA-MeBD. If the red-brown precipitates are iron-bound protein
crystals, and not contaminants, it is possible that the crystal screen trials described in
this chapter have identified several conditions that may be appropriate for crystallising
YecA. The data presented in this chapter suggested that YecA was a monomer in
solution. UPF0149-containing proteins YgfB and Lpg0076 have both been crystallised
as dimers. Therefore, crystallography trials could be repeated with a particular focus on
the conditions that produced the brown or red precipitates.
The data presented in this chapter suggested that the cognate metal cofactor of YecA
might not be zinc. Zinc compounds are generally colourless and zinc is diamagnetic.
The presence of zinc causes the chemical shift of neighbouring protons to change, which
would have been observed in the NMR spectra. Instead, resonances were absent from
the NMR spectrum of the second conformation of the YecA-MeBD, which suggested
the presence of a paramagnetic ion, such as iron. The investigation into the cognatemetal







The coordination of zinc by the SecA-MeBD has been investigated using NMR and
X-ray crystallography (Matousek and Alexandrescu, 2004; Dempsey et al., 2004; Gelis
et al., 2007). The interaction between SecA and zinc is thought to be functionally
relevant because the SecA-MeBD folds in the presence of zinc, which may contribute
to the interaction between this domain and SecB (Fekkes et al., 1999; Patel et al., 2006;
Matousek and Alexandrescu, 2004). The YecA-MeBD is predicted to be zinc-binding
domain based on sequence homology to the SecA-MeBD but the qualitative data
presented in Chapter 4 suggested that YecA may associate with iron.
Specificity of a metalloprotein for the cognate metal cofactor is affected by folding
location, relative affinity, metal availability and chaperones that can deliver and insert
metals (Waldron, 2009). However, mismetallation of a metalloprotein can occur during
the purification process (Cotruvo Jr. and Stubbe, 2012). For example, preparations of
azurin, a copper-binding protein, yields apo-azurin, copper-bound azurin and zinc-
bound azurin (McLaughlin et al., 2012). This occurs because the affinity of transition
metals for metalloproteins often follows the Irving-Williams series such that, outside of
metal-regulatory environment of the cell, metals that have a lower affinity for a binding
site can be out competed by another metal ion (Waldron, 2009).
It is possible to analyse the trace metal content of a sample using inductively coupled
plasma optical emission spectroscopy (ICP-OES). ICP-OES detects the electromagnetic
radiation that is emitted by excited atoms and ions. Each metal emits electromagnetic
radiation of a characteristic wavelength. By comparing the intensity of the emission
to a set of standards the concentration of a particular metal can be determined. This
technique does not provide information about the charge of the metal before analysis.
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Ultra-violet visible (UV-vis) spectroscopy can be used to investigate the binding of a
protein to a cofactor (Hamilton, 2009). UV-vis spectroscopy measures the absorbance
of electromagnetic radiation in the UV-vis range (200 - 800 nm). The contribution of
a metal cofactor to the UV-vis spectrum of a protein can be detected by comparison to
the apoprotein. For example, UV-vis was used to investigate the interaction of TauD
with its cognate metal cofactor, Fe2+. This analysis revealed that Fe2+-binding results in
a small, reproducible increase in the absorbance of electromagnetic radiation compared
with the apo-protein (Grzyska et al., 2010).
NMR spectroscopy was used in Chapter 4 to investigate the structure of YecA. It is
possible to use this technique to investigate the binding of YecA to a metal cofactor
and potentially identify the coordinating amino acid residues. Zn2+ is an example of a
diamagnetic ion. When a protein binds Zn2+, the interacting and neighbouring residues
would have a different chemical shift pattern compared with the apo-protein because
of structural and electronic changes around those residues. Paramagnetic metal ions
are characterised by unpaired electrons, which have large magnetic moments. There
are strong interactions between the unpaired electrons of a paramagnetic metal ion
and the nuclei of the surrounding protein (Jensen et al., 2007). The coordination of
a paramagnetic ion by a protein causes the proton NMR lines of coordinating and
proximal nuclei to broaden. The nuclei closest to the paramagnetic ion are not detectable
because of this phenomenon. Nuclei that are further away from the paramagnetic ion
exhibit fewer proton NMR line broadening effects (Figure 5.1). The size of this effect
depends on the nuclear relaxation of metal ion, which is affected by the number of
unpaired electrons, the electron relaxation time, and the rotational correlation time
of the molecule (Bertini et al., 2005). An example of a paramagnetic ion is Fe2+. The
NMR 1H-15N-HSQC spectrum of apo-protein would have more peaks than the NMR








Figure 5.1: Diagram to illustrate the effect of a paramagnetic ion on the visibility of amino
acid residues by NMR spectroscopy
The sphere around the paramagnetic metal ion is a blind zone because proton NMR
signals are too broad to be detected. Outside the blind zine is another sphere, which
represents the region where NMR signals are visible but still affected by paramagnetism.
The region with detectable paramagnetic effects can be used to gather information on
their position with respect to the metal ion. Figure adapted from Bertini et al. (2005)
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EPR can be used to investigate metalloproteins. The spectroscopic signature of a
metalloprotein is influenced by the number of ligands, the symmetry and the oxidation
state of the bound metal. Every electron has a magnetic moment and a spin quantum
number, S = 12 . When an external magnetic field, B0, is applied to a sample, the spin
quantum number (spin state) can either be S = +12 or S = −
1
2 depending on whether
the electron aligns against B0 or with B0. EPR depends on the energy difference (ΔE)
between two spin states of an electron when B0 is applied. An unpaired electron can
flip between the two energy levels by either absorbing or emitting a photon of an energy
that is equal to the difference between the two energy levels. The transition of an
electron between the two energy levels can be induced by the application of an oscillating
electromagnetic resonance that is equal toΔE.
The spin state of iron has an effect on the EPR spectrum. Fe3+ is the only oxidation state
of iron that is detectable by EPR because it is the only oxidation state that contains an
unpaired electron. The d electrons are distributed across five orbitals. Electrostatic repul-
sion means that these electrons are likely to occupy different orbitals. This is known as











The coordination of Fe3+ by a strong ligand causes the electrons to occupy the lower
energy d orbitals such that four electrons are paired and one electron is not to give a net
spin state of S = 12 . This is known as the low spin state. Fe
2+ is not observable in either










2 = 2 and in the low
spin state, the six electrons pair and cancel each other out to give a net spin of S = 0.
The g-factor is the measure of the electronic interaction between an unpaired electron
and B0 and is characteristic of the spin state and the geometry of the ligand binding.
In this chapter, a combination of UV-vis spectroscopy, ICP-OES, ICP-MS, EPR spec-
troscopy and 1H-15N-HSQCNMR spectroscopy was used to investigate themetal cofac-
tor of YecA. In Chapter 4, the observed colours during the purification and crystal screen
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trials of YecA suggested that iron could be the cognate metal cofactor of YecA. The data
presented in this chapter suggests that YecA binds iron.
5.2 Results
5.2.1 Inductively coupled plasma optical emission spectrometry to anal-
yse the metal content of YecA
The identity of the metal that co-purified with YecA after nickel-affinity chromatogra-
phy, as described in Chapter 4, was investigated using ICP-OES. YecA was purified as
described in Section 3.2.6 and prepared at a concentration of 50 mg/l in 2% v/v nitric
acid for ICP-OES. It was reasoned that the contaminant was most likely to be a divalent
ion that had exchanged with nickel during the purification. The column was washed
with 10 ml 0.1 M EDTA to elute the brown substance for analysis by ICP-OES. After
this step, the column was white, which indicated that the substance had been eluted.
The column eluate was prepared for ICP-OES by the addition of nitric acid to a final
concentration of 2% (v/v) .
A calibration curve for each metal was determined using metal standards of 18 nM, 180
nM and 1.8 µM that were prepared in 2% (v/v) nitric acid. The three elements analysed
were iron, manganese and zinc, which are the primary divalent transitionmetals in theE.
coli cytoplasm (Imlay, 2014). The standards are shown in Figure 5.2. The molar concen-
tration of each element in the protein and the column eluate samples were determined
using the standard calibration curves (Figure 5.2). The concentration of zinc in the YecA
sample was 6.8 µM and the concentration of zinc in the column eluate was 10.9 µM.
The concentration of manganese in the YecA sample was 0.3 µM, while the manganese
concentration was 0.8 µM in the column eluate. The concentration of iron in the YecA
samplewas 0.8 µM.The concentration of iron in the column eluatewas 255.7 µM,which
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y = 0.2189x + 1180.4
R² = 0.97625
y = 8.3108x + 13115
R² = 0.99998



























Figure 5.2: Three point calibration curves including linear regression coefficients for zinc,
manganese and iron
For every wavelength (200 - 260 nm) the emission intensity was recorded (a.u.). The in-
terval between each wavelength was 0.0038 nm. The wavelength that corresponded to
the maximal emission intensity was identified manually. The wavelengths used were λ=
206.2011 nm for zinc, λ= 257.61 nm for manganese and λ= 238.204 for iron. The emis-
sion intensity of each of the metal standards at this wavelength was plotted as a function
of concentration. The linear regression analysis was used to solve for the concentration



















































(b) Molar ratio of metal to YecA
Figure 5.3: ICP-OES to analyse the metal content of YecA
YecA and the column eluate were analysed by ICP-OES. The concentration of iron, zinc
and manganese in each sample was determined using the calibration curves. 5.3a shows
the metal content of YecA and the column eluate. The y-axis log scale shows the concen-
tration of each metal. The three metals analysed were iron, zinc and manganese. n = 1.
5.3b shows the molar ratio of metal cofactor to YecA. This was calculated by dividing the
molar concentration of metal by the molar concentration of YecA.
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was 96% of the total analysed metal content of this sample. The high concentration of
iron in the eluate indicated that iron had caused the nickel affinity column to turn from
blue to brown during the purification of YecA.
The molar ratio of each metal to YecA was determined (Figure 5.3b). This analysis in-
dicated that YecA had a zinc:YecA molar ratio of 3.3:1, or a three-fold excess of zinc per
molecule of YecA.The iron:YecAmolar ratiowas 0.4:1 and themanganese:YecAmolar ra-
tio was 0.1:1. The ICP-OES analysis of the column eluate suggested that the YecA-bound
ironwas lost during the nickel affinity purification. This result suggested that the identity
of the metal that co-purified with YecA was iron.
5.2.2 UV-visible spectroscopy to characterisation of the interaction of
YecA with iron
UV-vis spectroscopy was used to investigate the interaction between YecA and iron fur-
ther. YecA was purified to homogeneity and then treated with 0.2 M EDTA to chelate
any divalent cations. The EDTA was removed from the protein by dialysis into Buffer
1. The apo-YecA solution turned yellow when one equivalent molar concentration of
FeSO4 was added. Comparative analysis of the iron-incubated YecA with the apo-YecA
byUV-vis spectroscopy showed that after the incubationof apo-YecAwithFeSO4 abroad
shoulder with amaximumof 328 nmdeveloped (Figure 5.4). Furthermore, this peak was
intensified by the addition of 10 mM ascorbate, a reducing agent. The peak at 328 nm
was attributed to the formation of an Fe2+-YecA complex.
5.2.3 1H-15N-HSQCNMR spectra to investigate the metal-binding site
of YecA
1H-15N-HSQCNMR spectroscopywas used to investigate the iron-binding site of YecA.




















Apo-YecA Apo-YecA + FeSO Apo-YecA + FeSO4 + 10 mM ascorbate4 4
328 nm
Figure 5.4: UV-visible spectra to show Fe2+-binding of YecA
Apo-YecA was prepared by incubating YecA with 0.2 mM EDTA. The EDTA was re-
moved by dialysis into Buffer 1 prior to analysis. The samples were analysed at room
temperature under aerobic conditions. Solid line: the mean UV-vis spectrum of 0.8 mM
apo-YecA. Long-dashed line: The mean UV-vis spectrum of apo-YecA after it was incu-
bated with an equimolar concentration of FeSO4. Short-dashed line: The mean UV-vis
spectrum of the iron-bound protein plus 10 mM ascorbate. Data are buffer-corrected
mean values. n = 3.
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Figure 5.5: SDS-PAGE analysis of the nickel-affinity chromatography of 1H-15-N-His6-
SUMO-YecA201
His6-SUMO-YecA201 was expressed in E. coli strain BL21 DE3 in M9 media that was
supplemented with 15NH4Cl. The IPTG-induced cells were pelleted and the pellet was
resuspended in Buffer 1 that was supplemented with PMSF (to inhibit protein degrada-
tion) andDnase I (to degrade theDNA) and lysed by high pressure homogenisation. The
lysate was clarified by centrifugation and filtration before application to a nickel affin-
ity column. The lysate passed through the column at least five times before the column
was washed with five column volumes of Buffer 1 (LW). Subsequently, the column was
washedwith five columnvolumes ofHigh Salt Buffer (HW).Theproteinwas elutedwith
0.5 mM imidazole in 0.5 ml fractions. The washes and imidazole elutions were analysed
by SDS-PAGE and Coomassie staining. 1H-15-N-His6-SUMO-YecA201 eluted in frac-
tions 3 to 6. * indicates a protein of 75 kDa that co-purified with 1H-15-N-His6-SUMO-
YecA201, which was possibly CdsA. ** indicates a protein of between 20 and 25 kDa that
was possibly the cleaved YecA201, the band the is indicated by *** is possibly the His6-
SUMO tag.
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the YecA-MeBD suggested that the metal-binding site of YecA could be located in this
domain. Both full length YecA and YecA201, a variant of YecA that lacked the YecA-
MeBD, were analysed by 1H-15N-HSQC NMR spectroscopy to investigate whether the
metal-binding-site was in the YecA-MeBD .
1H-15N-YecA201 was prepared by growing E. coli strain BL21 DE3 pCA528-yecA201
in M9 media supplemented with 15NH4 as the sole nitrogen source. After overnight
induction, the cells were lysed and 1H-15N-His6-SUMO-YecA201 was purified as
described in Section 3.2.6. The washes and the imidazole elutions were analysed by
SDS-PAGE and Coomassie staining, (Figure 5.5). The His6-SUMO tag was cleaved by
incubating overnight withHis6-Ulp1, a SUMOprotease. After this step, the protein was
concentrated and applied to an anion exchange column and elutedwith aKOAc gradient
of 100 mM to 1 M. The protein-containing fractions were analysed by SDS-PAGE.
Figure 5.6 showed that after anion exchange chromatography cleaved textsuperscript1H-
15N-YecA201 had co-purified with a protein of 75 kDa, which was potentially CdsA,
and the 48 kDa 1H-15N-His6-SUMO-YecA201. The fractions from the anion exchange
chromatography step that contained 1H-15N-YecA201 were pooled, concentrated and
purified by size exclusion chromatography to remove these contaminants.
The protein-containing fractions were analysed by SDS-PAGE to determine the purity
of 1H-15N-YecA201 after size exclusion chromatography. Analysis of the SDS-PAGE
gel using Coomassie staining indicated that this step had resulted in 95% pure 1H-15N-
YecA201 (Figure 5.7). A protein of 75 kDa had co-purified with 1H-15N-YecA201, and
although the size exclusion chromatography had mostly separated the two proteins, a
small amount of the co-purifying protein remained. It is possible that this contaminant
was CdsA. The protein was treated with 0.1 M EDTA to chelate any divalent cations.
The EDTAwas removed by dialysis of the protein into 20mM [MES]-NaOH [pH 6.5],
10 mMNaCl. 1H-15N-YecA201 was subsequently concentrated to 0.84 mM.
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(a) Anion exchange chromatography elution trace of YecA201 of 1H-15N-YecA201














(b) SDS-PAGE analysis of the anion exchange chromatography of 1H-15N-YecA201
Figure 5.6: Anion exchange chromatography of 1H-15N-YecA201 for 1H-15N-HSQC
NMR spectroscopy
Anion exchange chromatographywas used to purify the cleaved 1H-15N-YecA201. A flow
rate of 0.5 ml/min was used. 5.6a shows the elution profile of 1H-15N-YecA201 from an
anion exchange column as the KOAc concentration increased from 100mM to 1M. The
elution of the protein (left y-axis) was detected by measuring the absorbance at 280 nm
(red) and the absorbance at 254 nm (blue). The concentration of KOAc is indicated in
green (right y-axis). The protein was eluted from the anion exchange chromatography
column between 800 mM to 950 mM KOAc. 5.6b shows the SDS-PAGE analysis and
Coomassie staining of the eluted fractions. 1H-15N-YecA201, which was resolved at 25
kDa, eluted between 25.5 ml and 29 ml. These fractions were pooled and concentrated
for further purification by size exclusion chromatography. * indicated a protein of 75 kDa
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Figure 5.7: SDS-PAGE analysis of the size exclusion chromatography of 1H-15N-YecA201
Size exclusion chromatography was used to separate proteins according to their size. 1H-
15N-YecA201 was applied to an S75 10/300 GL size exclusion chromatography column
that had been pre-equilibrated in Buffer 1 plus 1 mM TCEP. A flow rate of 1 ml/min
was used. The elution volume was collected in 5 ml fractions, which were analysed by
SDS-PAGE and Coomassie staining. * indicates a protein of 75 kDa that co-purified with
YecA201, which is possibly CdsA. Fractions 65 to 75 were pooled and dialysed into 20
mM [MES]-NaOH [pH 6.5], 10 mMNaCl and concentrated using a spin concentrator
to 0.84 mM for NMR spectroscopy experiments
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In initial experiments 1H-15N-YecA201 was analysed by 1H-15N-HSQC NMR spec-
troscopy to investigate whether the truncated variant of YecA could bind iron. The
overlaid 1H-15N-HSQC spectra of 1H-15N-YecA201 in the presence and absence of
FeSO4 are shown in Figure 5.8. The incubation of apo-1H-15N-YecA201 with FeSO4
did not result in the disappearance of any amide bond peaks. This result suggested
that theMeBDwas required for the binding of iron under these experimental conditions.
Subsequently, 1H-15N-YecA was analysed by 1H-15N-HSQC NMR spectroscopy. The
overlaid 1H-15N-HSQC spectra of the apo-1H-15N-YecA and iron-bound1H-15N-YecA
are shown in Figure 5.9. The incubation of apo-YecA with FeSO4 resulted in the
disappearance of several amide proton peaks, which suggested that YecA bound iron. In
Section 4.2.8, the YecA-MeBD was assigned in two, distinct conformations. Only one
of these conformations was fully assigned. Although the resonances that coordinated
iron were not annotated as being part of the YecA-MeBD, the 1H-15N-HSQC NMR
spectrum of YecA201 does not contain several of amide proton peaks that disappeared
or decreased in intensity in the 15N-HSQC NMR spectrum of iron-incubated YecA
(Figure 5.10). This result suggested that it is likely that the iron-binding site is located in
the YecA-MeBD.
E. coli SecA coordinates zinc via three cysteine residues and a histidine residue, which
suggests that YecAmay bind to zinc. TheNMR spectroscopy experiments were repeated
with apo-1H-15N-YecA and 1H-15N-YecA in the presence of a two-fold molar excess of
zinc sulphate to investigate whether YecA bound zinc (Figure 5.11). Zinc is diamagnetic,
which means that structural changes to the environment around the amide bonds are
detected by chemical shift perturbations. If YecA bound to zinc, the overlaid spectra of
YecA in the presence and absence of zinc sulphate would be expected to show different
positions of some amide bond peaks. However, no chemical shifts perturbations were
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Figure 5.8: The effect of FeSO4 on the 1H-15N-HSQC spectrum of apo-1H-15N-YecA201
The protein was dialysed into 20 mM [MES]-NaOH [pH 6.5], 10 mM NaCl and concentrated to 0.84 mM for analysis by 1H-15N-HSQC NMR
spectroscopy using the Bruker 900 mHz instrument. Each peak represents a 1H attached to a 15N. The 1H-15N-HSQC spectrum of apo-1H-15N-
YecA201 is shown in blue. The apo-1H-15N-YecA201 was incubated with a two-fold molar excess of FeSO4. The 1H-15N-HSQC spectrum of 1H-15N-
YecA201 after it had been incubated with FeSO4 is shown in orange.
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Figure 5.9: The effect of FeSO4 on the 1H-15N-HSQC spectrum of apo-1H-15N-YecA
The protein was dialysed into 20 mM [MES]-NaOH [pH 6.5], 10 mM NaCl and concentrated to 1.1 mM for analysis by 1H-15N-HSQC NMR
spectroscopy using the Bruker 900 mHz instrument. Each peak represents a 1H attached to a 15N. The 1H-15N-HSQC spectrum of apo-1H-15N-YecA
is shown in black. The apo-1H-15N-YecA was incubated with a two-fold excess of FeSO4. The 1H-15N-HSQC spectrum of 1H-15N-YecA after it had
been incubated with FeSO4 is shown in red. The two conformations of the YecA-MeBD are shown in green and black.
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Figure 5.10: The effect of iron-binding on the YecA-MeBD
The protein was dialysed into 20 mM [MES]-NaOH [pH 6.5], 10 mM NaCl and concentrated to 1.1 mM for analysis by 1H-15N-HSQC NMR
spectroscopy using the Bruker 900 mHz instrument. Each peak represents a 1H attached to a 15N. The 1H-15N-HSQC spectrum of apo-1H-15N-YecA
is shown in black. The apo-1H-15N-YecA was incubated with a two-fold excess of FeSO4. The 1H-15N-HSQC spectrum of 1H-15N-YecA after the
addition of FeSO4 is shown in red. The apo-1H-15N-YecA201 is shown in blue. The two conformations of the YecA-MeBD are shown in green and
black.
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Figure 5.11: The effect of ZnSO4 on the 1H-15N-HSQC spectrum of apo-1H-15N-YecA
After the iron-binding experiments, the protein was dialysed into 20 mM [MES]-NaOH [pH 6.5], 10 mM NaCl and concentrated to 1.1 mM for
analysis by 1H-15N-HSQCNMR spectroscopy using the Bruker 900mHz instrument. Each peak represents a 1Hattached to a 15N. The overlay of the
zinc-bound 1H-15N-YecA 1H-15N-HSQC spectrum is shown in purple and the apo-1H-15N-YecA 1H-15N-HSQC spectrum is shown in black. These
spectra were taken on the same day.
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Figure 5.12: Overlaid 1H-15N-HSQC spectra to show the degradation of the YecA-MeBD
After the iron-binding experiments, the protein was dialysed into 20 mM [MES]-NaOH [pH 6.5], 10 mM NaCl and concentrated to 1.1 mM for
analysis by 1H-15N-HSQCNMR spectroscopy using the Bruker 900mHz instrument. Each peak represents a 1Hattached to a 15N. The overlay of the
zinc-bound 1H-15N-YecA 1H-15N-HSQC spectrum is shown in purple and the apo-1H-15N-YecA 1H-15N-HSQC spectrum is shown in black. These
spectra were taken on the same day. 5.11 shows 5.12 shows the 1H-15N-HSQC spectra of the original apo-YecA (black) and the secondarily analysed
1H-15N-YecA (purple). The purple spectrum lacks many of the resonances that have been mapped to the YecA-MeBD.
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observed between the overlaid spectra of 1H-15N-YecA in the presence or absence of zinc.
This result indicated that YecA did not bind zinc under these conditions.
However, further analysis of this spectrum suggested that the protein had partially de-
graded between the iron-binding experiments and the zinc-binding experiments. When
the apo-1H-15N-HSQC spectrum of YecA was overlaid with the original 1H-15N-HSQC
spectrum of apo-YecA it was clear that the YecA-MeBD was not resolved in these later
experiments (Figure 5.12). Therefore it could not be concluded that YecA did not bind
zinc and these experiments should be repeated.
5.2.4 Analysis of the electronic state of iron in the presence of YecA by
EPR spectroscopy
EPRwas used to investigate the electronic state of iron when it was coordinated by YecA
in vitro. YecA was incubated with FeCl3 at a 1:1 molar ratio in Buffer 1 + 30% v/v glyc-
erol and analysed at the Q-band frequency (34 GHz). The Q-band EPR spectrum of
Fe3+ in the absence or presence of YecA is shown in Figure 5.13. In the presence of YecA,
the maximum is at 6145 G and the g factor was determined as being 3.95.1 The sharp-
ness and intensity of the peak at 6000 G and the calculated g-factor was indicative of a
mononuclear, rhombic, high-spin (S = 52 ) Fe
3+ ion (Bou-Abdallah and Chasteen, 2008;
Duin, 2008; Gaffney, 2009).
5.3 Discussion
The results presented in this chapter suggested that YecA was an iron-binding protein.
The YecA-MeBD is a predicted zinc-binding domain, based on sequence homology
to the SecA-MeBD. ICP-OES analysis indicated that YecA was co-purifying with
iron. UV-vis analysis showed that YecA could bind Fe2+ and 1H-15N-HSQC NMR
1With many thanks to Dr. J. Lovett, University of St. Andrews
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FeCl3 + YecA 
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g  = 3.95
Figure 5.13: Q-band EPR spectra of FeCl3 and Fe3+-bound YecA
The EPR spectra are expressed as relative to their maximal EPR intensity, as determined
byDr. J. Lovett, University of St. Andrews. Blue: FeCl3 in EPRbuffer. Orange: equimo-
lar concentration of YecA and FeCl3 in EPR buffer. The “crown” at 12000 G in both
spectra is typical of manganese, a contaminant.
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spectroscopy suggested that the iron-binding site was located in the YecA-MeBD. EPR
spectroscopy indicated that YecA bound amononuclear Fe3+ ion. Together, these results
suggested that YecA could bind labile iron cofactor.
Initially, ICP-OES was used to analyse the metal content of YecA. The analysis of the
iron content of the protein revealed that iron was present in a substoichiometric concen-
tration to YecA. This result was not unexpected because the observed colour change of
the column suggested that the cognate metal cofactor was exchanging with nickel during
the purification. Manganese was also observed at substoichiometric concentrations.
However, the colours of the YecA sample and the ICP-OES analysis of the content of
the nickel-affinity column both suggested that the cofactor was iron (Cadby et al., 2016).
Using UV-vis spectroscopy, it was possible to show that Fe2+-reconstituted YecA had a
broad shoulder with a maximum of 328 nm, which is indicative of iron binding by the
protein (Ding and Clark, 2004; Lu et al., 2010). The analysis of the interaction between
YecA and iron by EPR spectroscopy suggested that YecA coordinated a mononuclear
Fe3+ ion. Taken together, these data indicated that YecA coordinated a labile iron
cofactor.
The analysis of the zinc content of YecA by ICP-OES indicated that zinc was present
at a 3-fold excess of YecA. SecA coordinates a mononuclear divalent zinc ion via three
cysteine residues and a histidine residue that are located in the SecA-MeBD (Breukink et
al., 1995; Fekkes et al., 1999; Randall et al., 2004; Dempsey et al., 2004). It was predicted
that the coordination of a metal ion by YecA would occur via equivalent residues to
those that coordinate zinc in the SecA-MeBD. These residues are four cysteine residues
in YecA. Without a second metal binding site, it is unlikely that YecA was bound to
three zinc molecules, as the ICP-OES suggested. However, it is possible that a single
zinc molecule was coordinated by the YecA-MeBD and that contaminating zinc that was
present in the buffer was responsible for the excess. Azurin is a copper-binding protein
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that purifies as apo-azurin, Cu2+-bound azurin and Zn2+-bound azurin. During the
purification, the copper cofactor is outcompeted by zinc or lost, which could be the
case with YecA and iron. A study of the interaction between the SecA-MeBD and Fe2+
suggested that the addition of Zn2+ could not outcompete the bound iron (Jamshad
et al., 2017). However, the oxidation of the Fe2+ to Fe3+ during the purification could
affect the affinity of YecA for the metal cofactor.
Using NMR 1H-15N-HSQC experiments, it was possible to show that YecA bound
to Fe2+ and that this interaction only occurred in the full-length protein. It had not
been possible to assign all of the residues that interacted with Fe2+ in Chapter 4 because
the peak intensity of the amide bonds in question were too weak. It is possible that
YecA used both domains to coordinate the metal cofactor, however SAXS analysis
of the full-length protein indicated that the YecA-MeBD and UPF0149 domain were
independent of each other (described in Chapter 4) and comparison of the NMR
1H-15N-HSQC spectra of YecA and YecA201 showed that the amide bond peaks of
residues 1 to 201 of YecA have the same chemical bond shifts in the presence or absence
of the YecA-MeBD. These data indicated that the YecA-MeBD did not interact with the
rest of the protein. These results suggested that YecA bound Fe2+ via the YecA-MeBD,
which was consistent with the interaction between the SecA-MeBD and Fe2+ (Jamshad
et al., 2017) and Zn2+ (Dempsey et al., 2004; Matousek and Alexandrescu, 2004).
The data presented in this chapter suggested that YecA could coordinate both Fe2+ and
Fe3+. The UV-vis spectroscopy suggested that YecA bound an Fe2+ ion and the EPR
spectroscopy data suggested that mononucleic Fe3+ was bound by YecA in a tetrahedral
coordination. Transferrin, ferrichrome or rubredoxin are examples of non-haem iron
proteins with tetrahedral, mononuclear iron centres (Peisach et al., 1971). Rubredoxin
motifs have been found in nearly 2000 proteins, some of which have an unknownmetal
cofactor, while others have been characterised as a zinc-binding motif (Liu et al., 2015).
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Mononuclear Fe2+ cofactors are particularly sensitive to oxidation, the outcome ofwhich
is a poor understanding of the full extent of iron-binding proteins and their functions
(Anjem and Imlay, 2012). Literature searches did not reveal any examples of proteins
that detect fluctuations in the redox status of the cell via an iron cofactor. The coordi-
nation of high spin, mononuclear Fe3+ is indicative of a siderophore (Raymond and
Carrano, 1979), however YecA is a cytoplasmic protein. The cytoplasm is a reducing envi-
ronment, therefore the physiologically relevant state of the iron cofactor is probably Fe2+.
The interaction between YecA and Zn2+ was analysed using NMR 1H15N-HSQC
experiments. Initially, the analysis of the interaction between Zn2+ and YecA by NMR
spectroscopy did not indicate a binding event. However, the overlaid zinc-incubated
1H-15N-YecA HSQC spectrum and the original apo-1H-15N-YecA HSQC spectrum
revealed that the YecA-MeBDhad been degraded. Figure 5.12 shows that the degradation
of the YecA-MeBD had not affected the chemical shift pattern of the rest of the protein.
This result suggests that the YecA-MeBD and the main body of the protein, UPF0149,
did not interact and that zinc was not bound to YecA in the absence of the YecA-MeBD.
In the future, these experiments should be repeated to determine whether full-length
YecA can bind zinc. This result may help to identify the YecA residues that coordinate
the iron ion.
It has been suggested that role of zinc-binding by the SecA-MeBD is structural (Dempsey
et al., 2004; Matousek and Alexandrescu, 2004; Gelis et al., 2007) and it is possible that
the binding of iron by the YecA-MeBDhas a similar function. However, the coordinated
regulation of redox-dependent and oxidative pathways often requires a redox-sensitive
functional group, like a mononuclear iron cofactor or a thiol group. Hsp33 is a redox-
regulated chaperone that is activated by the oxidative unfolding of its redox-sensitive
domain (Graf et al., 2004; Reichmann et al., 2012). In the case of Hsp33, the oxidation
of the thiol groups that coordinate Fe2+ results in the release of its zinc cofactor and
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the activation of the protein. The activity of the secreted PnkG of Mycobacterium
tuberculosis is regulated by the redox-sensitive folding of the rubredoxin motif (Wittwer
et al., 2016). The oxidation of the iron cofactor bound in the rubredoxin motif of PnkG
results in the unfolding of this domain and the increased activity of the catalytic site. It
is possible that the activity of YecA could be regulated by either of these mechanisms.
In the future, the effect of the iron cofactor on the activity of YecA should be investigated.
The studies of the interaction between SecA and zinc in vivo relied on the over-expression
of SecA (Jamshad et al., 2017). The affinity of a divalent metal ion for a ligand is cor-
related with the second ionisation enthalpy of the metal, which is the energy required
to remove an electron from an atom with a single positive charge (Dudev and Lim,
2013). This is ranked by the Irving-Williams series. The cell machinery can regulate the
cellular concentrations of these ions to promote the binding of a protein to the correct
divalent metal ion and the balance between ion concentration, binding affinity and
protein concentration is tightly regulated to facilitate the insertion of the correct metal.
Therefore, the over-expression of a protein could result in mismetallation of the protein
or production of the apo-protein. For example, the protein IscU was characterised as
a zinc-binding protein (Liu et al., 2005; Zhang, 2000; Ramelot et al., 2004) but more
recent work has identified IscU is an iron-binding protein (Ding and Clark, 2004; Lu
et al., 2010) and a recent study of the physiological metal cofactor of SecA revealed that
SecA is an iron-binding protein (Jamshad et al., 2017), which suggests that SecA has
been misidentified as a zinc-binding protein. This reasoning is further strengthened by
a genetic screen for Acinetobacter baumanii mutants defective for growth under iron
limitation. The genetic screen identified an insertion that truncated the secA gene at the
3′ end, which deleted the SecA-MeBD (Fiester et al., 2015). This implies that SecA has a
role in iron acquisition, if not the direct coordination of iron by SecA.
The results presented in this chapter suggest that the cognate metal cofactor of YecA is
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iron, which is likely to be coordinated via the four cysteine residues in the YecA-MeBD.
The impact of the data described in this chapter related directly to the Sec pathway since
a recent study has suggested that the physiological metal of SecA is Fe2+ (Jamshad et al.,
2017). With the knowledge that Fe2+ is sensitive to oxidation (Waldron, 2009), it is pos-
sible that SecA and YecA both monitor the redox status of the cell and alter the activity





In this thesis, the investigation of the structure and function of YecA, which is not es-
sential for the growth of E. coli, was presented. The sequence homology between the
SecA-MeBD and the YecA-MeBD suggested that YecA could interact with components
of the Sec pathway. SecA binds to the ribosome (Huber et al., 2011) and an unpublished
study revealed that YecA also interactedwith the ribosome (Dr. D.Huber, personal com-
munication). The interaction of YecA with the ribosome was dependent on the YecA-
MeBD and it was hypothesised that YecA could interact with the ribosome to facilitate
the translocation of secretory substrates. This study indicated that YecAwas a chaperone
that improved the efficiency of the Sec-dependent translocation inE. coli. The functional
characterisation of YecA was further supplemented by structural investigations that re-
vealed that YecA was a monomeric protein that bound to a single iron ion. The results
presented in this study indicate that YecA is the first component of the Sec pathway to
be identified since the characterisation of YidC nearly two decades ago (Samuelson et al.,
2000; Scotti et al., 2000).
6.1 The relationship between YecA and the Sec pathway
The Sec pathway is a pathway by which secretory proteins are translocated from the
cytoplasm. In this thesis, a protein with sequence homology to SecA was investigated
using E. coli as a model organism. YecA was previously unstudied. The main aim of this
study was to investigate whether YecA was part of the Sec machinery of E. coli. Since
the identification of YidC, much of the research in the field has focussed on the char-
acterisation of the known components of the Sec pathway. This work has provided an
insight into the mechanisms of both the cotranslational and posttranslational pathway,
and how the two routes to translocation interact. However, by focussing on the core
translocation machinery and the accessory proteins, the adaptability of the Sec pathway
to either the diversity of secretory proteins or to changing environmental conditions, or
indeed both might have been overlooked. The identification of a novel, non-essential
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sec gene suggests thatmore proteinsmay be involvedwith protein translocation inE. coli.
One third of proteins are translocated by the Sec pathway. These proteins are directed to
the Sec pathway by an amino-terminal signal sequence. The diversity of the cohort of
secretory proteins is likely to necessitate a diverse network of chaperones. This study has
presented data to support the hypothesis that YecA is a chaperone inE. coli. However the
conditions under which yecA in E. coli is expressed is unknown. A study that explored
global gene expression patterns in Salmonella enterica serovar Typhimurium found that
yecA expression increased five-fold under anaerobic shock conditions (Kröger et al.,
2013). E. coli is a facultative anaerobe and the adaptation of this bacterium to changes in
the availability of oxygen requires differential gene expression (Outten and Theil, 2009).
It follows that the subset of secretory proteins that would be exported under aerobic
conditions would be different to the subset of secretory proteins that would be exported
under anaerobic conditions. Therefore, it is possible that YecA is a specific chaperone
of a specific subset of proteins that are expressed under anaerobic conditions. In the
future, Transposon Directed Insertion Sequencing (TraDIS) could be used to identify
other chaperones that facilitate the translocation of a specific subset of secretory proteins
or facilitate the translocation of secretory proteins under only a subset of conditions,
such as anaerobic growth or oxidative stress. An E. coli strain containing a secB deletion
could be screened under different conditions to identify potential sec genes. The data
presented in Chapter 3 could also be verified using TraDIS because a secB deletion strain
grown at cold temperatures should not have inactivating mutations in the yecA gene.
Currently, it is unknown how YecA interacts with SecA. SecA forms dimers under
physiological conditions but the role of dimerisation for Sec-dependent translocation
remains elusive (Ding et al., 2003; Vrontou and Economou, 2004). It has been suggested
that SecA can support translocation as a dimer (de Keyzer et al., 2005; Jilaveani and
Oliver, 2006), however other studies have suggested that the monomer is the functional
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form of SecA (Or et al., 2002, 2005; Or and Rapoport, 2007). It has been suggested
that SecA dissociates into monomers in the presence of phospholipids or when it binds
SecYEG (Or et al., 2002; Zimmer et al., 2008). It is possible that the oligomeric state
of SecA in response to ligands enables the protein to fulfil its role at the core of the
translocation machinery. With this in mind, it is possible that YecA interacts with SecA
to induce conformational changes or regulate its activity. It is important that future
work focusses on structurally and functionally characterising the interaction of these
two proteins.
In the future, the mechanism by which YecA interacts with the Sec machinery, the ri-
bosome and the mRNA degradation machinery could be investigated. Global inhibi-
tion of protein synthesis and mRNA turnover is a common response to stress condi-
tions, including oxidative stress (Shen et al., 2012). It is not currently known whether
YecA interacts with translating ribosome. The effect of translation arrest in response to
chloramphenicol-treatment followed by a ribosome-pelleting assay could provide an in-
sight into the interaction of YecA with the translating ribosome. A similar experiment
using rifampicin could help to determine whether transcription-arrest affected the inter-
action of YecA with the ribosome. Investigating the effect of YecA on the translocation
of secretory proteins, either by pulse chase or using a YFP-fusion protein-containing a
signal sequence, after translation arrest will help to determine whether YecA chaperones
secretory proteins under translation arrest. The possibility that YecA interacts with the
mRNA degradation machinery could be investigated by measuring the accumulation of
RNA fragments in response to H2O2-treatment (Liu, 2012).
6.2 The relationship between the Sec pathway and iron
This study revealed that the metal cofactor of YecA was iron. The observation that
YecA co-purified with iron prompted an investigation into the metal cofactor of SecA
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that revealed that SecA was also an iron-binding protein (Jamshad et al., 2017), which
demonstrates the impact of the discovery that YecA is an iron-binding protein. The
identification of two Sec proteins with iron cofactors implies that the Sec pathway
is sensitive to the iron availability or responds to the presence of iron. Lactobacillus
plantarum is one of the few known organisms that does not require iron for growth
(Archibald, 1983). The homologue of SecA in L. plantarum lacks the 95 amino acid
residues at the carboxy-tail that comprises the SecA-MeBD and the flexible linker region,
which supports finding that the SecA-MeBD is an iron-coordinating domain. However,
L. plantarum is not the only organism that lacks the carboxy-tail of SecA. A study
found that a mutation that resulted in the truncation of the carboxy-terminus of SecA
in Acinetobacter baumanii caused a poor growth phenotype in iron-depleted media,
but not iron-rich media (Fiester et al., 2015). The absence of key iron-receptors from
the outer membrane was thought to be the cause of this phenotype. However, when
this study was published, the SecA-MeBD was thought to be a zinc-binding domain
and the possibility that SecA could be an iron-sensor was not investigated. It is possible
that either the SecA-MeBD is required for the export of a subset of proteins under
iron-limited conditions, or the SecA-MeBDhas a iron-sensing role (Jamshad et al., 2017).
The similarity between the YecA-MeBD and the SecA-MeBD amino acid sequences,
combined with the role of both proteins in the Sec pathway, suggest a similar function
for iron-binding by SecA and YecA. It is possible that structural changes that are caused
by the presence or absence of iron, or changes induced by the redox state of the iron
cofactor, could influence the activity of both YecA and SecA. Studies have suggested that
the SecA-MeBD is folded in the presence of zinc and unfolded in the absence of zinc
(Dempsey et al., 2004; Matousek and Alexandrescu, 2004; Gelis et al., 2007) and the
presence of zinc stabilises the interaction between SecA and SecB (Fekkes et al., 1999).
Recently, it has been suggested that the interaction between SecA and SecB is more
stable when SecA is bound to Fe2+ compared with Zn2+ (Jamshad et al., 2017). It is
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possible that iron could induce similar structural changes in both the YecA-MeBD and
the SecA-MeBD. SAXS could be used to investigate the structure of apo-YecA compared
with iron-bound YecA under reducing or oxidised conditions, which would help to
determine whether YecA is a redox-sensitive protein.
The redox state of the iron could affect the function of the protein. An example of
a redox-activated protein is Hsp33, which is a chaperone that responds to oxidative
stress (Graumann et al., 2001; Graf et al., 2004). Hsp33, under the reducing conditions
of the cytoplasm is a monomer that coordinates a single molecule of zinc via four
conserved cysteine residues. Oxidative stress causes the four cysteine residues to form
two disulphide bonds and release zinc, which induces the dimerisation of oxidisedHsp33
(Graumann et al., 2001; Graf et al., 2004). Dimeric Hsp33 is an active chaperone with
two substrate-binding sites (Graumann et al., 2001). The structural model described
in this study suggests that YecA is a monomer in solution. However, this model was
derived from data that was collected under aerobic and non-reducing conditions. It is
possible that the chaperone activity of YecA is induced by the switch between aerobic
and anaerobic conditions. Therefore to investigate whether YecA is induced by such a
switch, crystal screen trials could be repeated to compare the X-ray crystal structure of
aerobically and anaerobically prepared YecA, or to compare Fe2+- and Fe3+-reconstituted
YecA.
This study has described a novel sec gene that had not been previously investigated. The
results demonstrate that yecA is not essential for the growth of E. coli but provides the






Full list of mass spectrometry results
Table 7.1: Strep(II)-SUMO-YecA
Experiment Description Score Coverage # Proteins # Unique Peptides # Peptides # PSMs # amino acids MW (kDa) calc. pI
1 DeaD/CdsA 416.84 66.61 1 36 36 168 629 70.5 8.72
1 YecA 340.04 49.77 2 10 12 150 221 25.0 4.59
2 SecA 276.93 57.94 2 48 49 109 901 102.0 5.60
2 FusA 225.56 59.80 1 31 31 81 704 77.5 5.38
2 YecA 200.95 64.25 2 10 11 94 221 25.0 4.59
2 DeaD/CdsA 200.43 58.66 1 30 30 81 629 70.5 8.72
2 InfB 162.07 40.00 1 35 35 73 890 97.3 6.07
1 RpsA 160.62 47.22 1 29 29 66 557 61.1 4.98
2 AceE 157.53 53.78 1 41 41 70 887 99.6 5.68
2 Pnp 145.13 56.54 1 31 31 58 711 77.1 5.21
2 AlaS 117.11 53.08 1 36 36 50 876 96.0 5.81
2 RpsA 103.77 50.81 1 26 26 39 557 61.1 4.98
2 AcnB 103.53 47.05 1 31 31 44 865 93.4 5.40
3 YecA 97.63 43.44 1 7 7 28 221 25.0 4.59
2 SucA 79.81 37.41 1 26 26 35 933 105.0 6.49
2 GyrB 75.17 36.94 1 23 23 31 804 89.9 6.06
2 DnaK 72.86 39.66 1 23 23 28 638 69.1 4.97
2 NuoG 70.34 33.81 1 24 24 32 908 100.2 6.25
2 Rnr 66.20 38.25 1 27 27 33 813 92.1 8.62
2 AceF 64.05 47.30 1 22 22 27 630 66.1 5.17
1 Pnp 60.98 37.97 1 20 20 24 711 77.1 5.21
2 ValS 52.85 27.02 1 21 21 23 951 108.1 5.34
2 Gcd 52.53 34.67 1 21 21 26 796 86.7 5.62
2 PflB 51.73 33.95 2 21 21 22 760 85.3 6.01
2 PheT 50.49 36.35 1 20 20 22 795 87.3 5.30
1 DnaK 49.89 33.70 1 17 17 20 638 69.1 4.97
2 ClpA 49.89 30.87 1 21 21 21 758 84.2 6.32
3 DnaK 49.86 19.28 1 10 10 14 638 69.1 4.97
2 Rne 49.42 27.90 1 20 20 23 1061 118.1 5.62
2 MalP 49.22 26.73 1 18 18 22 797 90.5 7.39
1 FusA 48.26 35.51 1 17 17 19 704 77.5 5.38
1 OmpF 46.87 37.85 4 11 11 18 362 39.3 4.96
2 AdhE 43.44 27.50 1 17 17 20 891 96.1 6.79
1 AtpA 42.72 37.62 1 15 16 18 513 55.2 6.13
2 GyrA 42.60 25.03 1 20 20 26 875 96.9 5.20
1 GroL 42.05 34.31 1 17 17 19 548 57.3 4.94
1 Tig 40.19 49.07 1 19 19 19 432 48.2 4.88
1 LpdA 40.07 35.23 1 12 12 16 474 50.7 6.15
2 Ppc 37.57 22.08 1 21 21 21 883 99.0 5.68
2 Pta 37.12 27.87 1 15 15 15 714 77.1 5.41
3 PpiD 36.71 27.29 1 12 12 12 623 68.1 5.07
2 IleS 36.36 27.40 1 22 22 22 938 104.2 6.01
2 TopA 36.02 26.59 1 22 22 24 865 97.3 8.46
3 RpsA 35.21 23.88 1 10 10 12 557 61.1 4.98
2 DeoD 32.91 51.88 1 11 11 18 239 25.9 5.66
2 LeuS 32.89 23.95 1 18 18 22 860 97.2 5.30
2 TolC 32.16 27.59 1 11 11 15 493 53.7 5.66
1 AceF 31.56 24.92 1 15 15 17 630 66.1 5.17
1 SucA 31.49 29.88 1 11 11 17 405 44.0 5.81
2 RpoD 30.47 21.70 1 13 13 16 613 70.2 4.79
2 TufA 30.30 41.62 2 12 12 12 394 43.3 5.45
3 FusA 29.70 16.90 1 8 8 8 704 77.5 5.38
Continued on next page
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Table 7.1 – continued from previous page
Experiment Description Score Coverage # Proteins # Unique Peptides # Peptides # PSMs # amino acids MW (kDa) calc. pI
2 RplB 29.24 37.00 1 9 9 13 273 29.8 10.93
2 TypA 26.41 18.45 1 10 10 11 607 67.3 5.33
2 PpsA 25.94 20.08 1 13 13 13 792 87.4 5.06
2 KatG 25.30 18.04 1 13 13 16 726 80.0 5.31
3 AceF 24.69 18.41 1 8 8 8 630 66.1 5.17
3 GroL 24.35 19.71 1 7 7 7 548 57.3 4.94
2 RpoC 23.10 9.38 1 11 11 11 1407 155.1 7.08
2 RpsC 21.91 48.50 1 9 9 9 233 26.0 10.27
2 MutS 20.94 13.48 1 10 10 10 853 95.2 5.55
2 GcvP 20.91 9.30 1 7 7 8 957 104.3 6.00
1 RpsC 20.52 30.04 1 6 6 7 233 26.0 10.27
2 RapA 20.21 12.71 1 11 11 13 968 109.7 5.17
3 SecA 19.31 7.77 1 5 5 6 901 102.0 5.60
3 RplF 18.75 42.37 1 7 7 7 177 18.9 9.70
1 AtpD 18.72 18.48 1 6 6 7 460 50.3 5.01
1 TypA 18.46 19.77 1 10 10 10 607 67.3 5.33
2 Prc 17.29 16.72 1 10 10 10 682 76.6 6.55
2 AcrB 17.25 9.72 1 8 8 8 1049 113.5 5.57
2 PepN 16.91 10.00 1 9 9 9 870 98.9 5.31
2 YhgF 16.42 15.14 1 11 11 12 773 85.1 6.30
1 LepA 16.19 14.36 1 8 8 8 599 66.5 5.59
1 NusA 15.34 17.78 1 8 8 8 495 54.8 4.64
2 FtsY 15.28 14.69 1 6 6 6 497 54.5 4.50
3 RpsC 14.92 33.91 1 5 5 6 233 26.0 10.27
3 Pnp 13.54 7.74 1 4 4 4 711 77.1 5.21
2 NrdA 13.42 18.27 1 12 12 12 761 85.7 6.18
2 LepA 12.72 11.02 1 7 7 7 599 66.5 5.59
2 OmpF 12.44 16.30 1 6 6 6 362 39.3 4.96
2 CarB 11.71 8.57 1 9 9 9 1073 117.8 5.34
3 LpdA 11.03 10.13 1 3 3 3 474 50.7 6.15
2 SucB 10.93 16.30 1 7 7 7 405 44.0 5.81
3 RplP 10.80 32.35 1 3 3 3 136 15.3 11.22
2 RecA 10.80 14.45 1 4 4 4 353 37.9 5.19
3 RpsD 10.55 20.87 1 3 3 3 206 23.5 10.05
1 SecD 10.54 9.11 1 4 5 5 615 66.6 8.60
1 RplB 10.24 30.04 1 6 6 6 273 29.8 10.93
2 AccB 9.95 23.72 1 3 3 6 156 16.7 4.65
3 Tig 9.92 12.50 1 4 4 4 432 48.2 4.88
2 RplO 9.61 34.03 1 4 4 4 144 15.0 11.18
3 DeaD/CdsA 9.58 10.81 1 5 5 5 629 70.5 8.72
2 MaeB 9.47 7.38 1 6 6 6 759 82.4 5.50
2 RpsM 9.43 38.14 1 3 3 3 118 13.1 10.78
3 RplD 9.34 24.38 1 3 3 3 201 22.1 9.73
3 TnaA 9.31 7.01 1 3 3 3 471 52.7 6.23
1 TufA 8.97 16.75 2 5 5 5 394 43.3 5.45
1 ClpA 8.93 6.60 1 5 5 5 758 84.2 6.32
2 RpsD 8.74 19.42 1 5 5 7 206 23.5 10.05
3 OmpC 8.63 7.90 1 3 3 3 367 40.3 4.82
1 RpsM 8.59 38.14 1 3 3 3 118 13.1 10.78
3 Enolase 8.33 11.81 1 3 3 3 432 45.6 5.48
3 TufA 8.30 10.15 2 3 3 3 394 43.3 5.45
1 SdhA 8.08 5.61 1 3 3 4 588 64.4 6.27
1 NuoG 8.07 14.93 1 8 8 8 596 68.2 6.42
2 GlyS 7.99 6.39 1 4 4 4 689 76.8 5.44
3 RplX 7.95 26.92 1 2 2 2 104 11.3 10.21
Continued on next page
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Table 7.1 – continued from previous page
Experiment Description Score Coverage # Proteins # Unique Peptides # Peptides # PSMs # amino acids MW (kDa) calc. pI
3 RplI 7.82 17.45 1 2 2 2 149 15.8 6.58
3 RplA 7.80 16.24 1 3 3 3 234 24.7 9.64
2 RpoD 7.64 4.69 1 7 7 7 1342 150.5 5.26
1 FtsH 7.51 6.52 1 3 3 3 644 70.7 6.24
2 SodB 7.48 31.61 1 5 5 5 193 21.3 5.95
3 RplB 7.48 12.09 1 2 2 2 273 29.8 10.93
2 RsxC 7.44 11.22 1 5 5 5 740 80.1 8.63
3 RpsB 7.22 12.45 1 2 2 2 241 26.7 7.14
3 RplO 7.02 18.06 1 2 2 2 144 15.0 11.18
2 RplA 7.01 16.24 1 3 3 3 234 24.7 9.64
3 RpsE 6.99 18.56 1 2 2 2 167 17.6 10.11
3 Lpp 6.90 33.33 1 2 2 2 78 8.3 9.25
3 RplN 6.77 21.14 1 2 2 2 123 13.5 10.42
2 TktA 6.61 6.64 1 4 4 4 663 72.2 5.67
3 RplE 6.46 17.88 1 2 2 2 179 20.3 9.48
1 PyrG 6.42 6.42 1 3 3 3 545 60.3 5.94
1 HslU 6.24 8.58 1 4 4 4 443 49.6 5.35
1 Der 6.17 10.82 1 5 5 5 490 55.0 5.85
2 MetE 6.14 4.52 1 3 3 3 753 84.6 5.92
3 RplJ 5.91 16.97 1 2 2 2 165 17.7 8.98
3 RplV 5.86 20.91 1 2 2 2 110 12.2 10.23
3 RplL 5.36 19.01 1 2 2 2 121 12.3 4.65
3 Hfq 5.28 24.51 1 2 2 2 102 11.2 7.65
2 BglX 5.08 5.23 1 3 3 3 765 83.4 6.21
3 RpsM 5.03 18.64 1 2 2 2 118 13.1 10.78
2 Ppa 4.93 14.20 1 2 2 3 176 19.7 5.17
3 NusA 4.85 5.45 1 2 2 2 495 54.8 4.64
3 RplQ 4.84 19.69 1 2 2 2 127 14.4 11.05
2 RplC 4.76 13.40 1 2 2 2 209 22.2 9.91
3 RplK 4.71 16.20 1 2 2 2 142 14.9 9.63
3 RplS 4.63 13.04 1 1 1 1 115 13.1 10.62
3 LacI 4.50 6.11 1 2 2 2 360 38.6 6.89
2 ClpP 4.31 14.01 1 2 2 2 207 23.2 5.80
2 GroL 4.21 5.11 1 3 3 3 548 57.3 4.94
2 LacI 4.11 5.28 1 2 2 2 360 38.6 6.89
2 MlaD 4.04 9.29 1 2 2 2 183 19.6 4.93
2 AtpD 3.97 7.39 1 3 3 3 460 50.3 5.01
2 HslU 3.83 8.13 1 4 4 4 443 49.6 5.35
2 SdhA 3.74 3.40 1 2 2 2 588 64.4 6.27
2 YgiQ 3.52 6.22 1 5 5 5 739 83.4 9.11
3 FtnA 3.45 7.88 1 1 1 1 165 19.4 4.83
3 OmpF 3.38 3.59 1 1 1 1 362 39.3 4.96
3 AtpD 3.27 4.13 1 1 1 1 460 50.3 5.01
3 RpsJ 3.26 13.59 1 1 1 1 103 11.7 9.69
3 RpmB 3.21 12.82 1 1 1 1 78 9.0 11.41
3 RplT 3.17 8.47 1 1 1 1 118 13.5 11.47
2 UvrA 3.15 1.81 1 1 1 1 940 103.8 6.64
2 IntQ 3.01 8.05 1 1 1 2 385 43.7 9.42
3 RpsK 2.82 12.40 1 1 1 1 129 13.8 11.33
3 Udp 2.81 4.35 1 1 1 1 253 27.1 6.21
3 YkgA 2.80 9.62 1 1 1 1 239 28.5 8.43
3 ClpB 2.78 1.52 1 1 1 1 857 95.5 5.52
3 RpsT 2.74 12.64 1 1 1 1 87 9.7 11.18
3 AceA 2.72 3.46 1 1 1 1 434 47.5 5.31
2 MgtA 2.70 2.00 1 1 1 2 898 99.4 5.96
Continued on next page
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Experiment Description Score Coverage # Proteins # Unique Peptides # Peptides # PSMs # amino acids MW (kDa) calc. pI
3 GapA 2.70 4.23 1 1 1 1 331 35.5 7.11
3 RpsG 2.68 5.59 1 1 1 1 179 20.0 10.36
3 RplM 2.67 7.04 1 1 1 1 142 16.0 9.91
3 RplC 2.62 4.78 1 1 1 1 209 22.2 9.91
3 GrxD 2.59 11.30 1 1 1 1 115 12.9 4.75
3 Mdh 2.57 3.53 1 1 1 1 312 32.3 5.77
3 RpmD 2.54 15.25 1 1 1 1 59 6.5 10.96
3 YghJ 2.45 1.18 1 1 1 1 1520 167.1 5.03
2 FdoG 2.43 4.63 1 4 4 4 1016 112.5 7.28
2 RpsL 2.41 10.48 1 1 1 1 124 13.7 10.87
3 RpsP 2.35 13.41 1 1 1 1 82 9.2 10.55
2 PdxY 2.35 4.53 1 1 1 1 287 31.3 6.52
3 OmpA 2.34 4.05 1 1 1 1 346 37.2 6.42
3 YffS 2.32 4.09 1 1 1 1 269 29.7 5.52
3 RplW 2.31 12.00 1 1 1 1 100 11.2 9.94
3 RpsO 2.30 7.87 1 1 1 1 89 10.3 10.40
3 RpsQ 2.24 9.52 1 1 1 1 84 9.7 9.60
2 RplJ 2.22 7.88 1 1 1 1 165 17.7 8.98
2 RpsE 2.18 15.57 1 2 2 2 167 17.6 10.11
3 FabZ 2.13 5.30 1 1 1 1 151 17.0 7.39
2 RpmB 2.07 12.82 1 1 1 1 78 9.0 11.41
3 PckA 2.05 2.78 1 1 1 1 540 59.6 5.71
3 SucB 2.04 4.44 1 1 1 1 405 44.0 5.81
3 FucU 2.02 8.57 1 1 1 1 140 15.5 5.86
2 ParC 2.00 1.46 1 1 1 1 752 83.8 6.68
2 SpeB 1.98 7.19 1 2 2 2 306 33.5 5.39
3 SdhA 1.94 1.53 1 1 1 1 588 64.4 6.27
3 DamX 1.94 2.10 1 1 1 1 428 46.1 5.81
2 RplQ 1.93 6.30 1 1 1 1 127 14.4 11.05
3 RpsH 1.93 6.15 1 1 1 1 130 14.1 9.42
2 RplF 1.91 6.78 1 1 1 1 177 18.9 9.70
2 RpsI 1.89 15.38 1 2 2 2 130 14.8 10.95
2 RibF 1.85 5.75 1 1 2 2 313 34.7 9.23
2 PolA 1.85 3.02 1 3 3 3 928 103.1 5.58
2 RpsK 1.83 6.20 1 1 1 1 129 13.8 11.33
2 CysJ 1.81 2.50 1 2 2 2 599 66.2 5.02
2 CyaA 1.79 2.71 1 2 2 2 848 97.5 6.21
2 HisG 1.73 2.01 1 1 1 1 299 33.3 5.63
2 RplM 1.73 4.93 1 1 1 1 142 16.0 9.91
2 RplT 1.72 7.63 1 1 1 1 118 13.5 11.47
2 AtpA 1.71 3.31 1 2 2 2 513 55.2 6.13
2 AcnA 1.68 1.91 1 2 2 2 891 97.6 5.88
2 YdiJ 1.66 0.79 1 1 1 1 1018 113.2 7.11
2 FtsH 1.66 1.24 1 1 1 1 644 70.7 6.24
2 DadX 0.00 8.15 1 1 1 1 356 38.8 7.05
2 AmiB 0.00 5.84 1 1 1 1 445 48.0 9.29
2 CyoB 0.00 1.66 1 1 1 1 663 74.3 7.20
2 EptC 0.00 1.39 1 1 1 1 577 66.6 7.39
2 FecB 0.00 5.33 1 1 1 1 300 33.1 8.88
2 FliS 0.00 9.56 1 1 1 1 136 14.9 4.75
2 GlgX 0.00 1.83 1 1 1 1 657 73.5 6.06
2 IscS 0.00 1.98 1 1 1 1 404 45.1 6.37
2 MalE 0.00 2.53 1 1 1 1 396 43.4 5.71
2 MatH 0.00 2.36 1 1 1 1 1227 135.9 5.07
2 MnmE 0.00 1.76 1 1 1 1 454 49.2 5.02
Continued on next page
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Experiment Description Score Coverage # Proteins # Unique Peptides # Peptides # PSMs # amino acids MW (kDa) calc. pI
2 MreB 0.00 3.46 1 1 1 1 347 36.9 5.26
2 MrcA 0.00 0.82 1 1 1 1 850 93.6 6.58
2 PtsI 0.00 3.83 1 1 1 1 575 63.5 4.87
2 RcsC 0.00 0.63 1 1 1 1 949 106.4 6.34
2 RplK 0.00 11.27 1 2 2 2 142 14.9 9.63
2 RplN 0.00 5.69 1 1 1 1 123 13.5 10.42
2 RplL 0.00 10.74 1 1 1 1 121 12.3 4.65
2 Rnb 0.00 1.71 1 1 1 1 644 72.4 5.62
2 RpsJ 0.00 9.71 1 1 1 1 103 11.7 9.69
2 RpsH 0.00 6.15 1 1 1 1 130 14.1 9.42
2 TamA 0.00 5.03 1 1 1 1 577 64.8 8.65
2 XapA 0.00 3.61 1 1 1 1 277 29.8 6.52
2 YceG 0.00 11.47 1 1 1 2 340 38.2 9.42
2 YegP 0.00 28.18 1 1 1 4 110 12.0 9.44
2 YffS 0.00 4.09 1 1 1 1 269 29.7 5.52
2 YghA 0.00 6.80 1 1 1 1 294 31.5 6.80
2 YhdP 0.00 2.13 1 1 1 1 1266 139.0 5.62
2 YnbC 0.00 2.05 1 1 1 1 585 65.4 8.85
Table 7.2: Strep(II)-SUMO-YecA201
Experiment Description Score Coverage # Proteins # Unique Peptides # Peptides # PSMs # amino acids MW (kDa) calc. pI
1 DeaD/CdsA 275.59 59.94 1 32 32 112 629 70.5 8.72
2 YecA 229.30 51.58 1 7 7 71 221 25.0 4.59
2 DeaD/CdsA 197.69 52.46 1 24 24 59 629 70.5 8.72
1 RpsA 67.61 39.32 1 22 22 28 557 61.1 4.98
1 OmpF 52.51 30.66 4 12 12 22 362 39.3 4.96
3 SecA 51.73 27.64 1 25 25 27 901 102 5.6
1 FusA 49.37 36.36 1 18 18 19 704 77.5 5.38
3 DeaD/CdsA 48.94 32.43 1 17 17 26 629 70.5 8.72
1 YecA 46.28 33.94 1 6 6 20 221 25.0 4.59
1 Pnp 38.15 27.00 1 15 15 20 711 77.1 5.21
1 SecA 32.35 17.98 1 14 14 18 901 102.0 5.60
1 DnaK 30.33 23.20 1 14 14 15 638 69.1 4.97
2 FusA 27.61 17.90 1 8 8 8 704 77.5 5.38
1 TypA 27.30 22.73 1 11 11 12 607 67.3 5.33
1 AceF 24.53 22.70 1 12 12 13 630 66.1 5.17
2 RpsA 24.39 18.49 1 7 7 8 557 61.1 4.98
2 OmpF 22.85 15.75 1 4 4 6 362 39.3 4.96
2 Pnp 21.99 15.61 1 6 6 7 711 77.1 5.21
1 GroL 21.00 21.53 1 10 10 10 548 57.3 4.94
2 RpsM 20.63 53.39 1 5 5 6 118 13.1 10.78
2 RpsD 19.15 20.87 1 4 4 5 206 23.5 10.05
1 ClpA 18.33 12.53 1 10 10 10 758 84.2 6.32
1 NusA 18.27 15.15 1 7 7 9 495 54.8 4.64
1 LepA 17.89 16.86 1 10 10 10 599 66.5 5.59
1 Tig 16.91 25.46 1 10 10 10 432 48.2 4.88
2 GroL 16.15 12.96 1 4 4 4 548 57.3 4.94
3 Pnp 15.63 10.97 1 8 8 8 711 77.1 5.21
2 TufA 15.37 18.78 2 5 5 6 394 43.3 5.45
2 RplF 14.88 35.03 1 5 5 5 177 18.9 9.70
2 SecA 14.47 7.55 1 4 4 4 901 102.0 5.60
1 RpsC 12.21 33.91 1 6 6 6 233 26.0 10.27
2 LamB 11.58 9.42 1 3 3 3 446 49.9 4.98
Continued on next page
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Table 7.2 – continued from previous page
Experiment Description Score Coverage # Proteins # Unique Peptides # Peptides # PSMs # amino acids MW (kDa) calc. pI
1 SdhA 11.05 11.05 1 6 6 6 588 64.4 6.27
1 NuoC 10.86 10.57 1 6 6 6 596 68.2 6.42
2 RpsC 10.53 20.17 1 4 4 4 233 26.0 10.27
1 RpoD 10.47 7.99 1 5 5 5 613 70.2 4.79
2 DnaK 10.06 6.74 1 3 3 3 638 69.1 4.97
1 TufA 9.76 18.78 2 7 7 7 394 43.3 5.45
1 YecA 9.08 17.19 1 3 3 7 221 25.0 4.59
3 YecA 9.08 17.19 1 3 3 7 221 25 4.59
1 RplB 9.04 14.65 1 4 4 4 273 29.8 10.93
2 RplJ 8.92 24.24 1 3 3 3 165 17.7 8.98
1 PpiD 8.90 9.31 1 6 6 6 623 68.1 5.07
1 AtpA 8.81 9.55 2 5 5 5 513 55.2 6.13
1 RpsM 8.22 38.14 1 3 3 3 118 13.1 10.78
2 RpsE 7.58 20.96 1 2 2 2 167 17.6 10.11
2 RplD 7.46 24.38 1 3 3 3 201 22.1 9.73
2 NusA 7.32 6.26 1 2 2 2 495 54.8 4.64
2 AceF 7.27 4.60 1 2 2 2 630 66.1 5.17
2 LpdA 7.23 10.76 1 3 3 3 474 50.7 6.15
2 RplC 6.90 14.35 1 2 2 2 209 22.2 9.91
2 PpiD 6.66 5.78 1 2 2 3 623 68.1 5.07
2 AtpD 6.47 7.17 1 2 2 2 460 50.3 5.01
2 SdhA 5.85 3.91 1 2 2 2 588 64.4 6.27
1 KatG 5.77 6.61 1 5 5 5 726 80.0 5.31
2 AtpA 5.75 7.41 1 2 2 2 513 55.2 6.13
3 InfB 5.55 3.71 1 3 3 3 890 97.3 6.07
1 LamB 5.41 7.40 1 3 3 3 446 49.9 4.98
2 RpsK 5.38 33.33 1 3 3 3 129 13.8 11.33
2 RplT 5.33 15.25 1 2 2 2 118 13.5 11.47
2 RpsJ 5.28 20.39 1 2 2 2 103 11.7 9.69
2 RpsR 5.27 29.33 1 2 2 2 75 9.0 10.59
2 RpsG 5.10 15.64 1 3 3 3 179 20.0 10.36
2 RplI 4.56 18.12 1 2 2 2 149 15.8 6.58
1 RpsD 4.54 18.45 1 4 4 4 206 23.5 10.05
2 RplA 4.50 11.11 1 2 2 2 234 24.7 9.64
1 HscA 4.47 5.03 1 3 3 3 616 65.6 5.16
1 InfB 4.30 2.36 1 2 2 2 890 97.3 6.07
2 RplK 4.30 16.20 1 2 2 2 142 14.9 9.63
1 FtsH 4.25 6.21 1 4 4 4 644 70.7 6.24
3 FusA 4.24 2.7 1 2 2 2 704 77.5 5.38
1 RplA 4.22 11.11 1 2 2 2 234 24.7 9.64
1 RplX 4.09 17.31 1 1 1 1 104 11.3 10.21
2 SucC 3.99 3.61 1 1 1 1 388 41.4 5.52
2 RplP 3.95 11.76 1 1 1 1 136 15.3 11.22
1 SucB 3.94 5.19 1 3 3 3 405 44.0 5.81
1 HtpG 3.71 3.21 1 2 2 2 624 71.4 5.21
2 YghJ 3.70 1.25 1 1 1 1 1520 167.1 5.03
1 DamX 3.42 4.91 1 2 2 2 428 46.1 5.81
2 RplE 3.40 11.73 1 1 1 1 179 20.3 9.48
1 RecA 3.37 6.52 1 2 2 2 353 37.9 5.19
2 TnaA 3.26 2.34 1 1 1 1 471 52.7 6.23
2 FabZ 3.19 10.60 1 1 1 1 151 17.0 7.39
2 MreB 3.17 4.32 1 1 1 1 347 36.9 5.26
2 Eno 3.12 5.09 1 1 1 1 432 45.6 5.48
2 SucB 3.09 4.44 1 1 1 1 405 44.0 5.81
2 RpoA 2.87 3.65 1 1 1 1 329 36.5 5.06
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Experiment Description Score Coverage # Proteins # Unique Peptides # Peptides # PSMs # amino acids MW (kDa) calc. pI
1 AtpD 2.79 8.04 1 3 3 3 460 50.3 5.01
2 FtnA 2.79 7.88 1 1 1 1 165 19.4 4.83
2 RpmB 2.77 12.82 1 1 1 1 78 9.0 11.41
2 RplB 2.70 4.03 1 1 1 1 273 29.8 10.93
1 RplO 2.67 9.72 1 1 1 1 144 15.0 11.18
2 RplX 2.64 9.62 1 1 1 1 104 11.3 10.21
2 OmpC 2.58 2.45 1 1 1 1 367 40.3 4.82
2 Tig 2.53 4.40 1 1 1 1 432 48.2 4.88
2 GapA 2.52 4.23 1 1 1 1 331 35.5 7.11
2 RpsH 2.50 6.15 1 1 1 1 130 14.1 9.42
2 RpsB 2.49 6.64 1 1 1 1 241 26.7 7.14
1 TufA 2.43 2.54 2 1 1 1 394 43.3 5.45
3 TufA 2.43 2.54 2 1 1 1 394 43.3 5.45
2 DnaJ 2.38 5.59 1 1 1 1 376 41.1 7.84
2 RpsT 2.33 12.64 1 1 1 1 87 9.7 11.18
1 RpsL 2.29 10.48 1 1 1 1 124 13.7 10.87
2 ClpX 2.27 2.36 1 1 1 1 424 46.3 5.35
2 AccB 2.25 5.77 1 1 1 1 156 16.7 4.65
1 RpsN 2.18 18.81 1 1 1 1 101 11.6 11.17
2 Udp 2.07 9.49 1 1 1 1 253 27.1 6.21
2 RpmI 2.03 20.00 1 1 1 1 65 7.3 11.78
1 Rne 2.02 0.85 1 1 1 1 1061 118.1 5.62
2 MppA 2.01 3.54 1 1 1 1 537 59.9 8.41
1 RpmB 1.99 12.82 1 1 1 1 78 9.0 11.41
1 FabZ 1.86 5.30 1 1 1 1 151 17.0 7.39
1 EptC 1.78 1.39 1 1 1 1 577 66.6 7.39
1 RplF 1.76 10.73 1 2 2 2 177 18.9 9.70
1 OmpF 1.73 1.11 1 1 1 1 810 90.5 5.12
1 GlpD 1.72 1.80 1 1 1 1 501 56.7 7.44
2 Rne 1.71 1.13 1 1 1 1 1061 118.1 5.62
2 MacA 1.70 3.50 1 1 1 1 371 40.6 8.98
1 RplM 1.67 4.93 1 1 1 1 142 16.0 9.91
1 RpsA 1.62 1.97 1 1 1 1 557 61.1 4.98
1 LpdA 1.62 2.32 1 1 1 1 474 50.7 6.15
3 RpsA 1.62 1.97 1 1 1 1 557 61.1 4.98
1 PtsI 0.00 1.57 1 1 1 1 575 63.5 4.87
1 PflB 0.00 0.92 1 1 1 1 760 85.3 6.01
1 HslU 0.00 1.81 1 1 1 1 443 49.6 5.35
1 RpsE 0.00 4.79 1 1 1 1 167 17.6 10.11
1 GapA 0.00 2.42 1 1 1 1 331 35.5 7.11
1 AccB 0.00 5.13 1 1 1 1 156 16.7 4.65
1 FolX 0.00 6.67 1 1 1 1 120 14.1 7.06
1 MalE 0.00 2.53 1 1 1 1 396 43.4 5.71
1 AceE 0.00 2.82 1 3 3 3 887 99.6 5.68
1 YejH 0.00 2.22 1 1 1 1 586 66.4 7.72
1 YhjJ 0.00 1.41 1 1 1 1 498 55.5 6.02
1 RplE 0.00 4.47 1 1 1 1 179 20.3 9.48
1 YffS 0.00 4.09 1 1 1 1 269 29.7 5.52
1 YfhM 0.00 0.60 1 1 1 2 1653 181.5 5.43
2 RplO 0.00 9.72 1 1 1 1 144 15.0 11.18
2 RplU 0.00 11.65 1 1 1 1 103 11.6 9.85
2 TraG 0.00 2.24 1 1 1 1 938 102.4 6.34
3 FolX 0 6.67 1 1 1 1 120 14.1 7.06
3 AceE 0 2.82 1 3 3 3 887 99.6 5.68
3 YejH 0 2.22 1 1 1 1 586 66.4 7.72
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Table 7.2 – continued from previous page
Experiment Description Score Coverage # Proteins # Unique Peptides # Peptides # PSMs # amino acids MW (kDa) calc. pI
3 YfhM 0 0.6 1 1 1 2 1653 181.5 5.43
Table 7.3: Strep(II)-SUMO
Experiment Description Score Coverage # Proteins # Unique Peptides # Peptides # PSMs # amino acids MW (kDa) calc. pI
3 SecA 112.18 29.86 1 26 26 50 901 102 5.6
1 DnaK 63.74 27.74 1 14 14 21 638 69.1 4.97
1 SecA 38.44 17.76 1 13 13 13 901 102.0 5.60
1 GroL 32.14 24.64 1 10 10 10 548 57.3 4.94
2 RpsA 25.57 22.44 1 11 11 13 557 61.1 4.98
1 FusA 25.50 12.22 1 6 6 7 704 77.5 5.38
1 LpdA 23.59 20.04 1 7 7 7 474 50.7 6.15
1 AceF 19.57 13.97 1 7 7 7 630 66.1 5.17
1 YecA 18.85 27.60 1 4 4 7 221 25.0 4.59
2 OmpF 16.13 16.85 1 7 7 8 362 39.3 4.96
1 TufA 15.52 19.80 2 6 6 7 394 43.3 5.45
1 OmpF 14.22 10.77 1 3 3 4 362 39.3 4.96
1 RplB 13.23 20.88 1 4 4 4 273 29.8 10.93
1 RpsA 12.57 7.90 1 3 3 4 557 61.1 4.98
1 NusA 12.45 9.90 1 4 4 4 495 54.8 4.64
1 RplI 12.05 26.85 1 3 3 3 149 15.8 6.58
1 OmpC 11.82 14.44 1 4 4 4 367 40.3 4.82
1 LamB 10.98 9.19 1 3 3 3 446 49.9 4.98
2 DeaD/CdsA 10.86 12.4 1 7 7 7 629 70.5 8.72
1 RpsE 10.70 26.95 1 3 3 4 167 17.6 10.11
1 LacI 10.03 10.28 1 3 3 3 360 38.6 6.89
2 DnaK 9.99 10.03 1 7 7 7 638 69.1 4.97
1 AccC 9.62 9.58 1 4 4 4 449 49.3 7.11
1 RpsD 9.57 16.50 1 3 3 3 206 23.5 10.05
1 TnaA 9.45 6.37 1 3 3 3 471 52.7 6.23
2 GroL 9.41 12.23 1 7 7 8 548 57.3 4.94
1 Tig 8.98 9.72 1 3 3 3 432 48.2 4.88
1 RplD 8.91 18.91 1 3 3 3 201 22.1 9.73
1 RpsK 8.80 42.64 1 4 4 5 129 13.8 11.33
1 HemL 8.75 10.09 1 3 3 3 426 45.3 4.84
1 RpsG 8.69 21.23 1 3 3 3 179 20.0 10.36
1 RpsC 8.54 12.88 1 3 3 3 233 26.0 10.27
1 LacZ 8.49 3.71 1 3 3 3 1024 116.4 5.50
1 SucA 8.28 3.32 1 3 3 3 933 105.0 6.49
1 Mdh 7.98 10.58 1 3 3 3 312 32.3 5.77
1 RplF 7.84 18.08 1 3 3 3 177 18.9 9.70
1 RplJ 7.47 27.88 1 3 3 3 165 17.7 8.98
1 PpiD 7.06 4.17 1 2 2 2 623 68.1 5.07
1 Lpp 7.02 33.33 1 2 2 2 78 8.3 9.25
1 MreB 6.90 7.78 1 2 2 2 347 36.9 5.26
1 RpsB 6.85 12.86 1 2 2 2 241 26.7 7.14
1 RpsJ 6.54 23.30 1 2 2 2 103 11.7 9.69
3 FusA 6.48 8.66 1 5 5 5 704 77.5 5.38
1 Pgi 6.43 5.28 1 2 2 2 549 61.5 6.29
1 RplA 6.24 11.11 1 2 2 2 234 24.7 9.64
1 RpsM 6.20 17.80 1 2 2 2 118 13.1 10.78
2 SecA 5.97 4.11 1 3 3 3 901 102 5.6
1 Crp 5.89 10.48 1 2 2 2 210 23.6 8.25
3 RpsC 5.87 8.58 1 2 2 3 233 26 10.27
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Table 7.3 – continued from previous page
Experiment Description Score Coverage # Proteins # Unique Peptides # Peptides # PSMs # amino acids MW (kDa) calc. pI
1 Hfq 5.72 24.51 1 2 2 2 102 11.2 7.65
1 ClpA 5.69 3.03 1 2 2 2 758 84.2 6.32
1 Prs 5.69 7.94 1 2 2 2 315 34.2 5.44
1 RplL 5.63 19.01 1 2 2 2 121 12.3 4.65
1 GapA 5.62 8.76 1 2 2 2 331 35.5 7.11
1 DeaD/CdsA 5.51 4.93 1 2 2 2 629 70.5 8.72
1 RplT 5.36 15.25 1 2 2 2 118 13.5 11.47
1 HslU 5.26 5.42 1 2 2 2 443 49.6 5.35
1 AceE 5.20 2.25 1 2 2 2 887 99.6 5.68
2 AtpA 5.14 7.21 2 4 4 4 513 55.2 6.13
2 TufA 4.89 8.12 2 3 3 3 394 43.3 5.45
2 RplA 4.71 11.54 1 2 2 2 234 24.7 9.64
1 RplN 4.64 13.82 1 1 1 1 123 13.5 10.42
2 SucB 4.48 7.65 1 3 3 3 405 44 5.81
1 FabZ 4.45 10.60 1 2 2 2 151 17.0 7.39
3 RpsA 4.18 8.8 1 5 5 5 557 61.1 4.98
2 RpsC 4.16 9.87 1 2 2 2 233 26 10.27
2 AceF 4.1 7.78 1 5 5 5 630 66.1 5.17
2 RpsD 4.09 8.74 1 2 2 2 206 23.5 10.05
1 SucB 3.84 4.44 1 1 1 1 405 44.0 5.81
1 RplV 3.84 11.82 1 1 1 1 110 12.2 10.23
1 Pta 3.82 2.24 1 1 1 1 714 77.1 5.41
1 FtsY 3.70 2.41 1 1 1 1 497 54.5 4.50
1 FtnA 3.55 7.88 1 1 1 1 165 19.4 4.83
1 Eno 3.55 3.24 1 1 1 1 432 45.6 5.48
1 RplO 3.54 9.72 1 1 1 1 144 15.0 11.18
1 HtpG 3.45 2.24 1 1 1 1 624 71.4 5.21
2 HslU 3.36 5.87 1 3 3 3 443 49.6 5.35
1 RpsI 3.34 9.23 1 1 1 1 130 14.8 10.95
1 FtsZ 3.34 3.92 1 1 1 1 383 40.3 4.78
1 RpmB 3.30 12.82 1 1 1 1 78 9.0 11.41
1 RpoA 3.29 3.65 1 1 1 1 329 36.5 5.06
1 Pgk 3.29 3.62 1 1 1 1 387 41.1 5.22
1 PflB 3.26 1.45 1 1 1 1 760 85.3 6.01
1 FucU 3.23 10.00 1 1 1 1 140 15.5 5.86
1 RplQ 3.16 11.81 1 1 1 1 127 14.4 11.05
1 MalE 3.13 3.03 1 1 1 1 396 43.4 5.71
1 RplP 2.98 11.76 1 1 1 1 136 15.3 11.22
1 GuaB 2.97 3.28 1 1 1 1 488 52.0 6.42
1 InfC 2.82 8.33 1 1 1 1 180 20.6 9.52
1 AccA 2.75 4.08 1 1 1 1 319 35.2 6.04
1 RplX 2.74 9.62 1 1 1 1 104 11.3 10.21
1 RplM 2.74 7.04 1 1 1 1 142 16.0 9.91
1 GatZ 2.74 2.38 2 1 1 1 420 47.1 5.77
1 KatG 2.72 1.93 1 1 1 1 726 80.0 5.31
1 SdhA 2.66 1.53 1 1 1 1 588 64.4 6.27
1 Rho 2.63 2.39 1 1 1 1 419 47.0 7.25
1 Pnp 2.60 2.11 1 1 1 1 711 77.1 5.21
3 TufA 2.55 2.54 2 1 1 1 394 43.3 5.45
1 MscM 2.54 2.26 1 1 1 4 1107 123.9 7.01
1 AcnB 2.52 1.27 1 1 1 1 865 93.4 5.40
1 AceA 2.50 3.46 1 1 1 1 434 47.5 5.31
2 RplB 2.5 4.03 1 1 1 1 273 29.8 10.93
1 RecA 2.48 3.40 1 1 1 1 353 37.9 5.19
3 AceE 2.38 3.16 1 3 3 3 887 99.6 5.68
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Experiment Description Score Coverage # Proteins # Unique Peptides # Peptides # PSMs # amino acids MW (kDa) calc. pI
1 RplE 2.37 4.47 1 1 1 1 179 20.3 9.48
3 YecA 2.36 6.33 1 1 1 1 221 25 4.59
1 LysS 2.36 2.38 2 1 1 1 505 57.6 5.24
1 DeoD 2.33 4.60 1 1 1 1 239 25.9 5.66
2 NusA 2.32 4.04 1 2 2 2 495 54.8 4.64
1 RpsR 2.27 13.33 1 1 1 1 75 9.0 10.59
1 YbeZ 2.20 4.05 1 1 1 1 346 39.0 5.97
1 GltA 2.14 2.58 1 1 1 1 427 48.0 6.68
3 InfB 2.13 2.02 1 2 2 2 890 97.3 6.07
1 EvgS 2.12 0.84 1 1 1 1 1197 134.7 6.21
2 NuoC 2.04 1.51 1 1 1 1 596 68.2 6.42
1 TreC 2.03 1.63 1 1 1 1 551 63.8 5.85
1 AccB 1.92 5.77 1 1 1 1 156 16.7 4.65
2 AtpD 1.71 4.78 1 2 2 2 460 50.3 5.01
2 KatG 1.67 3.31 1 3 3 3 726 80 5.31
3 RpsD 1.63 4.37 1 1 1 1 206 23.5 10.05
2 PpiD 1.63 1.44 1 1 1 1 623 68.1 5.07
2 TypA 1.62 1.81 1 1 1 1 607 67.3 5.33
3 MalE 1.61 2.53 1 1 1 1 396 43.4 5.71
2 FabZ 1.61 5.3 1 1 1 1 151 17 7.39
1 AtpD 0.00 2.39 1 1 1 1 460 50.3 5.01
1 SecD 0.00 5.53 1 1 1 1 615 66.6 8.60
1 YeaH 0.00 4.97 1 1 1 1 644 74.4 5.85
3 AceF 0 1.43 1 1 1 1 630 66.1 5.17
3 RplC 0 8.61 1 1 1 1 209 22.2 9.91
2 RmlA1 0 2.39 1 1 1 1 293 32.7 5.55
2 YafC 0 3.62 1 1 1 1 304 33.8 7.4
2 YecA 0 6.79 1 1 1 1 221 25 4.59
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Figure 7.1: Raw CD data to show the secondary structure of YecA as a function of tem-
perature (°C)
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(a) Test 1: Chi2 = 0.89 (b) Test 2: Chi2 = 0.87 (c) Test 3: Chi2 = 0.86
(d) Test 4: Chi2 = 0.84 (e) Test 5: Chi2 = 0.87 (f) Test 6: Chi2 = 0.90
(g) Test 7: Chi2 = 0.82 (h) Test 8: Chi2 = 0.83 (i) Test 9: Chi2 = 0.88
(j) Test 10: Chi2 = 0.88
Figure 7.2: 10 independent structural models of YecA compiled using CORAL
191
(a) Dummy atom representation of YecA (DAMAFILT)
(b)Ab initio surface model of YecA (DAMAFILT)
Figure 7.3: Ab initio DAMMIN model of YecA generated from small angle X-ray scat-
tering data
The program DAMMIN implements a method to restore an ab initio, low resolution
shape of randomly oriented particles in solution (e.g., biological macromolecules) from
its small angle X-ray scattering data using dummy molecules (Svergun, 1999). Chi2 =
0.791, calculated by Dr. TimKnowles. Images were rendered using UCSF Chimera (Pet-
tersen et al., 2004).
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